> top > docs > PMC:2674207 > spans > 34269-39907 > annotations

PMC:2674207 / 34269-39907 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
19436703-15591061-86274498 1721-1723 15591061 denotes 27
T7645 1721-1723 15591061 denotes 27

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T11309 0-3 DT denotes The
T11310 4-14 JJ denotes Inhibitory
T11311 15-21 NN denotes Effect
T11312 22-24 IN denotes of
T11313 25-40 NN denotes Corticosteroids
T11314 41-43 IN denotes on
T11315 44-50 NN denotes GATA-3
T11316 51-58 JJ denotes Nuclear
T11317 59-71 NN denotes Localization
T11318 72-74 IN denotes in
T11319 75-82 JJ denotes Primary
T11320 83-84 NN denotes T
T11321 85-96 NN denotes Lymphocytes
T11322 97-99 NNP denotes Ex
T11323 100-104 NNP denotes Vivo
T11324 105-108 CC denotes and
T11325 109-111 IN denotes In
T11326 112-116 FW denotes Vivo
T11327 117-126 NN denotes Treatment
T11328 127-131 IN denotes with
T11329 132-134 NN denotes FP
T11330 135-137 FW denotes ex
T11331 138-142 FW denotes vivo
T11332 143-155 VB denotes demonstrated
T11333 156-157 DT denotes a
T11334 158-181 JJ denotes concentration-dependent
T11335 182-190 NN denotes decrease
T11336 191-193 IN denotes in
T11337 194-197 DT denotes the
T11338 198-204 JJ denotes direct
T11339 205-216 NN denotes interaction
T11340 217-224 IN denotes between
T11341 225-239 NN denotes phospho-GATA-3
T11342 240-243 CC denotes and
T11343 244-254 NN denotes importin-α
T11344 255-257 IN denotes in
T11345 258-263 NN denotes PBMCs
T11346 264-268 IN denotes from
T11347 269-277 NN denotes patients
T11348 278-282 IN denotes with
T11349 283-289 NN denotes asthma
T11350 290-291 -LRB- denotes (
T11351 291-297 NN denotes Figure
T11352 298-300 NN denotes 6A
T11353 301-304 CC denotes and
T11354 305-307 NN denotes 6B
T11355 307-308 -RRB- denotes )
T11356 308-309 -COMMA- denotes ,
T11357 310-315 WDT denotes which
T11358 316-319 VB denotes was
T11359 320-333 RB denotes significantly
T11360 334-343 VB denotes inhibited
T11361 344-346 IN denotes at
T11362 347-352 CD denotes 10−12
T11363 353-354 NN denotes M
T11364 355-357 NN denotes FP
T11365 358-359 -LRB- denotes (
T11366 359-360 NN denotes p
T11367 360-361 JJ denotes <
T11368 361-366 CD denotes 0.001
T11369 366-367 -COMMA- denotes ,
T11370 368-373 NN denotes ANOVA
T11371 374-377 CC denotes and
T11372 378-390 NNP denotes Newman-Keuls
T11373 391-395 NN denotes test
T11374 395-396 -RRB- denotes )
T11375 397-400 CC denotes and
T11376 401-411 RB denotes completely
T11377 412-422 VB denotes attenuated
T11378 423-425 IN denotes by
T11379 426-430 CD denotes 10−8
T11380 431-432 NN denotes M
T11381 433-435 NN denotes FP
T11382 436-437 -LRB- denotes (
T11383 437-438 NN denotes p
T11384 438-439 JJ denotes <
T11385 439-444 CD denotes 0.001
T11386 444-445 -COMMA- denotes ,
T11387 446-451 NN denotes ANOVA
T11388 452-455 CC denotes and
T11389 456-468 NNP denotes Newman-Keuls
T11390 469-473 NN denotes test
T11391 473-474 -RRB- denotes )
T11392 1425-1428 PRP-DOLLAR- denotes Our
T11393 1429-1437 JJ denotes previous
T11394 1438-1439 NN denotes T
T11395 1440-1444 NN denotes cell
T11396 1445-1449 NN denotes line
T11397 1450-1457 NN denotes studies
T11398 1458-1467 VB denotes indicated
T11399 1468-1472 IN denotes that
T11400 1473-1478 CD denotes 10−12
T11401 1479-1480 NN denotes M
T11402 1481-1483 NN denotes FP
T11403 1484-1494 VB denotes suppresses
T11404 1495-1499 NN denotes IL-4
T11405 1500-1503 CC denotes and
T11406 1504-1506 CD denotes -5
T11407 1507-1511 NN denotes gene
T11408 1512-1522 NN denotes expression
T11409 1523-1526 CC denotes and
T11410 1527-1537 VB denotes attenuated
T11411 1538-1541 DT denotes the
T11412 1542-1553 NN denotes interaction
T11413 1554-1556 IN denotes of
T11414 1557-1563 NN denotes GATA-3
T11415 1564-1568 IN denotes with
T11416 1569-1579 NN denotes importin-α
T11417 1580-1581 -LRB- denotes (
T11418 1581-1584 VB denotes see
T11419 1585-1592 NN denotes Figures
T11420 1593-1595 NN denotes 1D
T11421 1596-1599 CC denotes and
T11422 1600-1601 CD denotes 2
T11423 1601-1602 -RRB- denotes )
T11424 1604-1608 DT denotes This
T11425 1609-1622 NN denotes concentration
T11426 1623-1625 VB denotes is
T11427 1626-1631 JJ denotes close
T11428 1632-1634 TO denotes to
T11429 1635-1639 JJ denotes peak
T11430 1640-1646 NN denotes plasma
T11431 1647-1653 NN denotes levels
T11432 1654-1662 VB denotes obtained
T11433 1663-1667 IN denotes from
T11434 1668-1677 JJ denotes asthmatic
T11435 1678-1686 NN denotes patients
T11436 1687-1694 VB denotes treated
T11437 1695-1699 IN denotes with
T11438 1700-1707 VB denotes inhaled
T11439 1708-1710 NN denotes FP
T11440 1711-1712 -LRB- denotes (
T11441 1712-1715 CD denotes 500
T11442 1716-1718 NN denotes µg
T11443 1718-1719 -RRB- denotes )
T11444 1720-1721 -LRB- denotes [
T11445 1721-1723 CD denotes 27
T11446 1723-1724 -RRB- denotes ]
T11447 1726-1733 VB denotes Inhaled
T11448 1734-1736 NN denotes FP
T11449 1737-1738 -LRB- denotes (
T11450 1738-1741 CD denotes 500
T11451 1742-1744 NN denotes µg
T11452 1744-1745 -RRB- denotes )
T11453 1746-1755 NN denotes treatment
T11454 1756-1758 IN denotes of
T11455 1759-1764 CD denotes seven
T11456 1765-1778 JJ denotes steroid-naive
T11457 1779-1785 NN denotes asthma
T11458 1786-1794 NN denotes patients
T11459 1795-1808 RB denotes significantly
T11460 1809-1816 VB denotes reduced
T11461 1817-1834 NN denotes GATA-3–importin-α
T11462 1835-1846 NN denotes interaction
T11463 1847-1849 FW denotes in
T11464 1850-1854 FW denotes vivo
T11465 1855-1857 IN denotes in
T11466 1858-1859 DT denotes a
T11467 1860-1874 JJ denotes time-dependent
T11468 1875-1881 NN denotes manner
T11469 1883-1887 DT denotes This
T11470 1888-1896 VB denotes produced
T11471 1897-1898 DT denotes a
T11472 1899-1900 JJ denotes >
T11473 1900-1902 CD denotes 90
T11474 1902-1903 NN denotes %
T11475 1904-1912 NN denotes decrease
T11476 1913-1915 IN denotes in
T11477 1916-1933 NN denotes GATA-3–importin-α
T11478 1934-1945 NN denotes association
T11479 1946-1948 IN denotes at
T11480 1949-1950 CD denotes 2
T11481 1951-1952 NN denotes h
T11482 1953-1954 -LRB- denotes (
T11483 1954-1960 NN denotes median
T11484 1961-1962 -LRB- denotes [
T11485 1962-1964 CD denotes 95
T11486 1964-1965 NN denotes %
T11487 1966-1968 NN denotes CI
T11488 1968-1969 -RRB- denotes ]
T11489 1969-1970 -COMMA- denotes ,
T11490 1971-1977 CD denotes 13,494
T11491 1978-1979 -LRB- denotes [
T11492 1979-1991 CD denotes 6,828–17,829
T11493 1991-1992 -RRB- denotes ]
T11494 1993-1999 IN denotes versus
T11495 2000-2003 CD denotes 879
T11496 2004-2005 -LRB- denotes [
T11497 2005-2014 CD denotes 597–1,165
T11498 2014-2015 -RRB- denotes ]
T11499 2015-2016 -COLON- denotes ;
T11500 2017-2018 NN denotes p
T11501 2018-2019 SYM denotes <
T11502 2019-2023 CD denotes 0.05
T11503 2024-2032 NNP denotes Friedman
T11504 2032-2034 POS denotes 's
T11505 2035-2043 NN denotes analysis
T11506 2043-2044 -RRB- denotes )
T11507 2046-2053 RB denotes However
T11508 2053-2054 -COMMA- denotes ,
T11509 2055-2059 DT denotes this
T11510 2060-2063 VB denotes did
T11511 2064-2067 RB denotes not
T11512 2068-2073 VB denotes reach
T11513 2074-2086 NN denotes significance
T11514 2087-2092 VB denotes using
T11515 2093-2101 NNP denotes Wilcoxon
T11516 2101-2103 POS denotes 's
T11517 2104-2113 JJ denotes post-test
T11518 2114-2122 NN denotes analysis
T11519 2123-2124 -LRB- denotes (
T11520 2124-2132 NN denotes W = 6.00
T11521 2132-2133 -RRB- denotes )
T11522 2134-2142 RB denotes probably
T11523 2143-2146 JJ denotes due
T11524 2147-2149 TO denotes to
T11525 2150-2153 JJ denotes low
T11526 2154-2161 NN denotes numbers
T11527 2162-2164 IN denotes of
T11528 2165-2177 NN denotes participants
T11529 2179-2186 JJ denotes Similar
T11530 2187-2194 NN denotes results
T11531 2195-2199 VB denotes were
T11532 2200-2208 VB denotes observed
T11533 2209-2213 WRB denotes when
T11534 2214-2231 NN denotes GATA-3–importin-α
T11535 2232-2243 NN denotes association
T11536 2244-2247 VB denotes was
T11537 2248-2256 VB denotes measured
T11538 2257-2258 -LRB- denotes (
T11539 2258-2264 NN denotes Figure
T11540 2265-2267 NN denotes 6C
T11541 2268-2271 CC denotes and
T11542 2272-2274 NN denotes 6D
T11543 2274-2275 -RRB- denotes )
T11544 2277-2280 DT denotes The
T11545 2281-2286 JJ denotes lower
T11546 2287-2291 NN denotes dose
T11547 2292-2294 IN denotes of
T11548 2295-2297 NN denotes FP
T11549 2298-2299 -LRB- denotes (
T11550 2299-2302 CD denotes 100
T11551 2303-2305 NN denotes µg
T11552 2305-2306 -RRB- denotes )
T11553 2307-2310 VB denotes was
T11554 2311-2314 RB denotes not
T11555 2315-2324 JJ denotes effective
T11556 2326-2329 DT denotes The
T11557 2330-2340 JJ denotes attenuated
T11558 2341-2352 NN denotes interaction
T11559 2353-2355 IN denotes of
T11560 2356-2362 NN denotes GATA-3
T11561 2363-2366 VB denotes did
T11562 2367-2370 RB denotes not
T11563 2371-2377 VB denotes result
T11564 2378-2382 IN denotes from
T11565 2383-2386 DT denotes the
T11566 2387-2396 JJ denotes defective
T11567 2397-2406 NN denotes recycling
T11568 2407-2409 IN denotes of
T11569 2410-2420 NN denotes importin-α
T11570 2420-2421 -COMMA- denotes ,
T11571 2422-2424 IN denotes as
T11572 2425-2426 DT denotes a
T11573 2427-2438 JJ denotes significant
T11574 2439-2447 NN denotes decrease
T11575 2448-2450 IN denotes in
T11576 2451-2454 DT denotes the
T11577 2455-2464 NN denotes abundance
T11578 2465-2467 IN denotes of
T11579 2468-2478 NN denotes importin-α
T11580 2479-2481 IN denotes in
T11581 2482-2485 DT denotes the
T11582 2486-2497 JJ denotes cytoplasmic
T11583 2498-2502 NN denotes pool
T11584 2503-2506 VB denotes was
T11585 2507-2510 RB denotes not
T11586 2511-2519 VB denotes detected
T11587 2520-2521 -LRB- denotes (
T11588 2521-2527 NN denotes Figure
T11589 2528-2530 NN denotes 6E
T11590 2530-2531 -RRB- denotes )
T11591 2533-2535 PRP denotes We
T11592 2536-2543 RB denotes further
T11593 2544-2552 VB denotes examined
T11594 2553-2560 IN denotes whether
T11595 2561-2568 VB denotes inhaled
T11596 2569-2571 NN denotes FP
T11597 2572-2577 MD denotes could
T11598 2578-2584 VB denotes affect
T11599 2585-2593 JJ denotes cellular
T11600 2594-2606 NN denotes localization
T11601 2607-2609 IN denotes of
T11602 2610-2616 NN denotes GATA-3
T11603 2617-2619 IN denotes in
T11604 2620-2630 JJ denotes peripheral
T11605 2631-2636 NN denotes blood
T11606 2637-2638 NN denotes T
T11607 2639-2644 NN denotes cells
T11608 2646-2655 NN denotes Treatment
T11609 2656-2660 IN denotes with
T11610 2661-2668 VB denotes inhaled
T11611 2669-2671 NN denotes FP
T11612 2672-2673 -LRB- denotes (
T11613 2673-2676 CD denotes 500
T11614 2677-2679 NN denotes µg
T11615 2679-2680 -RRB- denotes )
T11616 2681-2684 IN denotes for
T11617 2685-2686 CD denotes 2
T11618 2687-2688 NN denotes h
T11619 2689-2702 RB denotes significantly
T11620 2703-2712 VB denotes increased
T11621 2713-2715 NN denotes GR
T11622 2716-2723 JJ denotes nuclear
T11623 2724-2737 NN denotes translocation
T11624 2738-2739 -LRB- denotes (
T11625 2739-2745 NN denotes Figure
T11626 2746-2748 NN denotes 7A
T11627 2748-2749 -RRB- denotes )
T11628 2750-2753 CC denotes and
T11629 2754-2767 RB denotes concomitantly
T11630 2768-2777 VB denotes decreased
T11631 2778-2781 DT denotes the
T11632 2782-2788 NN denotes number
T11633 2789-2791 IN denotes of
T11634 2792-2799 JJ denotes nuclear
T11635 2800-2806 NN denotes GATA-3
T11636 2807-2821 JJ denotes immunoreactive
T11637 2822-2832 JJ denotes peripheral
T11638 2833-2838 NN denotes blood
T11639 2839-2840 NN denotes T
T11640 2841-2846 NN denotes cells
T11641 2847-2848 -LRB- denotes (
T11642 2848-2850 CD denotes 37
T11643 2850-2851 NN denotes %
T11644 2851-2855 CD denotes ±4.2
T11645 2855-2856 NN denotes %
T11646 2857-2863 IN denotes versus
T11647 2864-2868 CD denotes 58.2
T11648 2868-2869 NN denotes %
T11649 2869-2874 CD denotes ±4.95
T11650 2874-2875 NN denotes %
T11651 2875-2876 -COMMA- denotes ,
T11652 2877-2886 NN denotes p = 0.016
T11653 2886-2887 -COMMA- denotes ,
T11654 2888-2896 NN denotes W = 28.0
T11655 2896-2897 -COMMA- denotes ,
T11656 2898-2906 NNP denotes Wilcoxon
T11657 2906-2908 POS denotes 's
T11658 2909-2913 NN denotes rank
T11659 2914-2918 NN denotes test
T11660 2918-2919 -RRB- denotes )
T11661 2920-2928 VB denotes compared
T11662 2929-2933 IN denotes with
T11663 2934-2941 NN denotes placebo
T11664 2942-2944 IN denotes as
T11665 2945-2953 VB denotes measured
T11666 2954-2956 IN denotes by
T11667 2957-2976 NN denotes immunocytochemistry
T11668 2977-2978 -LRB- denotes (
T11669 2978-2984 NN denotes Figure
T11670 2985-2987 NN denotes 7A
T11671 2988-2991 CC denotes and
T11672 2992-2994 NN denotes 7B
T11673 2994-2995 -RRB- denotes )
T11674 2997-3001 DT denotes This
T11675 3002-3005 VB denotes was
T11676 3006-3015 VB denotes confirmed
T11677 3016-3018 IN denotes by
T11678 3019-3026 JJ denotes Western
T11679 3027-3035 NN denotes blotting
T11680 3035-3036 -COMMA- denotes ,
T11681 3037-3042 WDT denotes which
T11682 3043-3047 RB denotes also
T11683 3048-3057 VB denotes indicated
T11684 3058-3062 IN denotes that
T11685 3063-3067 DT denotes this
T11686 3068-3074 NN denotes effect
T11687 3075-3078 VB denotes was
T11688 3079-3083 CC denotes both
T11689 3084-3089 NN denotes time-
T11690 3090-3093 CC denotes and
T11691 3094-3108 JJ denotes dose-dependent
T11692 3109-3110 -LRB- denotes (
T11693 3110-3116 NN denotes Figure
T11694 3117-3119 NN denotes 7C
T11695 3120-3123 CC denotes and
T11696 3124-3126 NN denotes 7D
T11697 3126-3127 -RRB- denotes )
T11698 3129-3133 RB denotes Thus
T11699 3133-3134 -COMMA- denotes ,
T11700 3135-3142 VB denotes inhaled
T11701 3143-3145 NN denotes FP
T11702 3146-3147 -LRB- denotes (
T11703 3147-3150 CD denotes 500
T11704 3151-3153 NN denotes µg
T11705 3153-3154 -RRB- denotes )
T11706 3155-3162 VB denotes induced
T11707 3163-3174 JJ denotes significant
T11708 3175-3179 NN denotes loss
T11709 3180-3182 IN denotes in
T11710 3183-3190 JJ denotes nuclear
T11711 3191-3197 NN denotes GATA-3
T11712 3198-3200 IN denotes at
T11713 3201-3202 CD denotes 2
T11714 3203-3204 NN denotes h
T11715 3205-3206 -LRB- denotes (
T11716 3206-3212 NN denotes median
T11717 3213-3214 -LRB- denotes [
T11718 3214-3216 CD denotes 95
T11719 3216-3217 NN denotes %
T11720 3218-3220 NN denotes CI
T11721 3220-3221 -RRB- denotes ]
T11722 3221-3222 -COMMA- denotes ,
T11723 3223-3227 CD denotes 0.40
T11724 3228-3229 -LRB- denotes [
T11725 3229-3238 CD denotes 0.27–0.53
T11726 3238-3239 -RRB- denotes ]
T11727 3240-3246 IN denotes versus
T11728 3247-3251 CD denotes 0.14
T11729 3252-3253 -LRB- denotes [
T11730 3253-3262 CD denotes 0.11–0.19
T11731 3262-3263 -RRB- denotes ]
T11732 3263-3264 -COMMA- denotes ,
T11733 3265-3266 NN denotes p
T11734 3266-3267 SYM denotes <
T11735 3267-3271 CD denotes 0.05
T11736 3271-3272 -COMMA- denotes ,
T11737 3273-3282 NN denotes W = 21.00
T11738 3282-3283 -COMMA- denotes ,
T11739 3284-3292 NNP denotes Wilcoxon
T11740 3292-3294 POS denotes 's
T11741 3295-3299 NN denotes rank
T11742 3300-3304 NN denotes test
T11743 3304-3305 -RRB- denotes )
T11744 3306-3307 -LRB- denotes (
T11745 3307-3313 NN denotes Figure
T11746 3314-3316 NN denotes 7C
T11747 3316-3317 -RRB- denotes )
T11748 3318-3321 CC denotes and
T11749 3322-3333 JJ denotes cytoplasmic
T11750 3334-3340 NN denotes GATA-3
T11751 3341-3347 NN denotes levels
T11752 3348-3352 VB denotes were
T11753 3353-3361 VB denotes enhanced
T11754 3362-3364 IN denotes by
T11755 3365-3372 VB denotes inhaled
T11756 3373-3375 NN denotes FP
T11757 3376-3378 IN denotes in
T11758 3379-3380 DT denotes a
T11759 3381-3395 JJ denotes dose-dependent
T11760 3396-3402 NN denotes manner
T11761 3403-3404 -LRB- denotes (
T11762 3404-3410 NN denotes median
T11763 3411-3412 -LRB- denotes [
T11764 3412-3414 CD denotes 95
T11765 3414-3415 NN denotes %
T11766 3416-3418 NN denotes CI
T11767 3418-3419 -RRB- denotes ]
T11768 3419-3420 -COMMA- denotes ,
T11769 3421-3427 CD denotes 0.0032
T11770 3428-3429 -LRB- denotes [
T11771 3429-3442 CD denotes 0.0026–0.0039
T11772 3442-3443 -RRB- denotes ]
T11773 3444-3450 IN denotes versus
T11774 3451-3456 CD denotes 0.658
T11775 3457-3458 -LRB- denotes [
T11776 3458-3469 CD denotes 0.592–0.720
T11777 3469-3470 -RRB- denotes ]
T11778 3470-3471 -COMMA- denotes ,
T11779 3472-3473 NN denotes p
T11780 3473-3474 SYM denotes <
T11781 3474-3478 CD denotes 0.05
T11782 3478-3479 -COMMA- denotes ,
T11783 3480-3490 NN denotes W = −21.00
T11784 3490-3491 -COMMA- denotes ,
T11785 3492-3500 NNP denotes Wilcoxon
T11786 3500-3502 POS denotes 's
T11787 3503-3507 NN denotes rank
T11788 3508-3512 NN denotes test
T11789 3512-3513 -RRB- denotes )
T11790 3514-3515 -LRB- denotes (
T11791 3515-3521 NN denotes Figure
T11792 3522-3524 NN denotes 7D
T11793 3524-3525 -RRB- denotes )
T11794 3527-3529 IN denotes In
T11795 3530-3538 NN denotes addition
T11796 3538-3539 -COMMA- denotes ,
T11797 3540-3542 NN denotes FP
T11798 3543-3544 -LRB- denotes (
T11799 3544-3547 CD denotes 500
T11800 3548-3550 NN denotes µg
T11801 3550-3551 -RRB- denotes )
T11802 3552-3561 VB denotes inhibited
T11803 3562-3565 NN denotes p38
T11804 3566-3570 NN denotes MAPK
T11805 3571-3586 NN denotes phosphorylation
T11806 3587-3589 IN denotes in
T11807 3590-3597 JJ denotes primary
T11808 3598-3599 NN denotes T
T11809 3600-3605 NN denotes cells
T11810 3606-3608 FW denotes in
T11811 3609-3613 FW denotes vivo
T11812 3614-3616 IN denotes at
T11813 3617-3618 CD denotes 2
T11814 3619-3620 NN denotes h
T11815 3621-3623 IN denotes in
T11816 3624-3631 NN denotes samples
T11817 3632-3636 IN denotes from
T11818 3637-3640 CD denotes two
T11819 3641-3649 NN denotes patients
T11820 3650-3651 -LRB- denotes (
T11821 3651-3657 NN denotes Figure
T11822 3658-3660 NN denotes 7E
T11823 3660-3661 -RRB- denotes )
T11824 5149-5154 VB denotes Taken
T11825 5155-5163 RB denotes together
T11826 5163-5164 -COMMA- denotes ,
T11827 5165-5168 PRP-DOLLAR- denotes our
T11828 5169-5173 NN denotes data
T11829 5174-5181 VB denotes suggest
T11830 5182-5186 IN denotes that
T11831 5187-5194 VB denotes inhaled
T11832 5195-5197 NN denotes FP
T11833 5198-5205 VB denotes reduces
T11834 5206-5213 JJ denotes nuclear
T11835 5214-5226 NN denotes localization
T11836 5227-5229 IN denotes of
T11837 5230-5236 NN denotes GATA-3
T11838 5237-5239 FW denotes in
T11839 5240-5244 FW denotes vivo
T11840 5245-5247 IN denotes by
T11841 5248-5255 RB denotes acutely
T11842 5256-5266 VB denotes inhibiting
T11843 5267-5290 NN denotes phospho-GATA-3–importin
T11844 5291-5302 NN denotes association
T11845 5304-5308 DT denotes This
T11846 5309-5315 NN denotes effect
T11847 5316-5319 MD denotes may
T11848 5320-5322 VB denotes be
T11849 5323-5329 JJ denotes direct
T11850 5329-5330 -COMMA- denotes ,
T11851 5331-5338 IN denotes through
T11852 5339-5350 NN denotes competition
T11853 5351-5354 IN denotes for
T11854 5355-5365 JJ denotes importin-α
T11855 5366-5368 CC denotes or
T11856 5369-5379 VB denotes associated
T11857 5380-5389 NN denotes molecules
T11858 5389-5390 -COMMA- denotes ,
T11859 5391-5393 CC denotes or
T11860 5394-5403 JJ denotes secondary
T11861 5404-5406 TO denotes to
T11862 5407-5409 DT denotes an
T11863 5410-5416 NN denotes effect
T11864 5417-5419 IN denotes on
T11865 5420-5423 NN denotes p38
T11866 5424-5437 JJ denotes MAPK-mediated
T11867 5438-5444 NN denotes GATA-3
T11868 5445-5460 NN denotes phosphorylation
T11869 5461-5464 IN denotes via
T11870 5465-5470 JJ denotes rapid
T11871 5471-5480 NN denotes induction
T11872 5481-5483 IN denotes of
T11873 5484-5489 NN denotes MKP-1
T11874 5491-5494 DT denotes The
T11875 5495-5506 NN denotes combination
T11876 5507-5509 IN denotes of
T11877 5510-5515 DT denotes these
T11878 5516-5519 CD denotes two
T11879 5520-5531 VB denotes interacting
T11880 5532-5539 NN denotes effects
T11881 5540-5543 MD denotes can
T11882 5544-5550 VB denotes result
T11883 5551-5553 IN denotes in
T11884 5554-5562 JJ denotes complete
T11885 5563-5574 NN denotes suppression
T11886 5575-5577 IN denotes of
T11887 5578-5584 NN denotes GATA-3
T11888 5585-5592 JJ denotes nuclear
T11889 5593-5599 NN denotes import
T11890 5600-5603 CC denotes and
T11891 5604-5608 RB denotes thus
T11892 5609-5612 NN denotes Th2
T11893 5613-5621 NN denotes cytokine
T11894 5622-5626 NN denotes gene
T11895 5627-5637 NN denotes expression
T19291 520-531 NN denotes Fluticasone
T19292 532-542 NN denotes propionate
T19293 543-550 VB denotes impairs
T19294 551-557 NN denotes GATA-3
T19295 558-569 NN denotes interaction
T19296 570-574 IN denotes with
T19297 575-585 NN denotes importin-α
T19298 586-589 CC denotes and
T19299 590-596 NN denotes GATA-3
T19300 597-604 JJ denotes nuclear
T19301 605-617 NN denotes localization
T19302 618-620 FW denotes in
T19303 621-625 FW denotes vivo
T19304 626-629 CC denotes and
T19305 630-632 FW denotes ex
T19306 633-637 FW denotes vivo
T19307 639-640 -LRB- denotes (
T19308 640-641 NN denotes A
T19309 642-645 CC denotes and
T19310 646-647 NN denotes B
T19311 647-648 -RRB- denotes )
T19312 649-671 NN denotes Co-immunoprecipitation
T19313 672-680 NN denotes analysis
T19314 681-683 IN denotes of
T19315 684-689 NN denotes PBMCs
T19316 690-694 IN denotes from
T19317 695-708 JJ denotes steroid-naïve
T19318 709-715 NN denotes asthma
T19319 716-724 NN denotes patients
T19320 725-732 VB denotes treated
T19321 733-737 IN denotes with
T19322 738-740 NN denotes FP
T19323 741-743 FW denotes in
T19324 744-749 FW denotes vitro
T19325 750-762 VB denotes demonstrated
T19326 763-771 JJ denotes impaired
T19327 772-783 NN denotes interaction
T19328 784-791 IN denotes between
T19329 792-798 NN denotes GATA-3
T19330 799-802 CC denotes and
T19331 803-813 NN denotes importin-α
T19332 814-822 VB denotes measured
T19333 823-825 IN denotes at
T19334 826-828 CD denotes 60
T19335 829-832 NN denotes min
T19336 834-838 DT denotes Each
T19337 839-842 NN denotes bar
T19338 843-853 VB denotes represents
T19339 854-857 DT denotes the
T19340 858-866 NN denotes mean±SEM
T19341 867-869 IN denotes of
T19342 870-872 IN denotes at
T19343 873-878 JJ denotes least
T19344 879-884 CD denotes three
T19345 885-896 JJ denotes independent
T19346 897-908 NN denotes experiments
T19347 908-909 -COLON- denotes ;
T19348 910-913 SYM denotes ***
T19349 914-915 NN denotes p
T19350 915-916 SYM denotes <
T19351 916-921 CD denotes 0.001
T19352 922-930 VB denotes compared
T19353 931-935 IN denotes with
T19354 936-943 NN denotes control
T19355 944-946 IN denotes as
T19356 947-957 VB denotes determined
T19357 958-960 IN denotes by
T19358 961-979 JJ denotes ANOVA/Newman-Keuls
T19359 980-989 NN denotes analysis.
T19360 990-991 -LRB- denotes (
T19361 991-992 NN denotes C
T19362 993-996 CC denotes and
T19363 997-998 NN denotes D
T19364 998-999 -RRB- denotes )
T19365 1000-1022 NN denotes Co-immunoprecipitation
T19366 1023-1031 NN denotes analyses
T19367 1032-1034 IN denotes of
T19368 1035-1040 NN denotes PBMCs
T19369 1041-1045 IN denotes from
T19370 1046-1059 JJ denotes steroid-naïve
T19371 1060-1066 NN denotes asthma
T19372 1067-1075 NN denotes patients
T19373 1076-1083 VB denotes treated
T19374 1084-1088 IN denotes with
T19375 1089-1096 VB denotes inhaled
T19376 1097-1099 NN denotes FP
T19377 1100-1101 -LRB- denotes (
T19378 1101-1104 CD denotes 500
T19379 1105-1107 NN denotes µg
T19380 1108-1111 IN denotes via
T19381 1112-1113 DT denotes a
T19382 1114-1120 NN denotes spacer
T19383 1120-1121 -RRB- denotes )
T19384 1122-1124 FW denotes in
T19385 1125-1129 FW denotes vivo
T19386 1130-1142 VB denotes demonstrated
T19387 1143-1152 VB denotes decreased
T19388 1153-1164 NN denotes association
T19389 1165-1172 IN denotes between
T19390 1173-1179 NN denotes GATA-3
T19391 1180-1183 CC denotes and
T19392 1184-1194 NN denotes importin-α
T19393 1196-1199 DT denotes The
T19394 1200-1210 JJ denotes individual
T19395 1211-1217 NN denotes values
T19396 1218-1221 IN denotes for
T19397 1222-1226 DT denotes each
T19398 1227-1236 NN denotes treatment
T19399 1237-1240 VB denotes are
T19400 1241-1250 VB denotes presented
T19401 1251-1263 NN denotes graphically.
T19402 1264-1265 -LRB- denotes (
T19403 1265-1266 NN denotes E
T19404 1266-1267 -RRB- denotes )
T19405 1268-1282 JJ denotes Representative
T19406 1283-1290 JJ denotes Western
T19407 1291-1295 NN denotes blot
T19408 1296-1303 VB denotes showing
T19409 1304-1308 IN denotes that
T19410 1309-1319 JJ denotes importin-α
T19411 1320-1330 NN denotes expression
T19412 1331-1334 VB denotes was
T19413 1335-1345 JJ denotes unaffected
T19414 1346-1348 IN denotes by
T19415 1349-1359 NN denotes inhalation
T19416 1360-1362 IN denotes of
T19417 1363-1365 NN denotes FP
T19418 1367-1371 NN denotes Blot
T19419 1372-1374 VB denotes is
T19420 1375-1389 JJ denotes representative
T19421 1390-1392 IN denotes of
T19422 1393-1397 NN denotes gels
T19423 1398-1402 IN denotes from
T19424 1403-1408 CD denotes three
T19425 1409-1421 NN denotes participants
T19732 3707-3714 VB denotes Inhaled
T19733 3715-3726 NN denotes fluticasone
T19734 3727-3737 NN denotes propionate
T19735 3738-3745 VB denotes impairs
T19736 3746-3752 NN denotes GATA-3
T19737 3753-3760 JJ denotes nuclear
T19738 3761-3773 NN denotes localization
T19739 3774-3776 IN denotes in
T19740 3777-3782 NN denotes PBMCs
T19741 3784-3785 -LRB- denotes (
T19742 3785-3786 NN denotes A
T19743 3786-3787 -RRB- denotes )
T19744 3788-3802 JJ denotes Representative
T19745 3803-3822 NN denotes immunocytochemistry
T19746 3823-3825 IN denotes of
T19747 3826-3833 VB denotes showing
T19748 3834-3837 DT denotes the
T19749 3838-3844 NN denotes effect
T19750 3845-3847 IN denotes of
T19751 3848-3855 VB denotes inhaled
T19752 3856-3858 NN denotes FP
T19753 3859-3860 -LRB- denotes (
T19754 3860-3863 CD denotes 500
T19755 3864-3866 NN denotes µg
T19756 3866-3867 -RRB- denotes )
T19757 3868-3870 IN denotes on
T19758 3871-3873 NN denotes GR
T19759 3874-3877 CC denotes and
T19760 3878-3884 NN denotes GATA-3
T19761 3885-3892 JJ denotes nuclear
T19762 3893-3906 NN denotes localisation.
T19763 3907-3908 -LRB- denotes (
T19764 3908-3909 NN denotes B
T19765 3909-3910 -RRB- denotes )
T19766 3911-3918 JJ denotes Nuclear
T19767 3919-3925 NN denotes GATA-3
T19768 3926-3942 NN denotes immunoreactivity
T19769 3943-3945 IN denotes in
T19770 3946-3951 NN denotes PBMCs
T19771 3952-3956 IN denotes from
T19772 3957-3962 CD denotes seven
T19773 3963-3976 JJ denotes steroid-naïve
T19774 3977-3983 NN denotes asthma
T19775 3984-3992 NN denotes patients
T19776 3993-3994 CD denotes 2
T19777 3995-3996 NN denotes h
T19778 3997-4006 VB denotes following
T19779 4007-4014 VB denotes inhaled
T19780 4015-4017 NN denotes FP
T19781 4018-4027 NN denotes treatment
T19782 4028-4029 -LRB- denotes (
T19783 4029-4032 CD denotes 100
T19784 4033-4035 CC denotes or
T19785 4036-4039 CD denotes 500
T19786 4040-4042 NN denotes µg
T19787 4043-4046 IN denotes via
T19788 4047-4053 NN denotes spacer
T19789 4053-4054 -RRB- denotes )
T19790 4056-4059 DT denotes The
T19791 4060-4066 JJ denotes median
T19792 4067-4070 CC denotes and
T19793 4071-4084 JJ denotes interquartile
T19794 4085-4091 NN denotes ranges
T19795 4092-4095 IN denotes for
T19796 4096-4100 DT denotes each
T19797 4101-4110 NN denotes treatment
T19798 4111-4114 VB denotes are
T19799 4115-4124 VB denotes presented
T19800 4125-4127 IN denotes as
T19801 4128-4129 DT denotes a
T19802 4130-4146 NN denotes box-and-whiskers
T19803 4147-4151 NN denotes plot
T19804 4152-4153 -LRB- denotes (
T19805 4153-4158 NN denotes n = 7
T19806 4158-4159 -RRB- denotes )
T19807 4159-4160 -COLON- denotes ;
T19808 4161-4162 SYM denotes *
T19809 4163-4164 NN denotes p
T19810 4164-4165 SYM denotes <
T19811 4165-4169 CD denotes 0.05
T19812 4170-4178 NNP denotes Wilcoxon
T19813 4178-4180 POS denotes 's
T19814 4181-4185 NN denotes rank
T19815 4186-4190 NN denotes test
T19816 4191-4199 VB denotes compared
T19817 4200-4204 IN denotes with
T19818 4205-4213 NN denotes placebo.
T19819 4214-4215 -LRB- denotes (
T19820 4215-4216 NN denotes C
T19821 4216-4217 -RRB- denotes )
T19822 4218-4232 NN denotes Immunoblotting
T19823 4233-4241 NN denotes analyses
T19824 4242-4244 IN denotes of
T19825 4245-4250 NN denotes PBMCs
T19826 4251-4263 VB denotes demonstrated
T19827 4264-4265 DT denotes a
T19828 4266-4280 JJ denotes time-dependent
T19829 4281-4289 NN denotes decrease
T19830 4290-4292 IN denotes in
T19831 4293-4300 JJ denotes nuclear
T19832 4301-4311 NN denotes expression
T19833 4312-4314 IN denotes of
T19834 4315-4321 NN denotes GATA-3
T19835 4321-4322 -COMMA- denotes ,
T19836 4323-4326 CC denotes and
T19837 4327-4336 VB denotes increased
T19838 4337-4348 JJ denotes cytoplasmic
T19839 4349-4355 NN denotes GATA-3
T19840 4356-4366 NN denotes expression
T19841 4367-4372 IN denotes after
T19842 4373-4383 NN denotes inhalation
T19843 4384-4386 IN denotes of
T19844 4387-4390 NNP denotes FP.
T19845 4391-4392 -LRB- denotes (
T19846 4392-4393 NN denotes D
T19847 4393-4394 -RRB- denotes )
T19848 4395-4409 NN denotes Immunoblotting
T19849 4410-4418 NN denotes analyses
T19850 4419-4421 IN denotes of
T19851 4422-4427 NN denotes PBMCs
T19852 4428-4440 VB denotes demonstrated
T19853 4441-4442 DT denotes a
T19854 4443-4457 JJ denotes dose-dependent
T19855 4458-4466 NN denotes decrease
T19856 4467-4469 IN denotes in
T19857 4470-4477 JJ denotes nuclear
T19858 4478-4488 NN denotes expression
T19859 4489-4491 IN denotes of
T19860 4492-4498 NN denotes GATA-3
T19861 4498-4499 -COMMA- denotes ,
T19862 4500-4503 CC denotes and
T19863 4504-4513 VB denotes increased
T19864 4514-4525 JJ denotes cytoplasmic
T19865 4526-4532 NN denotes GATA-3
T19866 4533-4543 NN denotes expression
T19867 4544-4545 CD denotes 2
T19868 4546-4547 NN denotes h
T19869 4548-4553 IN denotes after
T19870 4554-4564 NN denotes inhalation
T19871 4565-4567 IN denotes of
T19872 4568-4570 NN denotes FP
T19873 4572-4579 NN denotes Histone
T19874 4580-4582 NN denotes H1
T19875 4583-4586 CC denotes and
T19876 4587-4592 NN denotes MEK-1
T19877 4593-4607 NN denotes immunoblotting
T19878 4608-4617 VB denotes confirmed
T19879 4618-4628 JJ denotes equivalent
T19880 4629-4634 JJ denotes total
T19881 4635-4642 NN denotes protein
T19882 4643-4650 VB denotes loading
T19883 4651-4654 IN denotes for
T19884 4655-4658 DT denotes the
T19885 4659-4666 JJ denotes nuclear
T19886 4667-4670 CC denotes and
T19887 4671-4682 JJ denotes cytoplasmic
T19888 4683-4692 NN denotes fractions
T19889 4693-4705 RB denotes respectively
T19890 4707-4721 NN denotes Quantification
T19891 4722-4724 IN denotes of
T19892 4725-4728 DT denotes the
T19893 4729-4741 NN denotes densitometry
T19894 4742-4746 NN denotes data
T19895 4747-4749 IN denotes in
T19896 4750-4751 -LRB- denotes (
T19897 4751-4752 NN denotes C
T19898 4752-4753 -RRB- denotes )
T19899 4754-4757 CC denotes and
T19900 4758-4759 -LRB- denotes (
T19901 4759-4760 NN denotes D
T19902 4760-4761 -RRB- denotes )
T19903 4762-4764 VB denotes is
T19904 4765-4770 VB denotes shown
T19905 4771-4773 IN denotes as
T19906 4774-4775 DT denotes a
T19907 4776-4792 JJ denotes box-and-whiskers
T19908 4793-4797 NN denotes plot
T19909 4798-4800 IN denotes of
T19910 4801-4808 NN denotes results
T19911 4809-4813 IN denotes from
T19912 4814-4819 NN denotes n = 6
T19913 4820-4832 NN denotes participants
T19914 4833-4836 IN denotes for
T19915 4837-4842 WDT denotes which
T19916 4843-4847 NN denotes data
T19917 4848-4852 VB denotes were
T19918 4853-4863 JJ denotes available.
T19919 4864-4866 NN denotes *p
T19920 4866-4867 SYM denotes <
T19921 4867-4871 CD denotes 0.05
T19922 4872-4880 VB denotes compared
T19923 4881-4883 TO denotes to
T19924 4884-4892 VB denotes control.
T19925 4893-4894 -LRB- denotes (
T19926 4894-4895 NN denotes E
T19927 4895-4896 -RRB- denotes )
T19928 4897-4904 JJ denotes Western
T19929 4905-4909 NN denotes blot
T19930 4910-4918 NN denotes analyses
T19931 4919-4921 IN denotes of
T19932 4922-4927 NN denotes PBMCs
T19933 4928-4940 VB denotes demonstrated
T19934 4941-4942 DT denotes a
T19935 4943-4957 JJ denotes time-dependent
T19936 4958-4966 NN denotes decrease
T19937 4967-4969 IN denotes in
T19938 4970-4974 JJ denotes dual
T19939 4975-4990 NN denotes phosphorylation
T19940 4991-4992 -LRB- denotes (
T19941 4992-5005 CD denotes threonine-180
T19942 5006-5009 CC denotes and
T19943 5010-5022 NN denotes tyrosine-182
T19944 5022-5023 -RRB- denotes )
T19945 5024-5026 IN denotes of
T19946 5027-5030 NN denotes p38
T19947 5031-5035 NN denotes MAPK
T19948 5036-5041 IN denotes after
T19949 5042-5052 NN denotes inhalation
T19950 5053-5055 IN denotes of
T19951 5056-5058 NN denotes FP
T19952 5059-5060 -LRB- denotes (
T19953 5060-5063 CD denotes 500
T19954 5064-5066 NN denotes µg
T19955 5066-5067 -RRB- denotes )
T19956 5069-5072 DT denotes The
T19957 5073-5080 NN denotes results
T19958 5081-5086 VB denotes shown
T19959 5087-5089 IN denotes in
T19960 5090-5091 -LRB- denotes (
T19961 5091-5092 NN denotes E
T19962 5092-5093 -RRB- denotes )
T19963 5094-5097 VB denotes are
T19964 5098-5112 JJ denotes representative
T19965 5113-5115 IN denotes of
T19966 5116-5123 NN denotes samples
T19967 5124-5128 IN denotes from
T19968 5129-5132 CD denotes two
T19969 5133-5145 NN denotes participants
R9645 T11311 T11309 arg1Of Effect,The
R9646 T11311 T11310 arg1Of Effect,Inhibitory
R9647 T11311 T11312 arg1Of Effect,of
R9648 T11311 T11314 arg1Of Effect,on
R9649 T11313 T11312 arg2Of Corticosteroids,of
R9650 T11317 T11314 arg2Of Localization,on
R9651 T11317 T11315 arg1Of Localization,GATA-3
R9652 T11317 T11316 arg1Of Localization,Nuclear
R9653 T11317 T11318 arg1Of Localization,in
R9654 T11317 T11325 arg1Of Localization,In
R9655 T11317 T11326 arg1Of Localization,Vivo
R9656 T11323 T11318 arg2Of Vivo,in
R9657 T11323 T11319 arg1Of Vivo,Primary
R9658 T11323 T11320 arg1Of Vivo,T
R9659 T11323 T11321 arg1Of Vivo,Lymphocytes
R9660 T11323 T11322 arg1Of Vivo,Ex
R9661 T11323 T11324 arg1Of Vivo,and
R9662 T11327 T11328 arg1Of Treatment,with
R9663 T11327 T11332 arg1Of Treatment,demonstrated
R9664 T11329 T11328 arg2Of FP,with
R9665 T11329 T11331 arg1Of FP,vivo
R9666 T11331 T11330 arg1Of vivo,ex
R9667 T11335 T11332 arg2Of decrease,demonstrated
R9668 T11335 T11333 arg1Of decrease,a
R9669 T11335 T11334 arg1Of decrease,concentration-dependent
R9670 T11335 T11336 arg1Of decrease,in
R9671 T11339 T11336 arg2Of interaction,in
R9672 T11339 T11337 arg1Of interaction,the
R9673 T11339 T11338 arg1Of interaction,direct
R9674 T11339 T11340 arg1Of interaction,between
R9675 T11341 T11342 arg1Of phospho-GATA-3,and
R9676 T11342 T11340 arg2Of and,between
R9677 T11342 T11344 arg1Of and,in
R9678 T11342 T11356 arg1Of and,","
R9679 T11342 T11357 arg1Of and,which
R9680 T11342 T11358 arg1Of and,was
R9681 T11342 T11360 arg2Of and,inhibited
R9682 T11342 T11377 arg2Of and,attenuated
R9683 T11343 T11342 arg2Of importin-α,and
R9684 T11345 T11344 arg2Of PBMCs,in
R9685 T11345 T11346 arg1Of PBMCs,from
R9686 T11347 T11346 arg2Of patients,from
R9687 T11347 T11348 arg1Of patients,with
R9688 T11347 T11350 arg1Of patients,(
R9689 T11349 T11348 arg2Of asthma,with
R9690 T11352 T11351 arg1Of 6A,Figure
R9691 T11352 T11353 arg1Of 6A,and
R9692 T11353 T11350 arg2Of and,(
R9693 T11354 T11353 arg2Of 6B,and
R9694 T11355 T11350 arg3Of ),(
R9695 T11360 T11361 arg1Of inhibited,at
R9696 T11360 T11375 arg1Of inhibited,and
R9697 T11362 T11363 arg1Of 10−12,M
R9698 T11364 T11361 arg2Of FP,at
R9699 T11364 T11362 arg1Of FP,10−12
R9700 T11364 T11365 arg1Of FP,(
R9701 T11366 T11365 arg2Of p,(
R9702 T11366 T11367 arg1Of p,<
R9703 T11366 T11369 arg1Of p,","
R9704 T11367 T11368 arg1Of <,0.001
R9705 T11370 T11371 arg1Of ANOVA,and
R9706 T11371 T11369 arg2Of and,","
R9707 T11373 T11371 arg2Of test,and
R9708 T11373 T11372 arg1Of test,Newman-Keuls
R9709 T11374 T11365 arg3Of ),(
R9710 T11375 T11358 arg2Of and,was
R9711 T11375 T11359 arg1Of and,significantly
R9712 T11377 T11375 arg2Of attenuated,and
R9713 T11377 T11376 arg1Of attenuated,completely
R9714 T11379 T11380 arg1Of 10−8,M
R9715 T11381 T11377 arg1Of FP,attenuated
R9716 T11381 T11378 arg2Of FP,by
R9717 T11381 T11379 arg1Of FP,10−8
R9718 T11381 T11382 arg1Of FP,(
R9719 T11383 T11382 arg2Of p,(
R9720 T11383 T11384 arg1Of p,<
R9721 T11383 T11386 arg1Of p,","
R9722 T11384 T11385 arg1Of <,0.001
R9723 T11387 T11388 arg1Of ANOVA,and
R9724 T11388 T11386 arg2Of and,","
R9725 T11390 T11388 arg2Of test,and
R9726 T11390 T11389 arg1Of test,Newman-Keuls
R9727 T11391 T11382 arg3Of ),(
R9728 T11397 T11392 arg1Of studies,Our
R9729 T11397 T11393 arg1Of studies,previous
R9730 T11397 T11394 arg1Of studies,T
R9731 T11397 T11395 arg1Of studies,cell
R9732 T11397 T11396 arg1Of studies,line
R9733 T11397 T11398 arg1Of studies,indicated
R9734 T11400 T11401 arg1Of 10−12,M
R9735 T11402 T11400 arg1Of FP,10−12
R9736 T11402 T11403 arg1Of FP,suppresses
R9737 T11402 T11410 arg1Of FP,attenuated
R9738 T11403 T11409 arg1Of suppresses,and
R9739 T11404 T11405 arg1Of IL-4,and
R9740 T11406 T11405 arg2Of -5,and
R9741 T11408 T11403 arg2Of expression,suppresses
R9742 T11408 T11404 arg1Of expression,IL-4
R9743 T11408 T11406 arg1Of expression,-5
R9744 T11408 T11407 arg1Of expression,gene
R9745 T11409 T11398 arg2Of and,indicated
R9746 T11409 T11399 arg1Of and,that
R9747 T11410 T11409 arg2Of attenuated,and
R9748 T11410 T11417 arg1Of attenuated,(
R9749 T11412 T11410 arg2Of interaction,attenuated
R9750 T11412 T11411 arg1Of interaction,the
R9751 T11412 T11413 arg1Of interaction,of
R9752 T11412 T11415 arg1Of interaction,with
R9753 T11414 T11413 arg2Of GATA-3,of
R9754 T11416 T11415 arg2Of importin-α,with
R9755 T11418 T11417 arg2Of see,(
R9756 T11420 T11421 arg1Of 1D,and
R9757 T11421 T11418 arg2Of and,see
R9758 T11421 T11419 arg1Of and,Figures
R9759 T11422 T11421 arg2Of 2,and
R9760 T11423 T11417 arg3Of ),(
R9761 T11425 T11424 arg1Of concentration,This
R9762 T11425 T11426 arg1Of concentration,is
R9763 T11425 T11427 arg1Of concentration,close
R9764 T11427 T11426 arg2Of close,is
R9765 T11427 T11428 arg1Of close,to
R9766 T11431 T11428 arg2Of levels,to
R9767 T11431 T11429 arg1Of levels,peak
R9768 T11431 T11430 arg1Of levels,plasma
R9769 T11431 T11432 arg2Of levels,obtained
R9770 T11432 T11433 arg1Of obtained,from
R9771 T11435 T11433 arg2Of patients,from
R9772 T11435 T11434 arg1Of patients,asthmatic
R9773 T11435 T11436 arg2Of patients,treated
R9774 T11436 T11437 arg1Of treated,with
R9775 T11436 T11444 arg1Of treated,[
R9776 T11439 T11437 arg2Of FP,with
R9777 T11439 T11438 arg2Of FP,inhaled
R9778 T11439 T11440 arg1Of FP,(
R9779 T11442 T11440 arg2Of µg,(
R9780 T11442 T11441 arg1Of µg,500
R9781 T11443 T11440 arg3Of ),(
R9782 T11445 T11444 arg2Of 27,[
R9783 T11446 T11444 arg3Of ],[
R9784 T11448 T11447 arg2Of FP,Inhaled
R9785 T11448 T11449 arg1Of FP,(
R9786 T11451 T11449 arg2Of µg,(
R9787 T11451 T11450 arg1Of µg,500
R9788 T11452 T11449 arg3Of ),(
R9789 T11453 T11448 arg1Of treatment,FP
R9790 T11453 T11454 arg1Of treatment,of
R9791 T11453 T11460 arg1Of treatment,reduced
R9792 T11458 T11454 arg2Of patients,of
R9793 T11458 T11455 arg1Of patients,seven
R9794 T11458 T11456 arg1Of patients,steroid-naive
R9795 T11458 T11457 arg1Of patients,asthma
R9796 T11460 T11459 arg1Of reduced,significantly
R9797 T11460 T11464 arg1Of reduced,vivo
R9798 T11460 T11465 arg1Of reduced,in
R9799 T11462 T11460 arg2Of interaction,reduced
R9800 T11462 T11461 arg1Of interaction,GATA-3–importin-α
R9801 T11464 T11463 arg1Of vivo,in
R9802 T11468 T11465 arg2Of manner,in
R9803 T11468 T11466 arg1Of manner,a
R9804 T11468 T11467 arg1Of manner,time-dependent
R9805 T11469 T11470 arg1Of This,produced
R9806 T11473 T11472 arg1Of 90,>
R9807 T11473 T11474 arg1Of 90,%
R9808 T11475 T11470 arg2Of decrease,produced
R9809 T11475 T11471 arg1Of decrease,a
R9810 T11475 T11473 arg1Of decrease,90
R9811 T11475 T11476 arg1Of decrease,in
R9812 T11475 T11479 arg1Of decrease,at
R9813 T11475 T11482 arg1Of decrease,(
R9814 T11478 T11476 arg2Of association,in
R9815 T11478 T11477 arg1Of association,GATA-3–importin-α
R9816 T11481 T11479 arg2Of h,at
R9817 T11481 T11480 arg1Of h,2
R9818 T11483 T11484 arg1Of median,[
R9819 T11483 T11489 arg1Of median,","
R9820 T11485 T11486 arg1Of 95,%
R9821 T11487 T11484 arg2Of CI,[
R9822 T11487 T11485 arg1Of CI,95
R9823 T11488 T11484 arg3Of ],[
R9824 T11489 T11482 arg2Of ",",(
R9825 T11489 T11494 arg1Of ",",versus
R9826 T11490 T11489 arg2Of "13,494",","
R9827 T11490 T11491 arg1Of "13,494",[
R9828 T11492 T11491 arg2Of "6,828–17,829",[
R9829 T11493 T11491 arg3Of ],[
R9830 T11495 T11496 arg1Of 879,[
R9831 T11495 T11499 arg1Of 879,;
R9832 T11495 T11504 arg2Of 879,'s
R9833 T11497 T11496 arg2Of "597–1,165",[
R9834 T11498 T11496 arg3Of ],[
R9835 T11500 T11499 arg2Of p,;
R9836 T11500 T11503 arg1Of p,Friedman
R9837 T11503 T11501 arg1Of Friedman,<
R9838 T11503 T11502 arg1Of Friedman,0.05
R9839 T11505 T11494 arg2Of analysis,versus
R9840 T11505 T11504 arg1Of analysis,'s
R9841 T11506 T11482 arg3Of ),(
R9842 T11509 T11510 arg1Of this,did
R9843 T11509 T11512 arg1Of this,reach
R9844 T11509 T11514 arg1Of this,using
R9845 T11512 T11507 arg1Of reach,However
R9846 T11512 T11508 arg1Of reach,","
R9847 T11512 T11510 arg2Of reach,did
R9848 T11512 T11511 arg1Of reach,not
R9849 T11512 T11514 modOf reach,using
R9850 T11512 T11522 arg1Of reach,probably
R9851 T11512 T11524 arg1Of reach,to
R9852 T11513 T11512 arg2Of significance,reach
R9853 T11515 T11516 arg2Of Wilcoxon,'s
R9854 T11518 T11514 arg2Of analysis,using
R9855 T11518 T11516 arg1Of analysis,'s
R9856 T11518 T11517 arg1Of analysis,post-test
R9857 T11518 T11519 arg1Of analysis,(
R9858 T11520 T11519 arg2Of W = 6.00,(
R9859 T11521 T11519 arg3Of ),(
R9860 T11524 T11523 arg1Of to,due
R9861 T11526 T11524 arg2Of numbers,to
R9862 T11526 T11525 arg1Of numbers,low
R9863 T11526 T11527 arg1Of numbers,of
R9864 T11528 T11527 arg2Of participants,of
R9865 T11530 T11529 arg1Of results,Similar
R9866 T11530 T11531 arg1Of results,were
R9867 T11530 T11532 arg2Of results,observed
R9868 T11532 T11531 arg2Of observed,were
R9869 T11532 T11533 arg1Of observed,when
R9870 T11535 T11534 arg1Of association,GATA-3–importin-α
R9871 T11535 T11536 arg1Of association,was
R9872 T11535 T11537 arg2Of association,measured
R9873 T11537 T11533 arg2Of measured,when
R9874 T11537 T11536 arg2Of measured,was
R9875 T11537 T11538 arg1Of measured,(
R9876 T11540 T11539 arg1Of 6C,Figure
R9877 T11540 T11541 arg1Of 6C,and
R9878 T11541 T11538 arg2Of and,(
R9879 T11542 T11541 arg2Of 6D,and
R9880 T11543 T11538 arg3Of ),(
R9881 T11546 T11544 arg1Of dose,The
R9882 T11546 T11545 arg1Of dose,lower
R9883 T11546 T11547 arg1Of dose,of
R9884 T11546 T11553 arg1Of dose,was
R9885 T11546 T11555 arg1Of dose,effective
R9886 T11548 T11547 arg2Of FP,of
R9887 T11548 T11549 arg1Of FP,(
R9888 T11551 T11549 arg2Of µg,(
R9889 T11551 T11550 arg1Of µg,100
R9890 T11552 T11549 arg3Of ),(
R9891 T11553 T11554 arg1Of was,not
R9892 T11555 T11553 arg2Of effective,was
R9893 T11558 T11556 arg1Of interaction,The
R9894 T11558 T11557 arg1Of interaction,attenuated
R9895 T11558 T11559 arg1Of interaction,of
R9896 T11558 T11561 arg1Of interaction,did
R9897 T11558 T11563 arg1Of interaction,result
R9898 T11560 T11559 arg2Of GATA-3,of
R9899 T11563 T11561 arg2Of result,did
R9900 T11563 T11562 arg1Of result,not
R9901 T11563 T11564 arg1Of result,from
R9902 T11563 T11570 arg1Of result,","
R9903 T11563 T11571 arg1Of result,as
R9904 T11567 T11564 arg2Of recycling,from
R9905 T11567 T11565 arg1Of recycling,the
R9906 T11567 T11566 arg1Of recycling,defective
R9907 T11567 T11568 arg1Of recycling,of
R9908 T11569 T11568 arg2Of importin-α,of
R9909 T11574 T11572 arg1Of decrease,a
R9910 T11574 T11573 arg1Of decrease,significant
R9911 T11574 T11575 arg1Of decrease,in
R9912 T11574 T11584 arg1Of decrease,was
R9913 T11574 T11586 arg2Of decrease,detected
R9914 T11577 T11575 arg2Of abundance,in
R9915 T11577 T11576 arg1Of abundance,the
R9916 T11577 T11578 arg1Of abundance,of
R9917 T11577 T11580 arg1Of abundance,in
R9918 T11579 T11578 arg2Of importin-α,of
R9919 T11583 T11580 arg2Of pool,in
R9920 T11583 T11581 arg1Of pool,the
R9921 T11583 T11582 arg1Of pool,cytoplasmic
R9922 T11586 T11571 arg2Of detected,as
R9923 T11586 T11584 arg2Of detected,was
R9924 T11586 T11585 arg1Of detected,not
R9925 T11586 T11587 arg1Of detected,(
R9926 T11589 T11587 arg2Of 6E,(
R9927 T11589 T11588 arg1Of 6E,Figure
R9928 T11590 T11587 arg3Of ),(
R9929 T11591 T11593 arg1Of We,examined
R9930 T11593 T11592 arg1Of examined,further
R9931 T11596 T11595 arg2Of FP,inhaled
R9932 T11596 T11597 arg1Of FP,could
R9933 T11596 T11598 arg1Of FP,affect
R9934 T11598 T11593 arg2Of affect,examined
R9935 T11598 T11594 arg1Of affect,whether
R9936 T11598 T11597 arg2Of affect,could
R9937 T11600 T11598 arg2Of localization,affect
R9938 T11600 T11599 arg1Of localization,cellular
R9939 T11600 T11601 arg1Of localization,of
R9940 T11600 T11603 arg1Of localization,in
R9941 T11602 T11601 arg2Of GATA-3,of
R9942 T11607 T11603 arg2Of cells,in
R9943 T11607 T11604 arg1Of cells,peripheral
R9944 T11607 T11605 arg1Of cells,blood
R9945 T11607 T11606 arg1Of cells,T
R9946 T11608 T11609 arg1Of Treatment,with
R9947 T11608 T11616 arg1Of Treatment,for
R9948 T11608 T11620 arg1Of Treatment,increased
R9949 T11608 T11630 arg1Of Treatment,decreased
R9950 T11611 T11609 arg2Of FP,with
R9951 T11611 T11610 arg2Of FP,inhaled
R9952 T11611 T11612 arg1Of FP,(
R9953 T11614 T11612 arg2Of µg,(
R9954 T11614 T11613 arg1Of µg,500
R9955 T11615 T11612 arg3Of ),(
R9956 T11618 T11616 arg2Of h,for
R9957 T11618 T11617 arg1Of h,2
R9958 T11620 T11628 arg1Of increased,and
R9959 T11623 T11620 arg2Of translocation,increased
R9960 T11623 T11621 arg1Of translocation,GR
R9961 T11623 T11622 arg1Of translocation,nuclear
R9962 T11623 T11624 arg1Of translocation,(
R9963 T11626 T11624 arg2Of 7A,(
R9964 T11626 T11625 arg1Of 7A,Figure
R9965 T11627 T11624 arg3Of ),(
R9966 T11628 T11619 arg1Of and,significantly
R9967 T11630 T11628 arg2Of decreased,and
R9968 T11630 T11629 arg1Of decreased,concomitantly
R9969 T11630 T11661 arg1Of decreased,compared
R9970 T11632 T11630 arg2Of number,decreased
R9971 T11632 T11631 arg1Of number,the
R9972 T11632 T11633 arg1Of number,of
R9973 T11640 T11633 arg2Of cells,of
R9974 T11640 T11634 arg1Of cells,nuclear
R9975 T11640 T11635 arg1Of cells,GATA-3
R9976 T11640 T11636 arg1Of cells,immunoreactive
R9977 T11640 T11637 arg1Of cells,peripheral
R9978 T11640 T11638 arg1Of cells,blood
R9979 T11640 T11639 arg1Of cells,T
R9980 T11640 T11641 arg1Of cells,(
R9981 T11645 T11641 arg2Of %,(
R9982 T11645 T11642 arg1Of %,37
R9983 T11645 T11643 arg1Of %,%
R9984 T11645 T11644 arg1Of %,±4.2
R9985 T11645 T11646 arg1Of %,versus
R9986 T11645 T11651 arg1Of %,","
R9987 T11650 T11646 arg2Of %,versus
R9988 T11650 T11647 arg1Of %,58.2
R9989 T11650 T11648 arg1Of %,%
R9990 T11650 T11649 arg1Of %,±4.95
R9991 T11652 T11651 arg2Of p = 0.016,","
R9992 T11652 T11653 arg1Of p = 0.016,","
R9993 T11652 T11655 arg1Of p = 0.016,","
R9994 T11654 T11653 arg2Of W = 28.0,","
R9995 T11656 T11657 arg2Of Wilcoxon,'s
R9996 T11659 T11655 arg2Of test,","
R9997 T11659 T11657 arg1Of test,'s
R9998 T11659 T11658 arg1Of test,rank
R9999 T11660 T11641 arg3Of ),(
R10000 T11662 T11661 arg2Of with,compared
R10001 T11663 T11662 arg2Of placebo,with
R10002 T11663 T11664 arg1Of placebo,as
R10003 T11665 T11664 arg2Of measured,as
R10004 T11665 T11666 arg1Of measured,by
R10005 T11667 T11666 arg2Of immunocytochemistry,by
R10006 T11667 T11668 arg1Of immunocytochemistry,(
R10007 T11670 T11669 arg1Of 7A,Figure
R10008 T11670 T11671 arg1Of 7A,and
R10009 T11671 T11668 arg2Of and,(
R10010 T11672 T11671 arg2Of 7B,and
R10011 T11673 T11668 arg3Of ),(
R10012 T11674 T11675 arg1Of This,was
R10013 T11674 T11676 arg2Of This,confirmed
R10014 T11676 T11675 arg2Of confirmed,was
R10015 T11679 T11676 arg1Of blotting,confirmed
R10016 T11679 T11677 arg2Of blotting,by
R10017 T11679 T11678 arg1Of blotting,Western
R10018 T11679 T11680 arg1Of blotting,","
R10019 T11679 T11681 arg1Of blotting,which
R10020 T11679 T11683 arg1Of blotting,indicated
R10021 T11683 T11682 arg1Of indicated,also
R10022 T11686 T11685 arg1Of effect,this
R10023 T11686 T11687 arg1Of effect,was
R10024 T11687 T11683 arg2Of was,indicated
R10025 T11687 T11684 arg1Of was,that
R10026 T11689 T11690 arg1Of time-,and
R10027 T11690 T11688 arg1Of and,both
R10028 T11691 T11690 arg2Of dose-dependent,and
R10029 T11694 T11693 arg1Of 7C,Figure
R10030 T11694 T11695 arg1Of 7C,and
R10031 T11695 T11687 arg2Of and,was
R10032 T11695 T11689 arg1Of and,time-
R10033 T11695 T11691 arg1Of and,dose-dependent
R10034 T11695 T11692 arg2Of and,(
R10035 T11696 T11695 arg2Of 7D,and
R10036 T11697 T11692 arg3Of ),(
R10037 T11701 T11700 arg2Of FP,inhaled
R10038 T11701 T11702 arg1Of FP,(
R10039 T11701 T11706 arg1Of FP,induced
R10040 T11704 T11702 arg2Of µg,(
R10041 T11704 T11703 arg1Of µg,500
R10042 T11705 T11702 arg3Of ),(
R10043 T11706 T11748 arg1Of induced,and
R10044 T11708 T11706 arg2Of loss,induced
R10045 T11708 T11707 arg1Of loss,significant
R10046 T11708 T11709 arg1Of loss,in
R10047 T11708 T11712 arg1Of loss,at
R10048 T11708 T11715 arg1Of loss,(
R10049 T11708 T11744 arg1Of loss,(
R10050 T11711 T11709 arg2Of GATA-3,in
R10051 T11711 T11710 arg1Of GATA-3,nuclear
R10052 T11714 T11712 arg2Of h,at
R10053 T11714 T11713 arg1Of h,2
R10054 T11716 T11715 arg2Of median,(
R10055 T11716 T11717 arg1Of median,[
R10056 T11716 T11722 arg1Of median,","
R10057 T11716 T11732 arg1Of median,","
R10058 T11718 T11719 arg1Of 95,%
R10059 T11720 T11717 arg2Of CI,[
R10060 T11720 T11718 arg1Of CI,95
R10061 T11721 T11717 arg3Of ],[
R10062 T11723 T11722 arg2Of 0.40,","
R10063 T11723 T11724 arg1Of 0.40,[
R10064 T11723 T11727 arg1Of 0.40,versus
R10065 T11725 T11724 arg2Of 0.27–0.53,[
R10066 T11726 T11724 arg3Of ],[
R10067 T11728 T11727 arg2Of 0.14,versus
R10068 T11728 T11729 arg1Of 0.14,[
R10069 T11730 T11729 arg2Of 0.11–0.19,[
R10070 T11731 T11729 arg3Of ],[
R10071 T11733 T11732 arg2Of p,","
R10072 T11733 T11734 arg1Of p,<
R10073 T11733 T11735 arg1Of p,0.05
R10074 T11733 T11736 arg1Of p,","
R10075 T11733 T11738 arg1Of p,","
R10076 T11737 T11736 arg2Of W = 21.00,","
R10077 T11739 T11740 arg2Of Wilcoxon,'s
R10078 T11742 T11738 arg2Of test,","
R10079 T11742 T11740 arg1Of test,'s
R10080 T11742 T11741 arg1Of test,rank
R10081 T11743 T11715 arg3Of ),(
R10082 T11746 T11744 arg2Of 7C,(
R10083 T11746 T11745 arg1Of 7C,Figure
R10084 T11747 T11744 arg3Of ),(
R10085 T11748 T11698 arg1Of and,Thus
R10086 T11748 T11699 arg1Of and,","
R10087 T11751 T11749 arg1Of levels,cytoplasmic
R10088 T11751 T11750 arg1Of levels,GATA-3
R10089 T11751 T11752 arg1Of levels,were
R10090 T11751 T11753 arg2Of levels,enhanced
R10091 T11753 T11748 arg2Of enhanced,and
R10092 T11753 T11752 arg2Of enhanced,were
R10093 T11753 T11757 arg1Of enhanced,in
R10094 T11756 T11753 arg1Of FP,enhanced
R10095 T11756 T11754 arg2Of FP,by
R10096 T11756 T11755 arg2Of FP,inhaled
R10097 T11760 T11757 arg2Of manner,in
R10098 T11760 T11758 arg1Of manner,a
R10099 T11760 T11759 arg1Of manner,dose-dependent
R10100 T11760 T11761 arg1Of manner,(
R10101 T11760 T11790 arg1Of manner,(
R10102 T11762 T11761 arg2Of median,(
R10103 T11762 T11763 arg1Of median,[
R10104 T11762 T11768 arg1Of median,","
R10105 T11762 T11778 arg1Of median,","
R10106 T11764 T11765 arg1Of 95,%
R10107 T11766 T11763 arg2Of CI,[
R10108 T11766 T11764 arg1Of CI,95
R10109 T11767 T11763 arg3Of ],[
R10110 T11769 T11768 arg2Of 0.0032,","
R10111 T11769 T11770 arg1Of 0.0032,[
R10112 T11769 T11773 arg1Of 0.0032,versus
R10113 T11771 T11770 arg2Of 0.0026–0.0039,[
R10114 T11772 T11770 arg3Of ],[
R10115 T11774 T11773 arg2Of 0.658,versus
R10116 T11774 T11775 arg1Of 0.658,[
R10117 T11776 T11775 arg2Of 0.592–0.720,[
R10118 T11777 T11775 arg3Of ],[
R10119 T11779 T11778 arg2Of p,","
R10120 T11779 T11780 arg1Of p,<
R10121 T11779 T11781 arg1Of p,0.05
R10122 T11779 T11782 arg1Of p,","
R10123 T11779 T11784 arg1Of p,","
R10124 T11783 T11782 arg2Of W = −21.00,","
R10125 T11785 T11786 arg2Of Wilcoxon,'s
R10126 T11788 T11784 arg2Of test,","
R10127 T11788 T11786 arg1Of test,'s
R10128 T11788 T11787 arg1Of test,rank
R10129 T11789 T11761 arg3Of ),(
R10130 T11792 T11790 arg2Of 7D,(
R10131 T11792 T11791 arg1Of 7D,Figure
R10132 T11793 T11790 arg3Of ),(
R10133 T11795 T11794 arg2Of addition,In
R10134 T11797 T11798 arg1Of FP,(
R10135 T11797 T11802 arg1Of FP,inhibited
R10136 T11800 T11798 arg2Of µg,(
R10137 T11800 T11799 arg1Of µg,500
R10138 T11801 T11798 arg3Of ),(
R10139 T11802 T11794 arg1Of inhibited,In
R10140 T11802 T11796 arg1Of inhibited,","
R10141 T11802 T11806 arg1Of inhibited,in
R10142 T11802 T11811 arg1Of inhibited,vivo
R10143 T11802 T11812 arg1Of inhibited,at
R10144 T11802 T11815 arg1Of inhibited,in
R10145 T11805 T11802 arg2Of phosphorylation,inhibited
R10146 T11805 T11803 arg1Of phosphorylation,p38
R10147 T11805 T11804 arg1Of phosphorylation,MAPK
R10148 T11809 T11806 arg2Of cells,in
R10149 T11809 T11807 arg1Of cells,primary
R10150 T11809 T11808 arg1Of cells,T
R10151 T11811 T11810 arg1Of vivo,in
R10152 T11814 T11812 arg2Of h,at
R10153 T11814 T11813 arg1Of h,2
R10154 T11816 T11815 arg2Of samples,in
R10155 T11816 T11817 arg1Of samples,from
R10156 T11819 T11817 arg2Of patients,from
R10157 T11819 T11818 arg1Of patients,two
R10158 T11819 T11820 arg1Of patients,(
R10159 T11822 T11820 arg2Of 7E,(
R10160 T11822 T11821 arg1Of 7E,Figure
R10161 T11823 T11820 arg3Of ),(
R10162 T11824 T11825 arg1Of Taken,together
R10163 T11828 T11827 arg1Of data,our
R10164 T11828 T11829 arg1Of data,suggest
R10165 T11829 T11824 modOf suggest,Taken
R10166 T11829 T11826 arg1Of suggest,","
R10167 T11832 T11831 arg2Of FP,inhaled
R10168 T11832 T11833 arg1Of FP,reduces
R10169 T11833 T11829 arg2Of reduces,suggest
R10170 T11833 T11830 arg1Of reduces,that
R10171 T11833 T11839 arg1Of reduces,vivo
R10172 T11833 T11840 arg1Of reduces,by
R10173 T11835 T11833 arg2Of localization,reduces
R10174 T11835 T11834 arg1Of localization,nuclear
R10175 T11835 T11836 arg1Of localization,of
R10176 T11837 T11836 arg2Of GATA-3,of
R10177 T11839 T11838 arg1Of vivo,in
R10178 T11842 T11840 arg2Of inhibiting,by
R10179 T11842 T11841 arg1Of inhibiting,acutely
R10180 T11844 T11842 arg2Of association,inhibiting
R10181 T11844 T11843 arg1Of association,phospho-GATA-3–importin
R10182 T11846 T11845 arg1Of effect,This
R10183 T11846 T11847 arg1Of effect,may
R10184 T11846 T11848 arg1Of effect,be
R10185 T11846 T11849 arg1Of effect,direct
R10186 T11846 T11860 arg1Of effect,secondary
R10187 T11848 T11847 arg2Of be,may
R10188 T11849 T11850 arg1Of direct,","
R10189 T11849 T11851 arg1Of direct,through
R10190 T11849 T11859 arg1Of direct,or
R10191 T11852 T11851 arg2Of competition,through
R10192 T11852 T11853 arg1Of competition,for
R10193 T11854 T11855 arg1Of importin-α,or
R10194 T11855 T11853 arg2Of or,for
R10195 T11857 T11855 arg2Of molecules,or
R10196 T11857 T11856 arg2Of molecules,associated
R10197 T11859 T11848 arg2Of or,be
R10198 T11859 T11858 arg1Of or,","
R10199 T11860 T11859 arg2Of secondary,or
R10200 T11860 T11861 arg1Of secondary,to
R10201 T11863 T11861 arg2Of effect,to
R10202 T11863 T11862 arg1Of effect,an
R10203 T11863 T11864 arg1Of effect,on
R10204 T11863 T11869 arg1Of effect,via
R10205 T11868 T11864 arg2Of phosphorylation,on
R10206 T11868 T11865 arg1Of phosphorylation,p38
R10207 T11868 T11866 arg1Of phosphorylation,MAPK-mediated
R10208 T11868 T11867 arg1Of phosphorylation,GATA-3
R10209 T11871 T11869 arg2Of induction,via
R10210 T11871 T11870 arg1Of induction,rapid
R10211 T11871 T11872 arg1Of induction,of
R10212 T11873 T11872 arg2Of MKP-1,of
R10213 T11875 T11874 arg1Of combination,The
R10214 T11875 T11876 arg1Of combination,of
R10215 T11875 T11881 arg1Of combination,can
R10216 T11875 T11882 arg1Of combination,result
R10217 T11880 T11876 arg2Of effects,of
R10218 T11880 T11877 arg1Of effects,these
R10219 T11880 T11878 arg1Of effects,two
R10220 T11880 T11879 arg1Of effects,interacting
R10221 T11882 T11881 arg2Of result,can
R10222 T11882 T11883 arg1Of result,in
R10223 T11885 T11884 arg1Of suppression,complete
R10224 T11885 T11886 arg1Of suppression,of
R10225 T11885 T11890 arg1Of suppression,and
R10226 T11889 T11886 arg2Of import,of
R10227 T11889 T11887 arg1Of import,GATA-3
R10228 T11889 T11888 arg1Of import,nuclear
R10229 T11890 T11883 arg2Of and,in
R10230 T11895 T11890 arg2Of expression,and
R10231 T11895 T11891 arg1Of expression,thus
R10232 T11895 T11892 arg1Of expression,Th2
R10233 T11895 T11893 arg1Of expression,cytokine
R10234 T11895 T11894 arg1Of expression,gene
R16458 T19292 T19291 arg1Of propionate,Fluticasone
R16459 T19292 T19293 arg1Of propionate,impairs
R16460 T19293 T19303 arg1Of impairs,vivo
R16461 T19293 T19306 arg1Of impairs,vivo
R16462 T19295 T19293 arg2Of interaction,impairs
R16463 T19295 T19294 arg1Of interaction,GATA-3
R16464 T19295 T19296 arg1Of interaction,with
R16465 T19297 T19298 arg1Of importin-α,and
R16466 T19298 T19296 arg2Of and,with
R16467 T19301 T19298 arg2Of localization,and
R16468 T19301 T19299 arg1Of localization,GATA-3
R16469 T19301 T19300 arg1Of localization,nuclear
R16470 T19303 T19302 arg1Of vivo,in
R16471 T19303 T19304 arg1Of vivo,and
R16472 T19306 T19304 arg2Of vivo,and
R16473 T19306 T19305 arg1Of vivo,ex
R16474 T19308 T19309 arg1Of A,and
R16475 T19309 T19307 arg2Of and,(
R16476 T19309 T19325 modOf and,demonstrated
R16477 T19310 T19309 arg2Of B,and
R16478 T19311 T19307 arg3Of ),(
R16479 T19313 T19312 arg1Of analysis,Co-immunoprecipitation
R16480 T19313 T19314 arg1Of analysis,of
R16481 T19313 T19325 arg1Of analysis,demonstrated
R16482 T19315 T19314 arg2Of PBMCs,of
R16483 T19315 T19316 arg1Of PBMCs,from
R16484 T19319 T19316 arg2Of patients,from
R16485 T19319 T19317 arg1Of patients,steroid-naïve
R16486 T19319 T19318 arg1Of patients,asthma
R16487 T19319 T19320 arg2Of patients,treated
R16488 T19319 T19324 arg1Of patients,vitro
R16489 T19320 T19321 arg1Of treated,with
R16490 T19322 T19321 arg2Of FP,with
R16491 T19324 T19323 arg1Of vitro,in
R16492 T19327 T19325 arg2Of interaction,demonstrated
R16493 T19327 T19326 arg1Of interaction,impaired
R16494 T19327 T19328 arg1Of interaction,between
R16495 T19329 T19330 arg1Of GATA-3,and
R16496 T19330 T19328 arg2Of and,between
R16497 T19330 T19332 arg2Of and,measured
R16498 T19331 T19330 arg2Of importin-α,and
R16499 T19332 T19333 arg1Of measured,at
R16500 T19335 T19333 arg2Of min,at
R16501 T19335 T19334 arg1Of min,60
R16502 T19337 T19336 arg1Of bar,Each
R16503 T19337 T19338 arg1Of bar,represents
R16504 T19338 T19347 arg1Of represents,;
R16505 T19340 T19338 arg2Of mean±SEM,represents
R16506 T19340 T19339 arg1Of mean±SEM,the
R16507 T19340 T19341 arg1Of mean±SEM,of
R16508 T19344 T19342 arg1Of three,at
R16509 T19344 T19343 arg1Of three,least
R16510 T19346 T19341 arg2Of experiments,of
R16511 T19346 T19344 arg1Of experiments,three
R16512 T19346 T19345 arg1Of experiments,independent
R16513 T19349 T19348 arg1Of p,***
R16514 T19349 T19351 arg1Of p,0.001
R16515 T19349 T19352 arg1Of p,compared
R16516 T19351 T19350 arg1Of 0.001,<
R16517 T19352 T19347 arg2Of compared,;
R16518 T19352 T19353 arg1Of compared,with
R16519 T19352 T19355 arg1Of compared,as
R16520 T19354 T19353 arg2Of control,with
R16521 T19356 T19355 arg2Of determined,as
R16522 T19356 T19357 arg1Of determined,by
R16523 T19359 T19357 arg2Of analysis.,by
R16524 T19359 T19358 arg1Of analysis.,ANOVA/Newman-Keuls
R16525 T19359 T19360 arg1Of analysis.,(
R16526 T19361 T19362 arg1Of C,and
R16527 T19362 T19360 arg2Of and,(
R16528 T19363 T19362 arg2Of D,and
R16529 T19364 T19360 arg3Of ),(
R16530 T19366 T19365 arg1Of analyses,Co-immunoprecipitation
R16531 T19366 T19367 arg1Of analyses,of
R16532 T19366 T19386 arg1Of analyses,demonstrated
R16533 T19368 T19367 arg2Of PBMCs,of
R16534 T19368 T19369 arg1Of PBMCs,from
R16535 T19372 T19369 arg2Of patients,from
R16536 T19372 T19370 arg1Of patients,steroid-naïve
R16537 T19372 T19371 arg1Of patients,asthma
R16538 T19372 T19373 arg2Of patients,treated
R16539 T19373 T19374 arg1Of treated,with
R16540 T19376 T19374 arg2Of FP,with
R16541 T19376 T19375 arg2Of FP,inhaled
R16542 T19376 T19377 arg1Of FP,(
R16543 T19376 T19385 arg1Of FP,vivo
R16544 T19379 T19377 arg2Of µg,(
R16545 T19379 T19378 arg1Of µg,500
R16546 T19379 T19380 arg1Of µg,via
R16547 T19382 T19380 arg2Of spacer,via
R16548 T19382 T19381 arg1Of spacer,a
R16549 T19383 T19377 arg3Of ),(
R16550 T19385 T19384 arg1Of vivo,in
R16551 T19386 T19347 arg3Of demonstrated,;
R16552 T19388 T19386 arg2Of association,demonstrated
R16553 T19388 T19387 arg2Of association,decreased
R16554 T19388 T19389 arg1Of association,between
R16555 T19390 T19391 arg1Of GATA-3,and
R16556 T19391 T19389 arg2Of and,between
R16557 T19392 T19391 arg2Of importin-α,and
R16558 T19395 T19393 arg1Of values,The
R16559 T19395 T19394 arg1Of values,individual
R16560 T19395 T19396 arg1Of values,for
R16561 T19395 T19399 arg1Of values,are
R16562 T19395 T19400 arg2Of values,presented
R16563 T19398 T19396 arg2Of treatment,for
R16564 T19398 T19397 arg1Of treatment,each
R16565 T19400 T19399 arg2Of presented,are
R16566 T19403 T19402 arg2Of E,(
R16567 T19404 T19402 arg3Of ),(
R16568 T19407 T19400 arg3Of blot,presented
R16569 T19407 T19401 arg1Of blot,graphically.
R16570 T19407 T19402 arg1Of blot,(
R16571 T19407 T19405 arg1Of blot,Representative
R16572 T19407 T19406 arg1Of blot,Western
R16573 T19407 T19408 arg1Of blot,showing
R16574 T19411 T19410 arg1Of expression,importin-α
R16575 T19411 T19412 arg1Of expression,was
R16576 T19411 T19413 arg2Of expression,unaffected
R16577 T19413 T19408 arg2Of unaffected,showing
R16578 T19413 T19409 arg1Of unaffected,that
R16579 T19413 T19412 arg2Of unaffected,was
R16580 T19415 T19413 arg1Of inhalation,unaffected
R16581 T19415 T19414 arg2Of inhalation,by
R16582 T19415 T19416 arg1Of inhalation,of
R16583 T19417 T19416 arg2Of FP,of
R16584 T19418 T19419 arg1Of Blot,is
R16585 T19418 T19420 arg1Of Blot,representative
R16586 T19420 T19419 arg2Of representative,is
R16587 T19420 T19421 arg1Of representative,of
R16588 T19422 T19421 arg2Of gels,of
R16589 T19422 T19423 arg1Of gels,from
R16590 T19425 T19423 arg2Of participants,from
R16591 T19425 T19424 arg1Of participants,three
R16836 T19734 T19732 arg2Of propionate,Inhaled
R16837 T19734 T19733 arg1Of propionate,fluticasone
R16838 T19734 T19735 arg1Of propionate,impairs
R16839 T19738 T19735 arg2Of localization,impairs
R16840 T19738 T19736 arg1Of localization,GATA-3
R16841 T19738 T19737 arg1Of localization,nuclear
R16842 T19738 T19739 arg1Of localization,in
R16843 T19740 T19739 arg2Of PBMCs,in
R16844 T19742 T19741 arg2Of A,(
R16845 T19743 T19741 arg3Of ),(
R16846 T19745 T19741 arg1Of immunocytochemistry,(
R16847 T19745 T19744 arg1Of immunocytochemistry,Representative
R16848 T19745 T19746 arg1Of immunocytochemistry,of
R16849 T19747 T19746 arg2Of showing,of
R16850 T19747 T19778 arg1Of showing,following
R16851 T19749 T19747 arg2Of effect,showing
R16852 T19749 T19748 arg1Of effect,the
R16853 T19749 T19750 arg1Of effect,of
R16854 T19749 T19757 arg1Of effect,on
R16855 T19752 T19750 arg2Of FP,of
R16856 T19752 T19751 arg2Of FP,inhaled
R16857 T19752 T19753 arg1Of FP,(
R16858 T19755 T19753 arg2Of µg,(
R16859 T19755 T19754 arg1Of µg,500
R16860 T19756 T19753 arg3Of ),(
R16861 T19758 T19759 arg1Of GR,and
R16862 T19760 T19759 arg2Of GATA-3,and
R16863 T19764 T19763 arg2Of B,(
R16864 T19765 T19763 arg3Of ),(
R16865 T19768 T19757 arg2Of immunoreactivity,on
R16866 T19768 T19758 arg1Of immunoreactivity,GR
R16867 T19768 T19760 arg1Of immunoreactivity,GATA-3
R16868 T19768 T19761 arg1Of immunoreactivity,nuclear
R16869 T19768 T19762 arg1Of immunoreactivity,localisation.
R16870 T19768 T19763 arg1Of immunoreactivity,(
R16871 T19768 T19766 arg1Of immunoreactivity,Nuclear
R16872 T19768 T19767 arg1Of immunoreactivity,GATA-3
R16873 T19768 T19769 arg1Of immunoreactivity,in
R16874 T19768 T19771 arg1Of immunoreactivity,from
R16875 T19770 T19769 arg2Of PBMCs,in
R16876 T19775 T19771 arg2Of patients,from
R16877 T19775 T19772 arg1Of patients,seven
R16878 T19775 T19773 arg1Of patients,steroid-naïve
R16879 T19775 T19774 arg1Of patients,asthma
R16880 T19777 T19776 arg1Of h,2
R16881 T19778 T19777 arg1Of following,h
R16882 T19781 T19778 arg2Of treatment,following
R16883 T19781 T19779 arg2Of treatment,inhaled
R16884 T19781 T19780 arg1Of treatment,FP
R16885 T19781 T19782 arg1Of treatment,(
R16886 T19783 T19784 arg1Of 100,or
R16887 T19785 T19784 arg2Of 500,or
R16888 T19786 T19782 arg2Of µg,(
R16889 T19786 T19783 arg1Of µg,100
R16890 T19786 T19785 arg1Of µg,500
R16891 T19786 T19787 arg1Of µg,via
R16892 T19788 T19787 arg2Of spacer,via
R16893 T19789 T19782 arg3Of ),(
R16894 T19791 T19792 arg1Of median,and
R16895 T19793 T19792 arg2Of interquartile,and
R16896 T19794 T19790 arg1Of ranges,The
R16897 T19794 T19791 arg1Of ranges,median
R16898 T19794 T19793 arg1Of ranges,interquartile
R16899 T19794 T19795 arg1Of ranges,for
R16900 T19794 T19798 arg1Of ranges,are
R16901 T19794 T19799 arg2Of ranges,presented
R16902 T19797 T19795 arg2Of treatment,for
R16903 T19797 T19796 arg1Of treatment,each
R16904 T19799 T19798 arg2Of presented,are
R16905 T19799 T19800 arg1Of presented,as
R16906 T19799 T19807 arg1Of presented,;
R16907 T19803 T19800 arg2Of plot,as
R16908 T19803 T19801 arg1Of plot,a
R16909 T19803 T19802 arg1Of plot,box-and-whiskers
R16910 T19803 T19804 arg1Of plot,(
R16911 T19805 T19804 arg2Of n = 7,(
R16912 T19806 T19804 arg3Of ),(
R16913 T19811 T19810 arg1Of 0.05,<
R16914 T19812 T19808 arg1Of Wilcoxon,*
R16915 T19812 T19809 arg1Of Wilcoxon,p
R16916 T19812 T19811 arg1Of Wilcoxon,0.05
R16917 T19812 T19813 arg2Of Wilcoxon,'s
R16918 T19815 T19813 arg1Of test,'s
R16919 T19815 T19814 arg1Of test,rank
R16920 T19815 T19816 arg1Of test,compared
R16921 T19815 T19826 arg1Of test,demonstrated
R16922 T19817 T19816 arg2Of with,compared
R16923 T19820 T19819 arg2Of C,(
R16924 T19821 T19819 arg3Of ),(
R16925 T19823 T19817 arg2Of analyses,with
R16926 T19823 T19818 arg1Of analyses,placebo.
R16927 T19823 T19819 arg1Of analyses,(
R16928 T19823 T19822 arg1Of analyses,Immunoblotting
R16929 T19823 T19824 arg1Of analyses,of
R16930 T19825 T19824 arg2Of PBMCs,of
R16931 T19826 T19836 arg1Of demonstrated,and
R16932 T19829 T19826 arg2Of decrease,demonstrated
R16933 T19829 T19827 arg1Of decrease,a
R16934 T19829 T19828 arg1Of decrease,time-dependent
R16935 T19829 T19830 arg1Of decrease,in
R16936 T19832 T19830 arg2Of expression,in
R16937 T19832 T19831 arg1Of expression,nuclear
R16938 T19832 T19833 arg1Of expression,of
R16939 T19834 T19833 arg2Of GATA-3,of
R16940 T19836 T19807 arg2Of and,;
R16941 T19836 T19835 arg1Of and,","
R16942 T19840 T19837 arg2Of expression,increased
R16943 T19840 T19838 arg1Of expression,cytoplasmic
R16944 T19840 T19839 arg1Of expression,GATA-3
R16945 T19840 T19841 arg1Of expression,after
R16946 T19840 T19852 arg1Of expression,demonstrated
R16947 T19840 T19863 arg1Of expression,increased
R16948 T19842 T19841 arg2Of inhalation,after
R16949 T19842 T19843 arg1Of inhalation,of
R16950 T19846 T19845 arg2Of D,(
R16951 T19847 T19845 arg3Of ),(
R16952 T19849 T19843 arg2Of analyses,of
R16953 T19849 T19844 arg1Of analyses,FP.
R16954 T19849 T19845 arg1Of analyses,(
R16955 T19849 T19848 arg1Of analyses,Immunoblotting
R16956 T19849 T19850 arg1Of analyses,of
R16957 T19851 T19850 arg2Of PBMCs,of
R16958 T19852 T19862 arg1Of demonstrated,and
R16959 T19855 T19852 arg2Of decrease,demonstrated
R16960 T19855 T19853 arg1Of decrease,a
R16961 T19855 T19854 arg1Of decrease,dose-dependent
R16962 T19855 T19856 arg1Of decrease,in
R16963 T19858 T19856 arg2Of expression,in
R16964 T19858 T19857 arg1Of expression,nuclear
R16965 T19858 T19859 arg1Of expression,of
R16966 T19860 T19859 arg2Of GATA-3,of
R16967 T19862 T19836 arg2Of and,and
R16968 T19862 T19861 arg1Of and,","
R16969 T19863 T19862 arg2Of increased,and
R16970 T19863 T19869 arg1Of increased,after
R16971 T19866 T19863 arg2Of expression,increased
R16972 T19866 T19864 arg1Of expression,cytoplasmic
R16973 T19866 T19865 arg1Of expression,GATA-3
R16974 T19868 T19867 arg1Of h,2
R16975 T19869 T19868 arg1Of after,h
R16976 T19870 T19869 arg2Of inhalation,after
R16977 T19870 T19871 arg1Of inhalation,of
R16978 T19872 T19871 arg2Of FP,of
R16979 T19874 T19873 arg1Of H1,Histone
R16980 T19874 T19875 arg1Of H1,and
R16981 T19875 T19878 arg1Of and,confirmed
R16982 T19877 T19875 arg2Of immunoblotting,and
R16983 T19877 T19876 arg1Of immunoblotting,MEK-1
R16984 T19881 T19878 arg2Of protein,confirmed
R16985 T19881 T19879 arg1Of protein,equivalent
R16986 T19881 T19880 arg1Of protein,total
R16987 T19881 T19882 arg1Of protein,loading
R16988 T19882 T19883 arg1Of loading,for
R16989 T19882 T19889 arg1Of loading,respectively
R16990 T19885 T19886 arg1Of nuclear,and
R16991 T19887 T19886 arg2Of cytoplasmic,and
R16992 T19888 T19883 arg2Of fractions,for
R16993 T19888 T19884 arg1Of fractions,the
R16994 T19888 T19885 arg1Of fractions,nuclear
R16995 T19888 T19887 arg1Of fractions,cytoplasmic
R16996 T19890 T19891 arg1Of Quantification,of
R16997 T19890 T19903 arg1Of Quantification,is
R16998 T19890 T19904 arg2Of Quantification,shown
R16999 T19894 T19891 arg2Of data,of
R17000 T19894 T19892 arg1Of data,the
R17001 T19894 T19893 arg1Of data,densitometry
R17002 T19894 T19895 arg1Of data,in
R17003 T19897 T19896 arg2Of C,(
R17004 T19897 T19899 arg1Of C,and
R17005 T19898 T19896 arg3Of ),(
R17006 T19899 T19895 arg2Of and,in
R17007 T19901 T19899 arg2Of D,and
R17008 T19901 T19900 arg2Of D,(
R17009 T19902 T19900 arg3Of ),(
R17010 T19904 T19903 arg2Of shown,is
R17011 T19904 T19905 arg1Of shown,as
R17012 T19908 T19905 arg2Of plot,as
R17013 T19908 T19906 arg1Of plot,a
R17014 T19908 T19907 arg1Of plot,box-and-whiskers
R17015 T19908 T19909 arg1Of plot,of
R17016 T19910 T19909 arg2Of results,of
R17017 T19910 T19911 arg1Of results,from
R17018 T19910 T19914 arg2Of results,for
R17019 T19910 T19915 arg1Of results,which
R17020 T19913 T19911 arg2Of participants,from
R17021 T19913 T19912 arg1Of participants,n = 6
R17022 T19916 T19917 arg1Of data,were
R17023 T19917 T19914 arg1Of were,for
R17024 T19919 T19920 arg1Of *p,<
R17025 T19921 T19917 arg2Of 0.05,were
R17026 T19921 T19918 arg1Of 0.05,available.
R17027 T19921 T19919 arg1Of 0.05,*p
R17028 T19921 T19922 arg2Of 0.05,compared
R17029 T19921 T19933 modOf 0.05,demonstrated
R17030 T19921 T19945 arg1Of 0.05,of
R17031 T19924 T19922 arg3Of control.,compared
R17032 T19924 T19923 arg1Of control.,to
R17033 T19924 T19925 arg1Of control.,(
R17034 T19926 T19925 arg2Of E,(
R17035 T19927 T19925 arg3Of ),(
R17036 T19930 T19928 arg1Of analyses,Western
R17037 T19930 T19929 arg1Of analyses,blot
R17038 T19930 T19931 arg1Of analyses,of
R17039 T19930 T19933 arg1Of analyses,demonstrated
R17040 T19932 T19931 arg2Of PBMCs,of
R17041 T19936 T19933 arg2Of decrease,demonstrated
R17042 T19936 T19934 arg1Of decrease,a
R17043 T19936 T19935 arg1Of decrease,time-dependent
R17044 T19936 T19937 arg1Of decrease,in
R17045 T19939 T19937 arg2Of phosphorylation,in
R17046 T19939 T19938 arg1Of phosphorylation,dual
R17047 T19939 T19940 arg1Of phosphorylation,(
R17048 T19941 T19942 arg1Of threonine-180,and
R17049 T19942 T19940 arg2Of and,(
R17050 T19943 T19942 arg2Of tyrosine-182,and
R17051 T19944 T19940 arg3Of ),(
R17052 T19947 T19945 arg2Of MAPK,of
R17053 T19947 T19946 arg1Of MAPK,p38
R17054 T19947 T19948 arg1Of MAPK,after
R17055 T19949 T19948 arg2Of inhalation,after
R17056 T19949 T19950 arg1Of inhalation,of
R17057 T19951 T19950 arg2Of FP,of
R17058 T19951 T19952 arg1Of FP,(
R17059 T19954 T19952 arg2Of µg,(
R17060 T19954 T19953 arg1Of µg,500
R17061 T19955 T19952 arg3Of ),(
R17062 T19957 T19956 arg1Of results,The
R17063 T19957 T19958 arg2Of results,shown
R17064 T19957 T19963 arg1Of results,are
R17065 T19957 T19964 arg1Of results,representative
R17066 T19958 T19959 arg1Of shown,in
R17067 T19961 T19959 arg2Of E,in
R17068 T19961 T19960 arg2Of E,(
R17069 T19962 T19960 arg3Of ),(
R17070 T19964 T19963 arg2Of representative,are
R17071 T19964 T19965 arg1Of representative,of
R17072 T19966 T19965 arg2Of samples,of
R17073 T19966 T19967 arg1Of samples,from
R17074 T19969 T19967 arg2Of participants,from
R17075 T19969 T19968 arg1Of participants,two

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T11922 0-3 DT denotes The
T11923 4-14 NNP denotes Inhibitory
T11924 15-21 NN denotes Effect
T11925 22-24 IN denotes of
T11926 25-40 NNS denotes Corticosteroids
T11927 41-43 IN denotes on
T11928 44-50 NNP denotes GATA-3
T11929 51-58 NNP denotes Nuclear
T11930 59-71 NNP denotes Localization
T11931 72-74 IN denotes in
T11932 75-82 JJ denotes Primary
T11933 83-84 NNP denotes T
T11934 85-96 NNP denotes Lymphocytes
T11935 97-99 NNP denotes Ex
T11936 100-104 NNP denotes Vivo
T11937 105-108 CC denotes and
T11938 109-111 IN denotes In
T11939 112-116 NNP denotes Vivo
T11940 117-126 NNP denotes Treatment
T11941 127-131 IN denotes with
T11942 132-134 NNP denotes FP
T11943 135-137 FW denotes ex
T11944 138-142 FW denotes vivo
T11945 143-155 VBD denotes demonstrated
T11946 156-157 DT denotes a
T11947 158-181 JJ denotes concentration-dependent
T11948 182-190 NN denotes decrease
T11949 191-193 IN denotes in
T11950 194-197 DT denotes the
T11951 198-204 JJ denotes direct
T11952 205-216 NN denotes interaction
T11953 217-224 IN denotes between
T11954 225-239 JJ denotes phospho-GATA-3
T11955 240-243 CC denotes and
T11956 244-254 JJ denotes importin-α
T11957 255-257 IN denotes in
T11958 258-263 NNS denotes PBMCs
T11959 264-268 IN denotes from
T11960 269-277 NNS denotes patients
T11961 278-282 IN denotes with
T11962 283-289 NN denotes asthma
T11963 290-291 -LRB- denotes (
T11964 291-297 NN denotes Figure
T11965 298-300 NN denotes 6A
T11966 301-304 CC denotes and
T11967 305-307 NN denotes 6B
T11968 307-308 -RRB- denotes )
T11969 308-309 , denotes ,
T11970 310-315 WDT denotes which
T11971 316-319 VBD denotes was
T11972 320-333 RB denotes significantly
T11973 334-343 VBN denotes inhibited
T11974 344-346 IN denotes at
T11975 347-349 CD denotes 10
T11976 349-350 CD denotes −
T11977 350-352 CD denotes 12
T11978 353-354 NNP denotes M
T11979 355-357 NNP denotes FP
T11980 358-359 -LRB- denotes (
T11981 359-360 FW denotes p
T11982 360-361 FW denotes <
T11983 361-366 CD denotes 0.001
T11984 366-367 , denotes ,
T11985 368-373 NNP denotes ANOVA
T11986 374-377 CC denotes and
T11987 378-390 NNP denotes Newman-Keuls
T11988 391-395 NN denotes test
T11989 395-396 -RRB- denotes )
T11990 397-400 CC denotes and
T11991 401-411 RB denotes completely
T11992 412-422 VBN denotes attenuated
T11993 423-425 IN denotes by
T11994 426-428 CD denotes 10
T11995 428-429 NN denotes −
T11996 429-430 CD denotes 8
T11997 431-432 NNP denotes M
T11998 433-435 NNP denotes FP
T11999 436-437 -LRB- denotes (
T12000 437-438 FW denotes p
T12001 438-439 FW denotes <
T12002 439-444 CD denotes 0.001
T12003 444-445 , denotes ,
T12004 446-451 NNP denotes ANOVA
T12005 452-455 CC denotes and
T12006 456-468 NNP denotes Newman-Keuls
T12007 469-473 NN denotes test
T12008 473-474 -RRB- denotes )
T12009 474-475 . denotes .
T12010 1425-1428 PRP$ denotes Our
T12011 1429-1437 JJ denotes previous
T12012 1438-1439 NNP denotes T
T12013 1440-1444 NN denotes cell
T12014 1445-1449 NN denotes line
T12015 1450-1457 NNS denotes studies
T12016 1458-1467 VBD denotes indicated
T12017 1468-1472 IN denotes that
T12018 1473-1475 CD denotes 10
T12019 1475-1476 CD denotes −
T12020 1476-1478 CD denotes 12
T12021 1479-1480 NNP denotes M
T12022 1481-1483 NNP denotes FP
T12023 1484-1494 VBZ denotes suppresses
T12024 1495-1499 NN denotes IL-4
T12025 1500-1503 CC denotes and
T12026 1504-1506 CD denotes -5
T12027 1507-1511 NN denotes gene
T12028 1512-1522 NN denotes expression
T12029 1523-1526 CC denotes and
T12030 1527-1537 VBD denotes attenuated
T12031 1538-1541 DT denotes the
T12032 1542-1553 NN denotes interaction
T12033 1554-1556 IN denotes of
T12034 1557-1563 NN denotes GATA-3
T12035 1564-1568 IN denotes with
T12036 1569-1579 JJ denotes importin-α
T12037 1580-1581 -LRB- denotes (
T12038 1581-1584 VB denotes see
T12039 1585-1592 NNS denotes Figures
T12040 1593-1595 CD denotes 1D
T12041 1596-1599 CC denotes and
T12042 1600-1601 CD denotes 2
T12043 1601-1602 -RRB- denotes )
T12044 1602-1603 . denotes .
T12045 1604-1608 DT denotes This
T12046 1609-1622 NN denotes concentration
T12047 1623-1625 VBZ denotes is
T12048 1626-1631 JJ denotes close
T12049 1632-1634 TO denotes to
T12050 1635-1639 VB denotes peak
T12051 1640-1646 NN denotes plasma
T12052 1647-1653 NNS denotes levels
T12053 1654-1662 VBN denotes obtained
T12054 1663-1667 IN denotes from
T12055 1668-1677 JJ denotes asthmatic
T12056 1678-1686 NNS denotes patients
T12057 1687-1694 VBN denotes treated
T12058 1695-1699 IN denotes with
T12059 1700-1707 JJ denotes inhaled
T12060 1708-1710 NNP denotes FP
T12061 1711-1712 -LRB- denotes (
T12062 1712-1715 CD denotes 500
T12063 1716-1718 NN denotes µg
T12064 1718-1719 -RRB- denotes )
T12065 1720-1721 NNP denotes [
T12066 1721-1723 CD denotes 27
T12067 1723-1724 NNP denotes ]
T12068 1724-1725 . denotes .
T12069 1726-1733 VBN denotes Inhaled
T12070 1734-1736 NNP denotes FP
T12071 1737-1738 -LRB- denotes (
T12072 1738-1741 CD denotes 500
T12073 1742-1744 NN denotes µg
T12074 1744-1745 -RRB- denotes )
T12075 1746-1755 NN denotes treatment
T12076 1756-1758 IN denotes of
T12077 1759-1764 CD denotes seven
T12078 1765-1778 JJ denotes steroid-naive
T12079 1779-1785 NN denotes asthma
T12080 1786-1794 NNS denotes patients
T12081 1795-1808 RB denotes significantly
T12082 1809-1816 VBD denotes reduced
T12083 1817-1823 NNP denotes GATA-3
T12084 1824-1834 JJ denotes importin-α
T12085 1835-1846 NN denotes interaction
T12086 1847-1849 IN denotes in
T12087 1850-1854 NN denotes vivo
T12088 1855-1857 IN denotes in
T12089 1858-1859 DT denotes a
T12090 1860-1874 JJ denotes time-dependent
T12091 1875-1881 NN denotes manner
T12092 1881-1882 . denotes .
T12093 1883-1887 DT denotes This
T12094 1888-1896 VBD denotes produced
T12095 1897-1898 DT denotes a
T12096 1899-1900 NN denotes >
T12097 1900-1902 CD denotes 90
T12098 1902-1903 NN denotes %
T12099 1904-1912 NN denotes decrease
T12100 1913-1915 IN denotes in
T12101 1916-1922 NNP denotes GATA-3
T12102 1923-1933 JJ denotes importin-α
T12103 1934-1945 NN denotes association
T12104 1946-1948 IN denotes at
T12105 1949-1950 CD denotes 2
T12106 1951-1952 NN denotes h
T12107 1953-1954 -LRB- denotes (
T12108 1954-1960 JJ denotes median
T12109 1961-1962 NNP denotes [
T12110 1962-1964 CD denotes 95
T12111 1964-1965 NN denotes %
T12112 1966-1968 NNP denotes CI
T12113 1968-1969 NNP denotes ]
T12114 1969-1970 , denotes ,
T12115 1971-1977 CD denotes 13,494
T12116 1978-1979 NNP denotes [
T12117 1979-1984 CD denotes 6,828
T12118 1985-1991 CD denotes 17,829
T12119 1991-1992 NNP denotes ]
T12120 1993-1999 CC denotes versus
T12121 2000-2003 CD denotes 879
T12122 2004-2005 JJ denotes [
T12123 2005-2008 CD denotes 597
T12124 2009-2014 CD denotes 1,165
T12125 2014-2015 NNP denotes ]
T12126 2015-2016 : denotes ;
T12127 2017-2018 VB denotes p
T12128 2018-2019 RB denotes <
T12129 2019-2023 CD denotes 0.05
T12130 2024-2032 NNP denotes Friedman
T12131 2032-2034 POS denotes 's
T12132 2035-2043 NN denotes analysis
T12133 2043-2044 -RRB- denotes )
T12134 2044-2045 . denotes .
T12135 2046-2053 RB denotes However
T12136 2053-2054 , denotes ,
T12137 2055-2059 DT denotes this
T12138 2060-2063 VBD denotes did
T12139 2064-2067 RB denotes not
T12140 2068-2073 VB denotes reach
T12141 2074-2086 NN denotes significance
T12142 2087-2092 VBG denotes using
T12143 2093-2101 NNP denotes Wilcoxon
T12144 2101-2103 POS denotes 's
T12145 2104-2113 JJ denotes post-test
T12146 2114-2122 NN denotes analysis
T12147 2123-2124 -LRB- denotes (
T12148 2124-2125 NNP denotes W
T12149 2126-2127 SYM denotes =
T12150 2128-2132 CD denotes 6.00
T12151 2132-2133 -RRB- denotes )
T12152 2134-2142 RB denotes probably
T12153 2143-2146 JJ denotes due
T12154 2147-2149 TO denotes to
T12155 2150-2153 JJ denotes low
T12156 2154-2161 NNS denotes numbers
T12157 2162-2164 IN denotes of
T12158 2165-2177 NNS denotes participants
T12159 2177-2178 . denotes .
T12160 2179-2186 JJ denotes Similar
T12161 2187-2194 NNS denotes results
T12162 2195-2199 VBD denotes were
T12163 2200-2208 VBN denotes observed
T12164 2209-2213 WRB denotes when
T12165 2214-2220 NNP denotes GATA-3
T12166 2221-2231 JJ denotes importin-α
T12167 2232-2243 NN denotes association
T12168 2244-2247 VBD denotes was
T12169 2248-2256 VBN denotes measured
T12170 2257-2258 -LRB- denotes (
T12171 2258-2264 NNP denotes Figure
T12172 2265-2267 NNP denotes 6C
T12173 2268-2271 CC denotes and
T12174 2272-2274 NNP denotes 6D
T12175 2274-2275 -RRB- denotes )
T12176 2275-2276 . denotes .
T12177 2277-2280 DT denotes The
T12178 2281-2286 JJR denotes lower
T12179 2287-2291 NN denotes dose
T12180 2292-2294 IN denotes of
T12181 2295-2297 NNP denotes FP
T12182 2298-2299 -LRB- denotes (
T12183 2299-2302 CD denotes 100
T12184 2303-2305 NN denotes µg
T12185 2305-2306 -RRB- denotes )
T12186 2307-2310 VBD denotes was
T12187 2311-2314 RB denotes not
T12188 2315-2324 JJ denotes effective
T12189 2324-2325 . denotes .
T12190 2326-2329 DT denotes The
T12191 2330-2340 JJ denotes attenuated
T12192 2341-2352 NN denotes interaction
T12193 2353-2355 IN denotes of
T12194 2356-2362 NN denotes GATA-3
T12195 2363-2366 VBD denotes did
T12196 2367-2370 RB denotes not
T12197 2371-2377 VB denotes result
T12198 2378-2382 IN denotes from
T12199 2383-2386 DT denotes the
T12200 2387-2396 JJ denotes defective
T12201 2397-2406 NN denotes recycling
T12202 2407-2409 IN denotes of
T12203 2410-2420 NN denotes importin-α
T12204 2420-2421 , denotes ,
T12205 2422-2424 IN denotes as
T12206 2425-2426 DT denotes a
T12207 2427-2438 JJ denotes significant
T12208 2439-2447 NN denotes decrease
T12209 2448-2450 IN denotes in
T12210 2451-2454 DT denotes the
T12211 2455-2464 NN denotes abundance
T12212 2465-2467 IN denotes of
T12213 2468-2478 NN denotes importin-α
T12214 2479-2481 IN denotes in
T12215 2482-2485 DT denotes the
T12216 2486-2497 JJ denotes cytoplasmic
T12217 2498-2502 NN denotes pool
T12218 2503-2506 VBD denotes was
T12219 2507-2510 RB denotes not
T12220 2511-2519 VBN denotes detected
T12221 2520-2521 -LRB- denotes (
T12222 2521-2527 NN denotes Figure
T12223 2528-2530 CD denotes 6E
T12224 2530-2531 -RRB- denotes )
T12225 2531-2532 . denotes .
T12226 2533-2535 PRP denotes We
T12227 2536-2543 RB denotes further
T12228 2544-2552 VBD denotes examined
T12229 2553-2560 IN denotes whether
T12230 2561-2568 JJ denotes inhaled
T12231 2569-2571 NNP denotes FP
T12232 2572-2577 MD denotes could
T12233 2578-2584 VB denotes affect
T12234 2585-2593 JJ denotes cellular
T12235 2594-2606 NN denotes localization
T12236 2607-2609 IN denotes of
T12237 2610-2616 NN denotes GATA-3
T12238 2617-2619 IN denotes in
T12239 2620-2630 JJ denotes peripheral
T12240 2631-2636 NN denotes blood
T12241 2637-2638 NNP denotes T
T12242 2639-2644 NNS denotes cells
T12243 2644-2645 . denotes .
T12244 2646-2655 NNP denotes Treatment
T12245 2656-2660 IN denotes with
T12246 2661-2668 JJ denotes inhaled
T12247 2669-2671 NNP denotes FP
T12248 2672-2673 -LRB- denotes (
T12249 2673-2676 CD denotes 500
T12250 2677-2679 NN denotes µg
T12251 2679-2680 -RRB- denotes )
T12252 2681-2684 IN denotes for
T12253 2685-2686 CD denotes 2
T12254 2687-2688 NN denotes h
T12255 2689-2702 RB denotes significantly
T12256 2703-2712 VBD denotes increased
T12257 2713-2715 NNP denotes GR
T12258 2716-2723 JJ denotes nuclear
T12259 2724-2737 NN denotes translocation
T12260 2738-2739 -LRB- denotes (
T12261 2739-2745 NN denotes Figure
T12262 2746-2748 NN denotes 7A
T12263 2748-2749 -RRB- denotes )
T12264 2750-2753 CC denotes and
T12265 2754-2767 RB denotes concomitantly
T12266 2768-2777 VBD denotes decreased
T12267 2778-2781 DT denotes the
T12268 2782-2788 NN denotes number
T12269 2789-2791 IN denotes of
T12270 2792-2799 JJ denotes nuclear
T12271 2800-2806 JJ denotes GATA-3
T12272 2807-2821 JJ denotes immunoreactive
T12273 2822-2832 JJ denotes peripheral
T12274 2833-2838 NN denotes blood
T12275 2839-2840 NNP denotes T
T12276 2841-2846 NNS denotes cells
T12277 2847-2848 -LRB- denotes (
T12278 2848-2850 CD denotes 37
T12279 2850-2851 NN denotes %
T12280 2851-2852 CD denotes ±
T12281 2852-2855 CD denotes 4.2
T12282 2855-2856 NN denotes %
T12283 2857-2863 CC denotes versus
T12284 2864-2868 CD denotes 58.2
T12285 2868-2869 NN denotes %
T12286 2869-2870 CD denotes ±
T12287 2870-2874 CD denotes 4.95
T12288 2874-2875 NN denotes %
T12289 2875-2876 , denotes ,
T12290 2877-2878 VBP denotes p
T12291 2879-2880 SYM denotes =
T12292 2881-2886 CD denotes 0.016
T12293 2886-2887 , denotes ,
T12294 2888-2889 NNP denotes W
T12295 2890-2891 SYM denotes =
T12296 2892-2896 CD denotes 28.0
T12297 2896-2897 , denotes ,
T12298 2898-2906 NNP denotes Wilcoxon
T12299 2906-2908 POS denotes 's
T12300 2909-2913 NN denotes rank
T12301 2914-2918 NN denotes test
T12302 2918-2919 -RRB- denotes )
T12303 2920-2928 VBN denotes compared
T12304 2929-2933 IN denotes with
T12305 2934-2941 NN denotes placebo
T12306 2942-2944 IN denotes as
T12307 2945-2953 VBN denotes measured
T12308 2954-2956 IN denotes by
T12309 2957-2976 NN denotes immunocytochemistry
T12310 2977-2978 -LRB- denotes (
T12311 2978-2984 NN denotes Figure
T12312 2985-2987 NN denotes 7A
T12313 2988-2991 CC denotes and
T12314 2992-2994 NN denotes 7B
T12315 2994-2995 -RRB- denotes )
T12316 2995-2996 . denotes .
T12317 2997-3001 DT denotes This
T12318 3002-3005 VBD denotes was
T12319 3006-3015 VBN denotes confirmed
T12320 3016-3018 IN denotes by
T12321 3019-3026 JJ denotes Western
T12322 3027-3035 VBG denotes blotting
T12323 3035-3036 , denotes ,
T12324 3037-3042 WDT denotes which
T12325 3043-3047 RB denotes also
T12326 3048-3057 VBD denotes indicated
T12327 3058-3062 IN denotes that
T12328 3063-3067 DT denotes this
T12329 3068-3074 NN denotes effect
T12330 3075-3078 VBD denotes was
T12331 3079-3083 DT denotes both
T12332 3084-3088 NN denotes time
T12333 3088-3089 : denotes -
T12334 3090-3093 CC denotes and
T12335 3094-3108 JJ denotes dose-dependent
T12336 3109-3110 -LRB- denotes (
T12337 3110-3116 NNP denotes Figure
T12338 3117-3119 NNP denotes 7C
T12339 3120-3123 CC denotes and
T12340 3124-3126 NNP denotes 7D
T12341 3126-3127 -RRB- denotes )
T12342 3127-3128 . denotes .
T12343 3129-3133 RB denotes Thus
T12344 3133-3134 , denotes ,
T12345 3135-3142 VBD denotes inhaled
T12346 3143-3145 NNP denotes FP
T12347 3146-3147 -LRB- denotes (
T12348 3147-3150 CD denotes 500
T12349 3151-3153 NN denotes µg
T12350 3153-3154 -RRB- denotes )
T12351 3155-3162 VBD denotes induced
T12352 3163-3174 JJ denotes significant
T12353 3175-3179 NN denotes loss
T12354 3180-3182 IN denotes in
T12355 3183-3190 JJ denotes nuclear
T12356 3191-3197 NN denotes GATA-3
T12357 3198-3200 IN denotes at
T12358 3201-3202 CD denotes 2
T12359 3203-3204 NN denotes h
T12360 3205-3206 -LRB- denotes (
T12361 3206-3212 JJ denotes median
T12362 3213-3214 NNP denotes [
T12363 3214-3216 CD denotes 95
T12364 3216-3217 NN denotes %
T12365 3218-3220 NNP denotes CI
T12366 3220-3221 NNP denotes ]
T12367 3221-3222 , denotes ,
T12368 3223-3227 CD denotes 0.40
T12369 3228-3229 NNP denotes [
T12370 3229-3233 CD denotes 0.27
T12371 3234-3238 CD denotes 0.53
T12372 3238-3239 NNP denotes ]
T12373 3240-3246 CC denotes versus
T12374 3247-3251 CD denotes 0.14
T12375 3252-3253 NNP denotes [
T12376 3253-3257 CD denotes 0.11
T12377 3258-3262 CD denotes 0.19
T12378 3262-3263 NNP denotes ]
T12379 3263-3264 , denotes ,
T12380 3265-3266 NN denotes p
T12381 3266-3267 NN denotes <
T12382 3267-3271 CD denotes 0.05
T12383 3271-3272 , denotes ,
T12384 3273-3274 NNP denotes W
T12385 3275-3276 SYM denotes =
T12386 3277-3282 CD denotes 21.00
T12387 3282-3283 , denotes ,
T12388 3284-3292 NNP denotes Wilcoxon
T12389 3292-3294 POS denotes 's
T12390 3295-3299 NN denotes rank
T12391 3300-3304 NN denotes test
T12392 3304-3305 -RRB- denotes )
T12393 3306-3307 -LRB- denotes (
T12394 3307-3313 NN denotes Figure
T12395 3314-3316 NN denotes 7C
T12396 3316-3317 -RRB- denotes )
T12397 3318-3321 CC denotes and
T12398 3322-3333 JJ denotes cytoplasmic
T12399 3334-3340 NN denotes GATA-3
T12400 3341-3347 NNS denotes levels
T12401 3348-3352 VBD denotes were
T12402 3353-3361 VBN denotes enhanced
T12403 3362-3364 IN denotes by
T12404 3365-3372 JJ denotes inhaled
T12405 3373-3375 NNP denotes FP
T12406 3376-3378 IN denotes in
T12407 3379-3380 DT denotes a
T12408 3381-3395 JJ denotes dose-dependent
T12409 3396-3402 NN denotes manner
T12410 3403-3404 -LRB- denotes (
T12411 3404-3410 JJ denotes median
T12412 3411-3412 NNP denotes [
T12413 3412-3414 CD denotes 95
T12414 3414-3415 NN denotes %
T12415 3416-3418 NNP denotes CI
T12416 3418-3419 NNP denotes ]
T12417 3419-3420 , denotes ,
T12418 3421-3427 CD denotes 0.0032
T12419 3428-3429 NNP denotes [
T12420 3429-3435 CD denotes 0.0026
T12421 3436-3442 CD denotes 0.0039
T12422 3442-3443 NNP denotes ]
T12423 3444-3450 CC denotes versus
T12424 3451-3456 CD denotes 0.658
T12425 3457-3458 NNP denotes [
T12426 3458-3463 CD denotes 0.592
T12427 3464-3469 CD denotes 0.720
T12428 3469-3470 NNP denotes ]
T12429 3470-3471 , denotes ,
T12430 3472-3473 NN denotes p
T12431 3473-3474 NN denotes <
T12432 3474-3478 CD denotes 0.05
T12433 3478-3479 , denotes ,
T12434 3480-3481 NNP denotes W
T12435 3482-3483 SYM denotes =
T12436 3484-3485 FW denotes −
T12437 3485-3490 CD denotes 21.00
T12438 3490-3491 , denotes ,
T12439 3492-3500 NNP denotes Wilcoxon
T12440 3500-3502 POS denotes 's
T12441 3503-3507 NN denotes rank
T12442 3508-3512 NN denotes test
T12443 3512-3513 -RRB- denotes )
T12444 3514-3515 -LRB- denotes (
T12445 3515-3521 NNP denotes Figure
T12446 3522-3524 NNP denotes 7D
T12447 3524-3525 -RRB- denotes )
T12448 3525-3526 . denotes .
T12449 3527-3529 IN denotes In
T12450 3530-3538 NN denotes addition
T12451 3538-3539 , denotes ,
T12452 3540-3542 NNP denotes FP
T12453 3543-3544 -LRB- denotes (
T12454 3544-3547 CD denotes 500
T12455 3548-3550 NN denotes µg
T12456 3550-3551 -RRB- denotes )
T12457 3552-3561 VBD denotes inhibited
T12458 3562-3565 CD denotes p38
T12459 3566-3570 NNP denotes MAPK
T12460 3571-3586 NN denotes phosphorylation
T12461 3587-3589 IN denotes in
T12462 3590-3597 JJ denotes primary
T12463 3598-3599 NNP denotes T
T12464 3600-3605 NNS denotes cells
T12465 3606-3608 IN denotes in
T12466 3609-3613 NN denotes vivo
T12467 3614-3616 IN denotes at
T12468 3617-3618 CD denotes 2
T12469 3619-3620 NN denotes h
T12470 3621-3623 IN denotes in
T12471 3624-3631 NNS denotes samples
T12472 3632-3636 IN denotes from
T12473 3637-3640 CD denotes two
T12474 3641-3649 NNS denotes patients
T12475 3650-3651 -LRB- denotes (
T12476 3651-3657 NN denotes Figure
T12477 3658-3660 CD denotes 7E
T12478 3660-3661 -RRB- denotes )
T12479 3661-3662 . denotes .
T12480 5149-5154 VBN denotes Taken
T12481 5155-5163 RB denotes together
T12482 5163-5164 , denotes ,
T12483 5165-5168 PRP$ denotes our
T12484 5169-5173 NNS denotes data
T12485 5174-5181 VBP denotes suggest
T12486 5182-5186 IN denotes that
T12487 5187-5194 VBD denotes inhaled
T12488 5195-5197 NNP denotes FP
T12489 5198-5205 VBZ denotes reduces
T12490 5206-5213 JJ denotes nuclear
T12491 5214-5226 NN denotes localization
T12492 5227-5229 IN denotes of
T12493 5230-5236 NN denotes GATA-3
T12494 5237-5239 IN denotes in
T12495 5240-5244 NN denotes vivo
T12496 5245-5247 IN denotes by
T12497 5248-5255 RB denotes acutely
T12498 5256-5266 VBG denotes inhibiting
T12499 5267-5281 JJ denotes phospho-GATA-3
T12500 5282-5290 NN denotes importin
T12501 5291-5302 NN denotes association
T12502 5302-5303 . denotes .
T12503 5304-5308 DT denotes This
T12504 5309-5315 NN denotes effect
T12505 5316-5319 MD denotes may
T12506 5320-5322 VB denotes be
T12507 5323-5329 JJ denotes direct
T12508 5329-5330 , denotes ,
T12509 5331-5338 IN denotes through
T12510 5339-5350 NN denotes competition
T12511 5351-5354 IN denotes for
T12512 5355-5365 JJ denotes importin-α
T12513 5366-5368 CC denotes or
T12514 5369-5379 VBN denotes associated
T12515 5380-5389 NNS denotes molecules
T12516 5389-5390 , denotes ,
T12517 5391-5393 CC denotes or
T12518 5394-5403 JJ denotes secondary
T12519 5404-5406 TO denotes to
T12520 5407-5409 DT denotes an
T12521 5410-5416 NN denotes effect
T12522 5417-5419 IN denotes on
T12523 5420-5423 CD denotes p38
T12524 5424-5437 JJ denotes MAPK-mediated
T12525 5438-5444 JJ denotes GATA-3
T12526 5445-5460 NN denotes phosphorylation
T12527 5461-5464 IN denotes via
T12528 5465-5470 JJ denotes rapid
T12529 5471-5480 NN denotes induction
T12530 5481-5483 IN denotes of
T12531 5484-5489 NN denotes MKP-1
T12532 5489-5490 . denotes .
T12533 5491-5494 DT denotes The
T12534 5495-5506 NN denotes combination
T12535 5507-5509 IN denotes of
T12536 5510-5515 DT denotes these
T12537 5516-5519 CD denotes two
T12538 5520-5531 VBG denotes interacting
T12539 5532-5539 NNS denotes effects
T12540 5540-5543 MD denotes can
T12541 5544-5550 VB denotes result
T12542 5551-5553 IN denotes in
T12543 5554-5562 JJ denotes complete
T12544 5563-5574 NN denotes suppression
T12545 5575-5577 IN denotes of
T12546 5578-5584 JJ denotes GATA-3
T12547 5585-5592 JJ denotes nuclear
T12548 5593-5599 NN denotes import
T12549 5600-5603 CC denotes and
T12550 5604-5608 RB denotes thus
T12551 5609-5612 JJ denotes Th2
T12552 5613-5621 NN denotes cytokine
T12553 5622-5626 NN denotes gene
T12554 5627-5637 NN denotes expression
T12555 5637-5638 . denotes .
T19430 520-531 NNP denotes Fluticasone
T19431 532-542 NN denotes propionate
T19432 543-550 VBZ denotes impairs
T19433 551-557 JJ denotes GATA-3
T19434 558-569 NN denotes interaction
T19435 570-574 IN denotes with
T19436 575-585 JJ denotes importin-α
T19437 586-589 CC denotes and
T19438 590-596 JJ denotes GATA-3
T19439 597-604 JJ denotes nuclear
T19440 605-617 NN denotes localization
T19441 618-620 IN denotes in
T19442 621-625 NN denotes vivo
T19443 626-629 CC denotes and
T19444 630-632 FW denotes ex
T19445 633-637 FW denotes vivo
T19446 637-638 . denotes .
T19447 639-640 -LRB- denotes (
T19448 640-641 DT denotes A
T19449 642-645 CC denotes and
T19450 646-647 NNP denotes B
T19451 647-648 -RRB- denotes )
T19452 649-671 NN denotes Co-immunoprecipitation
T19453 672-680 NN denotes analysis
T19454 681-683 IN denotes of
T19455 684-689 NNS denotes PBMCs
T19456 690-694 IN denotes from
T19457 695-708 JJ denotes steroid-naïve
T19458 709-715 NN denotes asthma
T19459 716-724 NNS denotes patients
T19460 725-732 VBN denotes treated
T19461 733-737 IN denotes with
T19462 738-740 NNP denotes FP
T19463 741-743 IN denotes in
T19464 744-749 NN denotes vitro
T19465 750-762 VBD denotes demonstrated
T19466 763-771 VBN denotes impaired
T19467 772-783 NN denotes interaction
T19468 784-791 IN denotes between
T19469 792-798 NNP denotes GATA-3
T19470 799-802 CC denotes and
T19471 803-813 JJ denotes importin-α
T19472 814-822 VBN denotes measured
T19473 823-825 IN denotes at
T19474 826-828 CD denotes 60
T19475 829-832 NN denotes min
T19476 832-833 . denotes .
T19477 834-838 DT denotes Each
T19478 839-842 NN denotes bar
T19479 843-853 VBZ denotes represents
T19480 854-857 DT denotes the
T19481 858-862 JJ denotes mean
T19482 862-863 NN denotes ±
T19483 863-866 NNP denotes SEM
T19484 867-869 IN denotes of
T19485 870-872 IN denotes at
T19486 873-878 JJS denotes least
T19487 879-884 CD denotes three
T19488 885-896 JJ denotes independent
T19489 897-908 NNS denotes experiments
T19490 908-909 : denotes ;
T19491 910-913 FW denotes ***
T19492 914-915 FW denotes p
T19493 915-916 FW denotes <
T19494 916-921 CD denotes 0.001
T19495 922-930 VBN denotes compared
T19496 931-935 IN denotes with
T19497 936-943 NN denotes control
T19498 944-946 IN denotes as
T19499 947-957 VBN denotes determined
T19500 958-960 IN denotes by
T19501 961-979 NNP denotes ANOVA/Newman-Keuls
T19502 980-988 NN denotes analysis
T19503 988-989 . denotes .
T19504 990-991 -LRB- denotes (
T19505 991-992 NNP denotes C
T19506 993-996 CC denotes and
T19507 997-998 NNP denotes D
T19508 998-999 -RRB- denotes )
T19509 1000-1022 NN denotes Co-immunoprecipitation
T19510 1023-1031 NNS denotes analyses
T19511 1032-1034 IN denotes of
T19512 1035-1040 NNS denotes PBMCs
T19513 1041-1045 IN denotes from
T19514 1046-1059 JJ denotes steroid-naïve
T19515 1060-1066 NN denotes asthma
T19516 1067-1075 NNS denotes patients
T19517 1076-1083 VBN denotes treated
T19518 1084-1088 IN denotes with
T19519 1089-1096 JJ denotes inhaled
T19520 1097-1099 NNP denotes FP
T19521 1100-1101 -LRB- denotes (
T19522 1101-1104 CD denotes 500
T19523 1105-1107 NN denotes µg
T19524 1108-1111 IN denotes via
T19525 1112-1113 DT denotes a
T19526 1114-1120 NN denotes spacer
T19527 1120-1121 -RRB- denotes )
T19528 1122-1124 IN denotes in
T19529 1125-1129 NN denotes vivo
T19530 1130-1142 VBD denotes demonstrated
T19531 1143-1152 VBN denotes decreased
T19532 1153-1164 NN denotes association
T19533 1165-1172 IN denotes between
T19534 1173-1179 NNP denotes GATA-3
T19535 1180-1183 CC denotes and
T19536 1184-1194 JJ denotes importin-α
T19537 1194-1195 . denotes .
T19538 1196-1199 DT denotes The
T19539 1200-1210 JJ denotes individual
T19540 1211-1217 NNS denotes values
T19541 1218-1221 IN denotes for
T19542 1222-1226 DT denotes each
T19543 1227-1236 NN denotes treatment
T19544 1237-1240 VBP denotes are
T19545 1241-1250 VBN denotes presented
T19546 1251-1262 RB denotes graphically
T19547 1262-1263 . denotes .
T19548 1264-1265 -LRB- denotes (
T19549 1265-1266 NNP denotes E
T19550 1266-1267 -RRB- denotes )
T19551 1268-1282 NNP denotes Representative
T19552 1283-1290 NNP denotes Western
T19553 1291-1295 NN denotes blot
T19554 1296-1303 VBG denotes showing
T19555 1304-1308 IN denotes that
T19556 1309-1319 JJ denotes importin-α
T19557 1320-1330 NN denotes expression
T19558 1331-1334 VBD denotes was
T19559 1335-1345 JJ denotes unaffected
T19560 1346-1348 IN denotes by
T19561 1349-1359 NN denotes inhalation
T19562 1360-1362 IN denotes of
T19563 1363-1365 NNP denotes FP
T19564 1365-1366 . denotes .
T19565 1367-1371 NNP denotes Blot
T19566 1372-1374 VBZ denotes is
T19567 1375-1389 NN denotes representative
T19568 1390-1392 IN denotes of
T19569 1393-1397 NNS denotes gels
T19570 1398-1402 IN denotes from
T19571 1403-1408 CD denotes three
T19572 1409-1421 NNS denotes participants
T19573 1421-1422 . denotes .
T19983 3707-3714 VBN denotes Inhaled
T19984 3715-3726 NN denotes fluticasone
T19985 3727-3737 NN denotes propionate
T19986 3738-3745 VBZ denotes impairs
T19987 3746-3752 JJ denotes GATA-3
T19988 3753-3760 JJ denotes nuclear
T19989 3761-3773 NN denotes localization
T19990 3774-3776 IN denotes in
T19991 3777-3782 NNP denotes PBMCs
T19992 3782-3783 . denotes .
T19993 3784-3785 -LRB- denotes (
T19994 3785-3786 NNP denotes A
T19995 3786-3787 -RRB- denotes )
T19996 3788-3802 NNP denotes Representative
T19997 3803-3822 NN denotes immunocytochemistry
T19998 3823-3825 IN denotes of
T19999 3826-3833 VBG denotes showing
T20000 3834-3837 DT denotes the
T20001 3838-3844 NN denotes effect
T20002 3845-3847 IN denotes of
T20003 3848-3855 JJ denotes inhaled
T20004 3856-3858 NNP denotes FP
T20005 3859-3860 -LRB- denotes (
T20006 3860-3863 CD denotes 500
T20007 3864-3866 NN denotes µg
T20008 3866-3867 -RRB- denotes )
T20009 3868-3870 IN denotes on
T20010 3871-3873 NNP denotes GR
T20011 3874-3877 CC denotes and
T20012 3878-3884 NNP denotes GATA-3
T20013 3885-3892 JJ denotes nuclear
T20014 3893-3905 NN denotes localisation
T20015 3905-3906 . denotes .
T20016 3907-3908 -LRB- denotes (
T20017 3908-3909 NNP denotes B
T20018 3909-3910 -RRB- denotes )
T20019 3911-3918 NNP denotes Nuclear
T20020 3919-3925 NNP denotes GATA-3
T20021 3926-3942 NN denotes immunoreactivity
T20022 3943-3945 IN denotes in
T20023 3946-3951 NNS denotes PBMCs
T20024 3952-3956 IN denotes from
T20025 3957-3962 CD denotes seven
T20026 3963-3976 JJ denotes steroid-naïve
T20027 3977-3983 NN denotes asthma
T20028 3984-3992 NNS denotes patients
T20029 3993-3994 CD denotes 2
T20030 3995-3996 NN denotes h
T20031 3997-4006 VBG denotes following
T20032 4007-4014 JJ denotes inhaled
T20033 4015-4017 NNP denotes FP
T20034 4018-4027 NN denotes treatment
T20035 4028-4029 -LRB- denotes (
T20036 4029-4032 CD denotes 100
T20037 4033-4035 CC denotes or
T20038 4036-4039 CD denotes 500
T20039 4040-4042 NN denotes µg
T20040 4043-4046 IN denotes via
T20041 4047-4053 NN denotes spacer
T20042 4053-4054 -RRB- denotes )
T20043 4054-4055 . denotes .
T20044 4056-4059 DT denotes The
T20045 4060-4066 NN denotes median
T20046 4067-4070 CC denotes and
T20047 4071-4084 JJ denotes interquartile
T20048 4085-4091 NNS denotes ranges
T20049 4092-4095 IN denotes for
T20050 4096-4100 DT denotes each
T20051 4101-4110 NN denotes treatment
T20052 4111-4114 VBP denotes are
T20053 4115-4124 VBN denotes presented
T20054 4125-4127 IN denotes as
T20055 4128-4129 DT denotes a
T20056 4130-4146 NNS denotes box-and-whiskers
T20057 4147-4151 NN denotes plot
T20058 4152-4153 -LRB- denotes (
T20059 4153-4154 FW denotes n
T20060 4155-4156 SYM denotes =
T20061 4157-4158 CD denotes 7
T20062 4158-4159 -RRB- denotes )
T20063 4159-4160 : denotes ;
T20064 4161-4162 SYM denotes *
T20065 4163-4164 NN denotes p
T20066 4164-4165 NN denotes <
T20067 4165-4169 CD denotes 0.05
T20068 4170-4178 NNP denotes Wilcoxon
T20069 4178-4180 POS denotes 's
T20070 4181-4185 NN denotes rank
T20071 4186-4190 NN denotes test
T20072 4191-4199 VBN denotes compared
T20073 4200-4204 IN denotes with
T20074 4205-4212 NN denotes placebo
T20075 4212-4213 . denotes .
T20076 4214-4215 -LRB- denotes (
T20077 4215-4216 NNP denotes C
T20078 4216-4217 -RRB- denotes )
T20079 4218-4232 NNP denotes Immunoblotting
T20080 4233-4241 NNS denotes analyses
T20081 4242-4244 IN denotes of
T20082 4245-4250 NNP denotes PBMCs
T20083 4251-4263 VBD denotes demonstrated
T20084 4264-4265 DT denotes a
T20085 4266-4280 JJ denotes time-dependent
T20086 4281-4289 NN denotes decrease
T20087 4290-4292 IN denotes in
T20088 4293-4300 JJ denotes nuclear
T20089 4301-4311 NN denotes expression
T20090 4312-4314 IN denotes of
T20091 4315-4321 NNP denotes GATA-3
T20092 4321-4322 , denotes ,
T20093 4323-4326 CC denotes and
T20094 4327-4336 VBD denotes increased
T20095 4337-4348 JJ denotes cytoplasmic
T20096 4349-4355 JJ denotes GATA-3
T20097 4356-4366 NN denotes expression
T20098 4367-4372 IN denotes after
T20099 4373-4383 NN denotes inhalation
T20100 4384-4386 IN denotes of
T20101 4387-4389 NNP denotes FP
T20102 4389-4390 . denotes .
T20103 4391-4392 -LRB- denotes (
T20104 4392-4393 NNP denotes D
T20105 4393-4394 -RRB- denotes )
T20106 4395-4409 NNP denotes Immunoblotting
T20107 4410-4418 NNS denotes analyses
T20108 4419-4421 IN denotes of
T20109 4422-4427 NNP denotes PBMCs
T20110 4428-4440 VBD denotes demonstrated
T20111 4441-4442 DT denotes a
T20112 4443-4457 JJ denotes dose-dependent
T20113 4458-4466 NN denotes decrease
T20114 4467-4469 IN denotes in
T20115 4470-4477 JJ denotes nuclear
T20116 4478-4488 NN denotes expression
T20117 4489-4491 IN denotes of
T20118 4492-4498 NNP denotes GATA-3
T20119 4498-4499 , denotes ,
T20120 4500-4503 CC denotes and
T20121 4504-4513 VBD denotes increased
T20122 4514-4525 JJ denotes cytoplasmic
T20123 4526-4532 JJ denotes GATA-3
T20124 4533-4543 NN denotes expression
T20125 4544-4545 CD denotes 2
T20126 4546-4547 NN denotes h
T20127 4548-4553 IN denotes after
T20128 4554-4564 NN denotes inhalation
T20129 4565-4567 IN denotes of
T20130 4568-4570 NNP denotes FP
T20131 4570-4571 . denotes .
T20132 4572-4579 NNP denotes Histone
T20133 4580-4582 NNP denotes H1
T20134 4583-4586 CC denotes and
T20135 4587-4592 NNP denotes MEK-1
T20136 4593-4607 VBG denotes immunoblotting
T20137 4608-4617 VBN denotes confirmed
T20138 4618-4628 JJ denotes equivalent
T20139 4629-4634 JJ denotes total
T20140 4635-4642 NN denotes protein
T20141 4643-4650 VBG denotes loading
T20142 4651-4654 IN denotes for
T20143 4655-4658 DT denotes the
T20144 4659-4666 JJ denotes nuclear
T20145 4667-4670 CC denotes and
T20146 4671-4682 JJ denotes cytoplasmic
T20147 4683-4692 NNS denotes fractions
T20148 4693-4705 RB denotes respectively
T20149 4705-4706 . denotes .
T20150 4707-4721 NN denotes Quantification
T20151 4722-4724 IN denotes of
T20152 4725-4728 DT denotes the
T20153 4729-4741 NN denotes densitometry
T20154 4742-4746 NNS denotes data
T20155 4747-4749 IN denotes in
T20156 4750-4751 -LRB- denotes (
T20157 4751-4752 NNP denotes C
T20158 4752-4753 -RRB- denotes )
T20159 4754-4757 CC denotes and
T20160 4758-4759 -LRB- denotes (
T20161 4759-4760 NNP denotes D
T20162 4760-4761 -RRB- denotes )
T20163 4762-4764 VBZ denotes is
T20164 4765-4770 VBN denotes shown
T20165 4771-4773 IN denotes as
T20166 4774-4775 DT denotes a
T20167 4776-4792 NNS denotes box-and-whiskers
T20168 4793-4797 NN denotes plot
T20169 4798-4800 IN denotes of
T20170 4801-4808 NNS denotes results
T20171 4809-4813 IN denotes from
T20172 4814-4815 JJ denotes n
T20173 4816-4817 SYM denotes =
T20174 4818-4819 CD denotes 6
T20175 4820-4832 NNS denotes participants
T20176 4833-4836 IN denotes for
T20177 4837-4842 WDT denotes which
T20178 4843-4847 NNS denotes data
T20179 4848-4852 VBD denotes were
T20180 4853-4862 JJ denotes available
T20181 4862-4863 . denotes .
T20182 4864-4865 SYM denotes *
T20183 4865-4866 NN denotes p
T20184 4866-4867 NN denotes <
T20185 4867-4871 CD denotes 0.05
T20186 4872-4880 VBN denotes compared
T20187 4881-4883 TO denotes to
T20188 4884-4891 VB denotes control
T20189 4891-4892 . denotes .
T20190 4893-4894 -LRB- denotes (
T20191 4894-4895 NNP denotes E
T20192 4895-4896 -RRB- denotes )
T20193 4897-4904 NNP denotes Western
T20194 4905-4909 NN denotes blot
T20195 4910-4918 NNS denotes analyses
T20196 4919-4921 IN denotes of
T20197 4922-4927 NNP denotes PBMCs
T20198 4928-4940 VBD denotes demonstrated
T20199 4941-4942 DT denotes a
T20200 4943-4957 JJ denotes time-dependent
T20201 4958-4966 NN denotes decrease
T20202 4967-4969 IN denotes in
T20203 4970-4974 JJ denotes dual
T20204 4975-4990 NN denotes phosphorylation
T20205 4991-4992 -LRB- denotes (
T20206 4992-5005 NN denotes threonine-180
T20207 5006-5009 CC denotes and
T20208 5010-5022 NN denotes tyrosine-182
T20209 5022-5023 -RRB- denotes )
T20210 5024-5026 IN denotes of
T20211 5027-5030 CD denotes p38
T20212 5031-5035 NNP denotes MAPK
T20213 5036-5041 IN denotes after
T20214 5042-5052 NN denotes inhalation
T20215 5053-5055 IN denotes of
T20216 5056-5058 NNP denotes FP
T20217 5059-5060 -LRB- denotes (
T20218 5060-5063 CD denotes 500
T20219 5064-5066 NN denotes µg
T20220 5066-5067 -RRB- denotes )
T20221 5067-5068 . denotes .
T20222 5069-5072 DT denotes The
T20223 5073-5080 NNS denotes results
T20224 5081-5086 VBN denotes shown
T20225 5087-5089 IN denotes in
T20226 5090-5091 -LRB- denotes (
T20227 5091-5092 NNP denotes E
T20228 5092-5093 -RRB- denotes )
T20229 5094-5097 VBP denotes are
T20230 5098-5112 NN denotes representative
T20231 5113-5115 IN denotes of
T20232 5116-5123 NNS denotes samples
T20233 5124-5128 IN denotes from
T20234 5129-5132 CD denotes two
T20235 5133-5145 NNS denotes participants
T20236 5145-5146 . denotes .
R10256 T11943 T11944 nmod ex,vivo
R10257 T11944 T11945 nsubj vivo,demonstrated
R10258 T11945 T11945 ROOT demonstrated,demonstrated
R10259 T11946 T11948 det a,decrease
R10260 T11947 T11948 amod concentration-dependent,decrease
R10261 T11948 T11945 dobj decrease,demonstrated
R10262 T11949 T11948 prep in,decrease
R10263 T11950 T11952 det the,interaction
R10264 T11951 T11952 amod direct,interaction
R10265 T11952 T11949 pobj interaction,in
R10266 T11953 T11952 prep between,interaction
R10267 T11954 T11953 pobj phospho-GATA-3,between
R10268 T11955 T11954 cc and,phospho-GATA-3
R10269 T11956 T11954 conj importin-α,phospho-GATA-3
R10270 T11957 T11956 prep in,importin-α
R10271 T11958 T11957 pobj PBMCs,in
R10272 T11959 T11954 prep from,phospho-GATA-3
R10273 T11960 T11959 pobj patients,from
R10274 T11961 T11960 prep with,patients
R10275 T11962 T11965 compound asthma,6A
R10276 T11963 T11964 punct (,Figure
R10277 T11964 T11965 compound Figure,6A
R10278 T11965 T11961 pobj 6A,with
R10279 T11966 T11965 cc and,6A
R10280 T11967 T11965 conj 6B,6A
R10281 T11968 T11967 punct ),6B
R10282 T11969 T11965 punct ",",6A
R10283 T11970 T11973 nsubjpass which,inhibited
R10284 T11971 T11973 auxpass was,inhibited
R10285 T11972 T11973 advmod significantly,inhibited
R10286 T11973 T11960 relcl inhibited,patients
R10287 T11974 T11973 prep at,inhibited
R10288 T11975 T11979 nummod 10,FP
R10289 T11976 T11979 nummod −,FP
R10290 T11977 T11979 nummod 12,FP
R10291 T11978 T11979 compound M,FP
R10292 T11979 T11974 pobj FP,at
R10293 T11980 T11979 punct (,FP
R10294 T11981 T11982 nmod p,<
R10295 T11982 T11983 nmod <,0.001
R10296 T11983 T11979 appos 0.001,FP
R10297 T11984 T11983 punct ",",0.001
R10298 T11985 T11983 conj ANOVA,0.001
R10299 T11986 T11985 cc and,ANOVA
R10300 T11987 T11988 compound Newman-Keuls,test
R10301 T11988 T11985 conj test,ANOVA
R10302 T11989 T11988 punct ),test
R10303 T11990 T11973 cc and,inhibited
R10304 T11991 T11992 advmod completely,attenuated
R10305 T11992 T11973 conj attenuated,inhibited
R10306 T11993 T11992 prep by,attenuated
R10307 T11994 T11998 nummod 10,FP
R10308 T11995 T11996 quantmod −,8
R10309 T11996 T11998 nummod 8,FP
R10310 T11997 T11998 compound M,FP
R10311 T11998 T12001 nmod FP,<
R10312 T11999 T12001 punct (,<
R10313 T12000 T12001 nmod p,<
R10314 T12001 T11993 pobj <,by
R10315 T12002 T12001 appos 0.001,<
R10316 T12003 T12001 punct ",",<
R10317 T12004 T12001 conj ANOVA,<
R10318 T12005 T12004 cc and,ANOVA
R10319 T12006 T12007 compound Newman-Keuls,test
R10320 T12007 T12004 conj test,ANOVA
R10321 T12008 T12001 punct ),<
R10322 T12009 T11945 punct .,demonstrated
R10323 T12010 T12015 poss Our,studies
R10324 T12011 T12015 amod previous,studies
R10325 T12012 T12015 compound T,studies
R10326 T12013 T12014 compound cell,line
R10327 T12014 T12015 compound line,studies
R10328 T12015 T12016 nsubj studies,indicated
R10329 T12016 T12016 ROOT indicated,indicated
R10330 T12017 T12023 mark that,suppresses
R10331 T12018 T12023 nsubj 10,suppresses
R10332 T12019 T12023 dep −,suppresses
R10333 T12020 T12023 dep 12,suppresses
R10334 T12021 T12022 compound M,FP
R10350 T12037 T12038 punct (,see
R10351 T12038 T12016 parataxis see,indicated
R10352 T12039 T12038 npadvmod Figures,see
R10353 T12040 T12043 nmod 1D,)
R10354 T12041 T12040 cc and,1D
R10355 T12042 T12040 conj 2,1D
R10356 T12043 T12038 punct ),see
R10357 T12044 T12016 punct .,indicated
R10358 T12045 T12046 det This,concentration
R10359 T12046 T12047 nsubj concentration,is
R10360 T12047 T12047 ROOT is,is
R10361 T12048 T12047 acomp close,is
R10362 T12049 T12050 aux to,peak
R10363 T12050 T12047 xcomp peak,is
R10364 T12051 T12052 compound plasma,levels
R10365 T12052 T12050 dobj levels,peak
R10366 T12053 T12052 acl obtained,levels
R10367 T12054 T12053 prep from,obtained
R10368 T12055 T12056 amod asthmatic,patients
R10369 T12056 T12054 pobj patients,from
R10370 T12057 T12056 acl treated,patients
R10371 T12058 T12057 prep with,treated
R10372 T12059 T12060 amod inhaled,FP
R10373 T12060 T12065 nmod FP,[
R10374 T12061 T12060 punct (,FP
R10375 T12062 T12063 nummod 500,µg
R10376 T12063 T12060 appos µg,FP
R10377 T12064 T12065 punct ),[
R10378 T12065 T12067 nmod [,]
R10379 T12066 T12067 nummod 27,]
R10380 T12067 T12058 pobj ],with
R10381 T12068 T12047 punct .,is
R10382 T12069 T12070 compound Inhaled,FP
R10383 T12070 T12082 nsubj FP,reduced
R10384 T12071 T12073 punct (,µg
R10385 T12072 T12073 nummod 500,µg
R10386 T12073 T12070 appos µg,FP
R10387 T12074 T12073 punct ),µg
R10388 T12075 T12070 appos treatment,FP
R10389 T12076 T12075 prep of,treatment
R10390 T12077 T12080 nummod seven,patients
R10391 T12078 T12080 amod steroid-naive,patients
R10392 T12079 T12080 compound asthma,patients
R10393 T12080 T12076 pobj patients,of
R10394 T12081 T12082 advmod significantly,reduced
R10395 T12082 T12082 ROOT reduced,reduced
R10396 T12083 T12082 dobj GATA-3,reduced
R10397 T12084 T12085 amod importin-α,interaction
R10398 T12085 T12083 appos interaction,GATA-3
R10399 T12086 T12085 prep in,interaction
R10400 T12087 T12086 pobj vivo,in
R10401 T12088 T12082 prep in,reduced
R10402 T12089 T12091 det a,manner
R10403 T12090 T12091 amod time-dependent,manner
R10404 T12091 T12088 pobj manner,in
R10405 T12092 T12082 punct .,reduced
R10406 T12093 T12094 nsubj This,produced
R10407 T12094 T12094 ROOT produced,produced
R10408 T12095 T12096 det a,>
R10409 T12096 T12099 compound >,decrease
R10410 T12097 T12098 nummod 90,%
R10411 T12098 T12099 compound %,decrease
R10412 T12099 T12094 dobj decrease,produced
R10413 T12100 T12099 prep in,decrease
R10414 T12101 T12100 pobj GATA-3,in
R10415 T12102 T12103 compound importin-α,association
R10416 T12103 T12099 appos association,decrease
R10417 T12104 T12099 prep at,decrease
R10418 T12105 T12106 nummod 2,h
R10419 T12106 T12104 pobj h,at
R10420 T12107 T12113 punct (,]
R10421 T12108 T12113 amod median,]
R10422 T12109 T12113 compound [,]
R10423 T12110 T12111 nummod 95,%
R10424 T12111 T12113 compound %,]
R10425 T12112 T12113 compound CI,]
R10426 T12113 T12099 appos ],decrease
R10427 T12114 T12113 punct ",",]
R10428 T12115 T12117 nummod "13,494","6,828"
R10429 T12116 T12117 compound [,"6,828"
R10430 T12117 T12113 appos "6,828",]
R10431 T12118 T12119 compound "17,829",]
R10432 T12119 T12113 conj ],]
R10433 T12120 T12119 cc versus,]
R10434 T12121 T12127 dep 879,p
R10435 T12122 T12127 ccomp [,p
R10436 T12123 T12122 nummod 597,[
R10437 T12124 T12122 nummod "1,165",[
R10438 T12125 T12125 ROOT ],]
R10439 T12126 T12127 punct ;,p
R10440 T12127 T12113 parataxis p,]
R10441 T12128 T12127 advmod <,p
R10442 T12129 T12132 nummod 0.05,analysis
R10443 T12130 T12132 poss Friedman,analysis
R10444 T12131 T12130 case 's,Friedman
R10445 T12132 T12128 appos analysis,<
R10446 T12133 T12128 punct ),<
R10447 T12134 T12127 punct .,p
R10448 T12135 T12140 advmod However,reach
R10449 T12136 T12140 punct ",",reach
R10475 T12162 T12163 auxpass were,observed
R10476 T12163 T12163 ROOT observed,observed
R10477 T12164 T12169 advmod when,measured
R10478 T12165 T12169 nsubjpass GATA-3,measured
R10479 T12166 T12167 amod importin-α,association
R10480 T12167 T12165 appos association,GATA-3
R10481 T12168 T12169 auxpass was,measured
R10482 T12169 T12163 advcl measured,observed
R10483 T12170 T12172 punct (,6C
R10484 T12171 T12172 compound Figure,6C
R10485 T12172 T12169 dobj 6C,measured
R10486 T12173 T12172 cc and,6C
R10487 T12174 T12172 conj 6D,6C
R10488 T12175 T12172 punct ),6C
R10489 T12176 T12163 punct .,observed
R10490 T12177 T12179 det The,dose
R10491 T12178 T12179 amod lower,dose
R10492 T12179 T12186 nsubj dose,was
R10493 T12180 T12179 prep of,dose
R10494 T12181 T12180 pobj FP,of
R10495 T12182 T12181 punct (,FP
R10496 T12183 T12184 nummod 100,µg
R10497 T12184 T12181 appos µg,FP
R10498 T12185 T12184 punct ),µg
R10499 T12186 T12186 ROOT was,was
R10500 T12187 T12186 neg not,was
R10501 T12188 T12186 acomp effective,was
R10502 T12189 T12186 punct .,was
R10503 T12190 T12192 det The,interaction
R10504 T12191 T12192 amod attenuated,interaction
R10554 T12241 T12242 compound T,cells
R10555 T12242 T12238 pobj cells,in
R10556 T12243 T12228 punct .,examined
R10557 T12244 T12256 nsubj Treatment,increased
R10558 T12245 T12244 prep with,Treatment
R10559 T12246 T12247 amod inhaled,FP
R10560 T12247 T12245 pobj FP,with
R10561 T12248 T12247 punct (,FP
R10562 T12249 T12250 nummod 500,µg
R10563 T12250 T12247 appos µg,FP
R10564 T12251 T12244 punct ),Treatment
R10565 T12252 T12244 prep for,Treatment
R10566 T12253 T12254 nummod 2,h
R10567 T12254 T12252 pobj h,for
R10568 T12255 T12256 advmod significantly,increased
R10569 T12256 T12256 ROOT increased,increased
R10570 T12257 T12259 nmod GR,translocation
R10571 T12258 T12259 amod nuclear,translocation
R10572 T12259 T12256 dobj translocation,increased
R10573 T12260 T12262 punct (,7A
R10574 T12261 T12262 compound Figure,7A
R10575 T12262 T12259 appos 7A,translocation
R10576 T12263 T12262 punct ),7A
R10577 T12264 T12256 cc and,increased
R10578 T12265 T12266 advmod concomitantly,decreased
R10579 T12266 T12256 conj decreased,increased
R10580 T12267 T12268 det the,number
R10581 T12268 T12266 dobj number,decreased
R10582 T12269 T12268 prep of,number
R10583 T12270 T12276 amod nuclear,cells
R10585 T12272 T12276 amod immunoreactive,cells
R10586 T12273 T12276 amod peripheral,cells
R10587 T12274 T12276 compound blood,cells
R10588 T12275 T12276 compound T,cells
R10589 T12276 T12269 pobj cells,of
R10590 T12277 T12276 punct (,cells
R10591 T12278 T12279 nummod 37,%
R10592 T12279 T12276 appos %,cells
R10593 T12280 T12290 nummod ±,p
R10594 T12281 T12282 nummod 4.2,%
R10595 T12282 T12280 quantmod %,±
R10596 T12283 T12280 cc versus,±
R10597 T12284 T12285 nummod 58.2,%
R10598 T12285 T12290 dep %,p
R10599 T12286 T12288 nummod ±,%
R10600 T12287 T12288 nummod 4.95,%
R10601 T12288 T12285 appos %,%
R10602 T12289 T12290 punct ",",p
R10603 T12290 T12276 parataxis p,cells
R10604 T12291 T12292 punct =,0.016
R10605 T12292 T12290 prep 0.016,p
R10606 T12293 T12303 punct ",",compared
R10607 T12294 T12303 nsubj W,compared
R10608 T12295 T12294 punct =,W
R10609 T12296 T12294 appos 28.0,W
R10610 T12297 T12294 punct ",",W
R10611 T12298 T12301 poss Wilcoxon,test
R10612 T12299 T12298 case 's,Wilcoxon
R10613 T12300 T12301 compound rank,test
R10614 T12301 T12294 appos test,W
R10615 T12302 T12294 punct ),W
R10616 T12303 T12256 prep compared,increased
R10617 T12304 T12303 prep with,compared
R10618 T12305 T12304 pobj placebo,with
R10619 T12306 T12307 mark as,measured
R10620 T12307 T12303 advcl measured,compared
R10621 T12308 T12307 agent by,measured
R10622 T12309 T12308 pobj immunocytochemistry,by
R10623 T12310 T12312 punct (,7A
R10624 T12311 T12312 compound Figure,7A
R10625 T12312 T12309 appos 7A,immunocytochemistry
R10626 T12313 T12312 cc and,7A
R10627 T12314 T12312 conj 7B,7A
R10628 T12315 T12312 punct ),7A
R10629 T12316 T12303 punct .,compared
R10630 T12317 T12319 nsubjpass This,confirmed
R10631 T12318 T12319 auxpass was,confirmed
R10632 T12319 T12319 ROOT confirmed,confirmed
R10633 T12320 T12319 agent by,confirmed
R10634 T12321 T12322 amod Western,blotting
R10635 T12322 T12320 pobj blotting,by
R10636 T12323 T12322 punct ",",blotting
R10637 T12324 T12326 nsubj which,indicated
R10638 T12325 T12326 advmod also,indicated
R10639 T12326 T12319 ccomp indicated,confirmed
R10640 T12327 T12330 mark that,was
R10641 T12328 T12329 det this,effect
R10642 T12329 T12330 nsubj effect,was
R10643 T12330 T12326 ccomp was,indicated
R10644 T12331 T12332 preconj both,time
R10645 T12332 T12330 attr time,was
R10646 T12333 T12332 punct -,time
R10647 T12334 T12332 cc and,time
R10648 T12335 T12332 conj dose-dependent,time
R10649 T12336 T12338 punct (,7C
R10650 T12337 T12338 compound Figure,7C
R10651 T12338 T12335 appos 7C,dose-dependent
R10652 T12339 T12338 cc and,7C
R10653 T12340 T12338 conj 7D,7C
R10654 T12341 T12338 punct ),7C
R10655 T12342 T12319 punct .,confirmed
R10656 T12343 T12345 advmod Thus,inhaled
R10657 T12344 T12345 punct ",",inhaled
R10658 T12345 T12345 ROOT inhaled,inhaled
R10659 T12346 T12345 dobj FP,inhaled
R10660 T12347 T12346 punct (,FP
R10666 T12353 T12351 dobj loss,induced
R10667 T12354 T12351 prep in,induced
R10668 T12355 T12356 amod nuclear,GATA-3
R10669 T12356 T12354 pobj GATA-3,in
R10670 T12357 T12351 prep at,induced
R10671 T12358 T12359 nummod 2,h
R10672 T12359 T12357 pobj h,at
R10673 T12360 T12366 punct (,]
R10674 T12361 T12366 amod median,]
R10675 T12362 T12366 compound [,]
R10676 T12363 T12364 nummod 95,%
R10677 T12364 T12366 compound %,]
R10678 T12365 T12366 compound CI,]
R10679 T12366 T12381 meta ],<
R10680 T12367 T12366 punct ",",]
R10681 T12368 T12370 compound 0.40,0.27
R10682 T12369 T12370 compound [,0.27
R10683 T12370 T12366 appos 0.27,]
R10684 T12371 T12372 nummod 0.53,]
R10685 T12372 T12366 conj ],]
R10686 T12373 T12372 cc versus,]
R10687 T12374 T12376 compound 0.14,0.11
R10688 T12375 T12376 compound [,0.11
R10689 T12376 T12366 appos 0.11,]
R10690 T12377 T12378 nummod 0.19,]
R10691 T12378 T12366 appos ],]
R10692 T12379 T12378 punct ",",]
R10693 T12380 T12381 compound p,<
R10694 T12381 T12351 npadvmod <,induced
R10695 T12382 T12381 nummod 0.05,<
R10696 T12383 T12381 punct ",",<
R10697 T12384 T12400 nmod W,levels
R10698 T12385 T12384 punct =,W
R10699 T12386 T12384 appos 21.00,W
R10700 T12387 T12384 punct ",",W
R10701 T12388 T12391 poss Wilcoxon,test
R10702 T12389 T12388 case 's,Wilcoxon
R10703 T12390 T12391 compound rank,test
R10704 T12391 T12384 appos test,W
R10705 T12392 T12384 punct ),W
R10706 T12393 T12395 punct (,7C
R10707 T12394 T12395 compound Figure,7C
R10708 T12395 T12384 appos 7C,W
R10709 T12396 T12395 punct ),7C
R10710 T12397 T12384 cc and,W
R10711 T12398 T12400 amod cytoplasmic,levels
R10712 T12399 T12400 compound GATA-3,levels
R10713 T12400 T12402 nsubjpass levels,enhanced
R10714 T12401 T12402 auxpass were,enhanced
R10715 T12402 T12351 conj enhanced,induced
R10716 T12403 T12402 agent by,enhanced
R10717 T12404 T12405 amod inhaled,FP
R10718 T12405 T12403 pobj FP,by
R10719 T12406 T12402 prep in,enhanced
R10720 T12407 T12409 det a,manner
R10721 T12408 T12409 amod dose-dependent,manner
R10722 T12409 T12406 pobj manner,in
R10723 T12410 T12416 punct (,]
R10724 T12411 T12416 amod median,]
R10725 T12412 T12416 compound [,]
R10726 T12413 T12414 nummod 95,%
R10727 T12414 T12416 compound %,]
R10728 T12415 T12416 compound CI,]
R10729 T12416 T12409 appos ],manner
R10730 T12417 T12416 punct ",",]
R10731 T12418 T12420 nummod 0.0032,0.0026
R10732 T12419 T12420 compound [,0.0026
R10733 T12420 T12416 appos 0.0026,]
R10734 T12421 T12422 nummod 0.0039,]
R10735 T12422 T12416 conj ],]
R10736 T12423 T12422 cc versus,]
R10737 T12424 T12426 compound 0.658,0.592
R10738 T12425 T12426 compound [,0.592
R10739 T12426 T12416 appos 0.592,]
R10740 T12427 T12428 nummod 0.720,]
R10741 T12428 T12416 appos ],]
R10742 T12429 T12428 punct ",",]
R10743 T12430 T12431 compound p,<
R10744 T12431 T12432 compound <,0.05
R10745 T12432 T12428 appos 0.05,]
R10746 T12433 T12428 punct ",",]
R10747 T12434 T12428 amod W,]
R10748 T12435 T12416 punct =,]
R10749 T12436 T12416 punct −,]
R10750 T12437 T12416 appos 21.00,]
R10751 T12438 T12416 punct ",",]
R10752 T12439 T12442 poss Wilcoxon,test
R10753 T12440 T12439 case 's,Wilcoxon
R10754 T12441 T12442 compound rank,test
R10755 T12442 T12416 appos test,]
R10756 T12443 T12416 punct ),]
R10757 T12444 T12446 punct (,7D
R10758 T12445 T12446 compound Figure,7D
R10759 T12446 T12416 appos 7D,]
R10760 T12447 T12416 punct ),]
R10761 T12448 T12345 punct .,inhaled
R10762 T12449 T12457 prep In,inhibited
R10763 T12450 T12449 pobj addition,In
R10764 T12451 T12457 punct ",",inhibited
R10765 T12452 T12457 nsubj FP,inhibited
R10766 T12453 T12455 punct (,µg
R10767 T12454 T12455 nummod 500,µg
R10768 T12455 T12452 appos µg,FP
R10769 T12456 T12455 punct ),µg
R10770 T12457 T12457 ROOT inhibited,inhibited
R10771 T12458 T12460 nummod p38,phosphorylation
R10772 T12459 T12460 compound MAPK,phosphorylation
R10773 T12460 T12457 dobj phosphorylation,inhibited
R10774 T12461 T12460 prep in,phosphorylation
R10775 T12462 T12464 amod primary,cells
R10812 T12499 T12498 dobj phospho-GATA-3,inhibiting
R10813 T12500 T12501 compound importin,association
R10814 T12501 T12498 npadvmod association,inhibiting
R10815 T12502 T12485 punct .,suggest
R10816 T12503 T12504 det This,effect
R10817 T12504 T12506 nsubj effect,be
R10818 T12505 T12506 aux may,be
R10819 T12506 T12506 ROOT be,be
R10820 T12507 T12506 acomp direct,be
R10821 T12508 T12507 punct ",",direct
R10822 T12509 T12506 prep through,be
R10823 T12510 T12509 pobj competition,through
R10824 T12511 T12510 prep for,competition
R10825 T12512 T12515 amod importin-α,molecules
R10826 T12513 T12512 cc or,importin-α
R10827 T12514 T12512 conj associated,importin-α
R10828 T12515 T12511 pobj molecules,for
R10829 T12516 T12515 punct ",",molecules
R10830 T12517 T12510 cc or,competition
R10831 T12518 T12510 conj secondary,competition
R10832 T12519 T12518 prep to,secondary
R10833 T12520 T12521 det an,effect
R10834 T12521 T12519 pobj effect,to
R10835 T12522 T12521 prep on,effect
R10836 T12523 T12526 nummod p38,phosphorylation
R10837 T12524 T12526 nmod MAPK-mediated,phosphorylation
R10838 T12525 T12526 amod GATA-3,phosphorylation
R10839 T12526 T12522 pobj phosphorylation,on
R10840 T12527 T12506 prep via,be
R10841 T12528 T12529 amod rapid,induction
R10842 T12529 T12527 pobj induction,via
R10843 T12530 T12529 prep of,induction
R10844 T12531 T12530 pobj MKP-1,of
R10845 T12532 T12506 punct .,be
R10846 T12533 T12534 det The,combination
R10847 T12534 T12541 nsubj combination,result
R10848 T12535 T12534 prep of,combination
R10849 T12536 T12539 det these,effects
R10850 T12537 T12539 nummod two,effects
R10851 T12538 T12539 amod interacting,effects
R10852 T12539 T12535 pobj effects,of
R10853 T12540 T12541 aux can,result
R10854 T12541 T12541 ROOT result,result
R10855 T12542 T12541 prep in,result
R10856 T12543 T12544 amod complete,suppression
R10857 T12544 T12542 pobj suppression,in
R10858 T12545 T12544 prep of,suppression
R10859 T12546 T12554 amod GATA-3,expression
R10860 T12547 T12548 amod nuclear,import
R10861 T12548 T12554 nmod import,expression
R10862 T12549 T12548 cc and,import
R10863 T12550 T12554 advmod thus,expression
R10864 T12551 T12554 amod Th2,expression
R10865 T12552 T12554 amod cytokine,expression
R10866 T12553 T12554 compound gene,expression
R10867 T12554 T12545 pobj expression,of
R10868 T12555 T12541 punct .,result
R16592 T19430 T19431 compound Fluticasone,propionate
R16593 T19431 T19432 nsubj propionate,impairs
R16594 T19432 T19432 ROOT impairs,impairs
R16595 T19433 T19434 amod GATA-3,interaction
R16596 T19434 T19432 dobj interaction,impairs
R16597 T19435 T19434 prep with,interaction
R16598 T19436 T19440 amod importin-α,localization
R16599 T19437 T19436 cc and,importin-α
R16600 T19438 T19436 conj GATA-3,importin-α
R16601 T19439 T19440 amod nuclear,localization
R16602 T19440 T19435 pobj localization,with
R16603 T19441 T19440 prep in,localization
R16604 T19442 T19441 pobj vivo,in
R16605 T19443 T19442 cc and,vivo
R16606 T19444 T19445 dep ex,vivo
R16607 T19445 T19442 conj vivo,vivo
R16608 T19446 T19432 punct .,impairs
R16609 T19447 T19448 punct (,A
R16610 T19448 T19448 ROOT A,A
R16611 T19449 T19448 cc and,A
R16612 T19450 T19453 nmod B,analysis
R16613 T19451 T19450 punct ),B
R16614 T19452 T19453 compound Co-immunoprecipitation,analysis
R16615 T19453 T19465 nsubj analysis,demonstrated
R16616 T19454 T19453 prep of,analysis
R16617 T19455 T19454 pobj PBMCs,of
R16618 T19456 T19455 prep from,PBMCs
R16619 T19457 T19459 amod steroid-naïve,patients
R16620 T19458 T19459 compound asthma,patients
R16621 T19459 T19456 pobj patients,from
R16622 T19460 T19459 acl treated,patients
R16623 T19461 T19460 prep with,treated
R16624 T19462 T19461 pobj FP,with
R16625 T19463 T19460 prep in,treated
R16626 T19464 T19463 pobj vitro,in
R16627 T19465 T19448 conj demonstrated,A
R16628 T19466 T19467 amod impaired,interaction
R16629 T19467 T19465 dobj interaction,demonstrated
R16630 T19468 T19467 prep between,interaction
R16631 T19469 T19468 pobj GATA-3,between
R16632 T19470 T19469 cc and,GATA-3
R16633 T19471 T19469 conj importin-α,GATA-3
R16634 T19472 T19465 conj measured,demonstrated
R16635 T19473 T19472 prep at,measured
R16636 T19474 T19475 nummod 60,min
R16637 T19475 T19473 pobj min,at
R16638 T19476 T19465 punct .,demonstrated
R16639 T19477 T19478 det Each,bar
R16640 T19478 T19479 nsubj bar,represents
R16641 T19479 T19479 ROOT represents,represents
R16642 T19480 T19483 det the,SEM
R16643 T19481 T19483 amod mean,SEM
R16644 T19482 T19483 compound ±,SEM
R16645 T19483 T19479 dobj SEM,represents
R16646 T19484 T19483 prep of,SEM
R16647 T19485 T19486 advmod at,least
R16648 T19486 T19487 advmod least,three
R16649 T19487 T19489 nummod three,experiments
R16650 T19488 T19489 amod independent,experiments
R16651 T19489 T19484 pobj experiments,of
R16652 T19490 T19483 punct ;,SEM
R16653 T19491 T19493 nmod ***,<
R16654 T19492 T19493 nmod p,<
R16655 T19493 T19494 nmod <,0.001
R16656 T19494 T19483 appos 0.001,SEM
R16657 T19495 T19494 prep compared,0.001
R16658 T19496 T19495 prep with,compared
R16659 T19497 T19496 pobj control,with
R16660 T19498 T19499 mark as,determined
R16661 T19499 T19494 advcl determined,0.001
R16662 T19500 T19499 agent by,determined
R16663 T19501 T19502 compound ANOVA/Newman-Keuls,analysis
R16664 T19502 T19500 pobj analysis,by
R16665 T19503 T19479 punct .,represents
R16666 T19504 T19505 punct (,C
R16667 T19505 T19505 ROOT C,C
R16668 T19506 T19505 cc and,C
R16669 T19507 T19505 conj D,C
R16670 T19508 T19505 punct ),C
R16671 T19509 T19510 compound Co-immunoprecipitation,analyses
R16672 T19510 T19530 nsubj analyses,demonstrated
R16673 T19511 T19510 prep of,analyses
R16674 T19512 T19511 pobj PBMCs,of
R16675 T19513 T19512 prep from,PBMCs
R16676 T19514 T19516 amod steroid-naïve,patients
R16677 T19515 T19516 compound asthma,patients
R16678 T19516 T19513 pobj patients,from
R16679 T19517 T19516 acl treated,patients
R16680 T19518 T19517 prep with,treated
R16681 T19519 T19520 amod inhaled,FP
R16682 T19520 T19518 pobj FP,with
R16683 T19521 T19520 punct (,FP
R16684 T19522 T19523 nummod 500,µg
R16685 T19523 T19520 appos µg,FP
R16686 T19524 T19517 prep via,treated
R16687 T19525 T19526 det a,spacer
R16688 T19526 T19524 pobj spacer,via
R16689 T19527 T19517 punct ),treated
R16690 T19528 T19517 prep in,treated
R16691 T19529 T19528 pobj vivo,in
R16692 T19530 T19530 ROOT demonstrated,demonstrated
R16693 T19531 T19532 amod decreased,association
R16694 T19532 T19530 dobj association,demonstrated
R16695 T19533 T19532 prep between,association
R16696 T19534 T19533 pobj GATA-3,between
R16697 T19535 T19534 cc and,GATA-3
R16698 T19536 T19534 conj importin-α,GATA-3
R16699 T19537 T19530 punct .,demonstrated
R16700 T19538 T19540 det The,values
R16701 T19539 T19540 amod individual,values
R16702 T19540 T19545 nsubjpass values,presented
R16703 T19541 T19540 prep for,values
R16704 T19542 T19543 det each,treatment
R16705 T19543 T19541 pobj treatment,for
R16706 T19544 T19545 auxpass are,presented
R16707 T19545 T19545 ROOT presented,presented
R16708 T19546 T19545 advmod graphically,presented
R16709 T19547 T19545 punct .,presented
R16710 T19548 T19554 punct (,showing
R16711 T19549 T19553 nmod E,blot
R16712 T19550 T19549 punct ),E
R16713 T19551 T19553 compound Representative,blot
R16714 T19552 T19553 compound Western,blot
R16715 T19553 T19554 nsubj blot,showing
R16716 T19554 T19554 ROOT showing,showing
R16717 T19555 T19559 mark that,unaffected
R16718 T19556 T19557 amod importin-α,expression
R16719 T19557 T19559 nsubjpass expression,unaffected
R16720 T19558 T19559 auxpass was,unaffected
R16721 T19559 T19554 ccomp unaffected,showing
R16722 T19560 T19559 prep by,unaffected
R16723 T19561 T19560 pobj inhalation,by
R16724 T19562 T19561 prep of,inhalation
R16725 T19563 T19562 pobj FP,of
R16726 T19564 T19554 punct .,showing
R16727 T19565 T19566 nsubj Blot,is
R16728 T19566 T19566 ROOT is,is
R16729 T19567 T19566 attr representative,is
R16730 T19568 T19567 prep of,representative
R16731 T19569 T19568 pobj gels,of
R16732 T19570 T19567 prep from,representative
R16733 T19571 T19572 nummod three,participants
R16734 T19572 T19570 pobj participants,from
R16735 T19573 T19566 punct .,is
R17076 T19983 T19985 amod Inhaled,propionate
R17077 T19984 T19985 compound fluticasone,propionate
R17078 T19985 T19986 nsubj propionate,impairs
R17079 T19986 T19986 ROOT impairs,impairs
R17080 T19987 T19989 amod GATA-3,localization
R17081 T19988 T19989 amod nuclear,localization
R17082 T19989 T19986 dobj localization,impairs
R17083 T19990 T19989 prep in,localization
R17084 T19991 T19990 pobj PBMCs,in
R17085 T19992 T19986 punct .,impairs
R17086 T19993 T19993 ROOT (,(
R17087 T19994 T19993 dep A,(
R17088 T19995 T19994 punct ),A
R17089 T19996 T19997 compound Representative,immunocytochemistry
R17090 T19997 T19997 ROOT immunocytochemistry,immunocytochemistry
R17091 T19998 T19997 prep of,immunocytochemistry
R17092 T19999 T19998 pcomp showing,of
R17093 T20000 T20001 det the,effect
R17094 T20001 T19999 dobj effect,showing
R17095 T20002 T20001 prep of,effect
R17096 T20003 T20004 amod inhaled,FP
R17097 T20004 T20002 pobj FP,of
R17098 T20005 T20007 punct (,µg
R17099 T20006 T20007 nummod 500,µg
R17100 T20007 T20004 appos µg,FP
R17122 T20029 T20030 nummod 2,h
R17123 T20030 T20031 amod h,following
R17124 T20031 T20021 prep following,immunoreactivity
R17125 T20032 T20034 amod inhaled,treatment
R17126 T20033 T20034 compound FP,treatment
R17127 T20034 T20031 dobj treatment,following
R17128 T20035 T20034 punct (,treatment
R17129 T20036 T20039 nummod 100,µg
R17130 T20037 T20036 cc or,100
R17131 T20038 T20036 conj 500,100
R17132 T20039 T20034 appos µg,treatment
R17133 T20040 T20039 prep via,µg
R17134 T20041 T20040 pobj spacer,via
R17135 T20042 T20034 punct ),treatment
R17136 T20043 T20021 punct .,immunoreactivity
R17137 T20044 T20048 det The,ranges
R17138 T20045 T20048 amod median,ranges
R17139 T20046 T20045 cc and,median
R17140 T20047 T20045 conj interquartile,median
R17141 T20048 T20053 nsubjpass ranges,presented
R17142 T20049 T20048 prep for,ranges
R17143 T20050 T20051 det each,treatment
R17144 T20051 T20049 pobj treatment,for
R17145 T20052 T20053 auxpass are,presented
R17146 T20053 T20053 ROOT presented,presented
R17147 T20054 T20053 prep as,presented
R17148 T20055 T20057 det a,plot
R17149 T20056 T20057 compound box-and-whiskers,plot
R17150 T20057 T20054 pobj plot,as
R17151 T20058 T20061 punct (,7
R17152 T20059 T20061 advmod n,7
R17153 T20060 T20061 punct =,7
R17154 T20061 T20057 appos 7,plot
R17155 T20062 T20061 punct ),7
R17156 T20063 T20053 punct ;,presented
R17200 T20107 T20110 nsubj analyses,demonstrated
R17201 T20108 T20107 prep of,analyses
R17202 T20109 T20108 pobj PBMCs,of
R17203 T20110 T20110 ROOT demonstrated,demonstrated
R17204 T20111 T20113 det a,decrease
R17205 T20112 T20113 amod dose-dependent,decrease
R17206 T20113 T20110 dobj decrease,demonstrated
R17207 T20114 T20113 prep in,decrease
R17208 T20115 T20116 amod nuclear,expression
R17209 T20116 T20114 pobj expression,in
R17210 T20117 T20116 prep of,expression
R17211 T20118 T20117 pobj GATA-3,of
R17212 T20119 T20110 punct ",",demonstrated
R17213 T20120 T20110 cc and,demonstrated
R17214 T20121 T20110 conj increased,demonstrated
R17215 T20122 T20124 amod cytoplasmic,expression
R17216 T20123 T20124 amod GATA-3,expression
R17217 T20124 T20121 dobj expression,increased
R17218 T20125 T20126 nummod 2,h
R17219 T20126 T20124 appos h,expression
R17220 T20127 T20126 prep after,h
R17221 T20128 T20127 pobj inhalation,after
R17222 T20129 T20128 prep of,inhalation
R17223 T20130 T20129 pobj FP,of
R17224 T20131 T20110 punct .,demonstrated
R17225 T20132 T20133 compound Histone,H1
R17226 T20133 T20137 nsubj H1,confirmed
R17227 T20134 T20133 cc and,H1
R17228 T20135 T20133 conj MEK-1,H1
R17229 T20136 T20137 nsubj immunoblotting,confirmed
R17230 T20137 T20137 ROOT confirmed,confirmed
R17231 T20138 T20141 amod equivalent,loading
R17232 T20139 T20140 amod total,protein
R17233 T20140 T20141 compound protein,loading
R17234 T20141 T20137 dobj loading,confirmed
R17235 T20142 T20141 prep for,loading
R17236 T20143 T20147 det the,fractions
R17279 T20186 T20186 ROOT compared,compared
R17280 T20187 T20188 aux to,control
R17281 T20188 T20186 xcomp control,compared
R17282 T20189 T20164 punct .,shown
R17283 T20190 T20198 punct (,demonstrated
R17284 T20191 T20195 nmod E,analyses
R17285 T20192 T20191 punct ),E
R17286 T20193 T20195 amod Western,analyses
R17287 T20194 T20195 compound blot,analyses
R17288 T20195 T20198 nsubj analyses,demonstrated
R17289 T20196 T20195 prep of,analyses
R17290 T20197 T20196 pobj PBMCs,of
R17291 T20198 T20198 ROOT demonstrated,demonstrated
R17292 T20199 T20201 det a,decrease
R17293 T20200 T20201 amod time-dependent,decrease
R17294 T20201 T20198 dobj decrease,demonstrated
R17295 T20202 T20201 prep in,decrease
R17296 T20203 T20204 amod dual,phosphorylation
R17297 T20204 T20202 pobj phosphorylation,in
R17298 T20205 T20206 punct (,threonine-180
R17299 T20206 T20204 appos threonine-180,phosphorylation
R17300 T20207 T20206 cc and,threonine-180
R17301 T20208 T20206 conj tyrosine-182,threonine-180
R17302 T20209 T20206 punct ),threonine-180
R17303 T20210 T20206 prep of,threonine-180
R17304 T20211 T20212 nummod p38,MAPK
R17305 T20212 T20210 pobj MAPK,of
R17306 T20213 T20198 prep after,demonstrated
R17307 T20214 T20213 pobj inhalation,after
R17308 T20215 T20214 prep of,inhalation
R17309 T20216 T20215 pobj FP,of
R17310 T20217 T20219 punct (,µg
R17311 T20218 T20219 nummod 500,µg
R17312 T20219 T20216 appos µg,FP
R17313 T20220 T20219 punct ),µg
R17314 T20221 T20198 punct .,demonstrated
R17321 T20228 T20223 punct ),results
R17322 T20229 T20229 ROOT are,are
R17323 T20230 T20229 attr representative,are
R17324 T20231 T20230 prep of,representative
R17325 T20232 T20231 pobj samples,of
R17326 T20233 T20232 prep from,samples
R17327 T20234 T20235 nummod two,participants
R17328 T20235 T20233 pobj participants,from
R17329 T20236 T20229 punct .,are
R10235 T11922 T11924 det The,Effect
R10236 T11923 T11924 compound Inhibitory,Effect
R10237 T11924 T11945 nsubj Effect,demonstrated
R10238 T11925 T11924 prep of,Effect
R10239 T11926 T11925 pobj Corticosteroids,of
R10240 T11927 T11924 prep on,Effect
R10241 T11928 T11930 compound GATA-3,Localization
R10242 T11929 T11930 compound Nuclear,Localization
R10243 T11930 T11927 pobj Localization,on
R10244 T11931 T11930 prep in,Localization
R10245 T11932 T11933 compound Primary,T
R10246 T11933 T11934 compound T,Lymphocytes
R10247 T11934 T11936 compound Lymphocytes,Vivo
R10248 T11935 T11936 compound Ex,Vivo
R10249 T11936 T11931 pobj Vivo,in
R10250 T11937 T11924 cc and,Effect
R10251 T11938 T11945 prep In,demonstrated
R10252 T11939 T11940 compound Vivo,Treatment
R10253 T11940 T11938 pobj Treatment,In
R10254 T11941 T11940 prep with,Treatment
R10255 T11942 T11944 compound FP,vivo
R10335 T12022 T12023 nsubj FP,suppresses
R10336 T12023 T12016 ccomp suppresses,indicated
R10337 T12024 T12023 dobj IL-4,suppresses
R10338 T12025 T12024 cc and,IL-4
R10339 T12026 T12028 nummod -5,expression
R10340 T12027 T12028 compound gene,expression
R10341 T12028 T12024 conj expression,IL-4
R10342 T12029 T12028 cc and,expression
R10343 T12030 T12016 conj attenuated,indicated
R10344 T12031 T12032 det the,interaction
R10345 T12032 T12030 dobj interaction,attenuated
R10346 T12033 T12032 prep of,interaction
R10347 T12034 T12033 pobj GATA-3,of
R10348 T12035 T12032 prep with,interaction
R10349 T12036 T12035 pobj importin-α,with
R10450 T12137 T12140 nsubj this,reach
R10451 T12138 T12140 aux did,reach
R10452 T12139 T12140 neg not,reach
R10453 T12140 T12140 ROOT reach,reach
R10454 T12141 T12140 dobj significance,reach
R10455 T12142 T12140 advcl using,reach
R10456 T12143 T12146 poss Wilcoxon,analysis
R10457 T12144 T12143 case 's,Wilcoxon
R10458 T12145 T12146 amod post-test,analysis
R10459 T12146 T12142 dobj analysis,using
R10460 T12147 T12153 punct (,due
R10461 T12148 T12153 nsubj W,due
R10462 T12149 T12150 punct =,6.00
R10463 T12150 T12148 nummod 6.00,W
R10464 T12151 T12148 punct ),W
R10465 T12152 T12153 advmod probably,due
R10466 T12153 T12140 advcl due,reach
R10467 T12154 T12153 pcomp to,due
R10468 T12155 T12156 amod low,numbers
R10469 T12156 T12154 pobj numbers,to
R10470 T12157 T12156 prep of,numbers
R10471 T12158 T12157 pobj participants,of
R10472 T12159 T12140 punct .,reach
R10473 T12160 T12161 amod Similar,results
R10474 T12161 T12163 nsubjpass results,observed
R10505 T12192 T12197 nsubj interaction,result
R10506 T12193 T12192 prep of,interaction
R10507 T12194 T12193 pobj GATA-3,of
R10508 T12195 T12197 aux did,result
R10509 T12196 T12197 neg not,result
R10510 T12197 T12197 ROOT result,result
R10511 T12198 T12197 prep from,result
R10512 T12199 T12201 det the,recycling
R10513 T12200 T12201 amod defective,recycling
R10514 T12201 T12198 pobj recycling,from
R10515 T12202 T12201 prep of,recycling
R10516 T12203 T12202 pobj importin-α,of
R10517 T12204 T12197 punct ",",result
R10518 T12205 T12197 prep as,result
R10519 T12206 T12208 det a,decrease
R10520 T12207 T12208 amod significant,decrease
R10521 T12208 T12205 pobj decrease,as
R10522 T12209 T12208 prep in,decrease
R10523 T12210 T12211 det the,abundance
R10524 T12211 T12209 pobj abundance,in
R10525 T12212 T12211 prep of,abundance
R10526 T12213 T12212 pobj importin-α,of
R10527 T12214 T12208 prep in,decrease
R10528 T12215 T12217 det the,pool
R10529 T12216 T12217 amod cytoplasmic,pool
R10530 T12217 T12214 pobj pool,in
R10531 T12218 T12220 auxpass was,detected
R10532 T12219 T12220 neg not,detected
R10533 T12220 T12197 conj detected,result
R10534 T12221 T12222 punct (,Figure
R10535 T12222 T12220 advmod Figure,detected
R10536 T12223 T12222 nummod 6E,Figure
R10537 T12224 T12222 punct ),Figure
R10538 T12225 T12197 punct .,result
R10539 T12226 T12228 nsubj We,examined
R10540 T12227 T12228 advmod further,examined
R10541 T12228 T12228 ROOT examined,examined
R10542 T12229 T12233 mark whether,affect
R10543 T12230 T12231 amod inhaled,FP
R10544 T12231 T12233 nsubj FP,affect
R10545 T12232 T12233 aux could,affect
R10546 T12233 T12228 ccomp affect,examined
R10547 T12234 T12235 amod cellular,localization
R10548 T12235 T12233 dobj localization,affect
R10549 T12236 T12235 prep of,localization
R10550 T12237 T12236 pobj GATA-3,of
R10551 T12238 T12235 prep in,localization
R10552 T12239 T12242 amod peripheral,cells
R10553 T12240 T12242 compound blood,cells
R10584 T12271 T12276 amod GATA-3,cells
R10661 T12348 T12349 nummod 500,µg
R10662 T12349 T12346 appos µg,FP
R10663 T12350 T12346 punct ),FP
R10664 T12351 T12345 conj induced,inhaled
R10665 T12352 T12353 amod significant,loss
R10776 T12463 T12464 compound T,cells
R10777 T12464 T12461 pobj cells,in
R10778 T12465 T12457 prep in,inhibited
R10779 T12466 T12465 pobj vivo,in
R10780 T12467 T12457 prep at,inhibited
R10781 T12468 T12469 nummod 2,h
R10782 T12469 T12467 pobj h,at
R10783 T12470 T12469 prep in,h
R10784 T12471 T12470 pobj samples,in
R10785 T12472 T12471 prep from,samples
R10786 T12473 T12474 nummod two,patients
R10787 T12474 T12472 pobj patients,from
R10788 T12475 T12474 punct (,patients
R10789 T12476 T12474 appos Figure,patients
R10790 T12477 T12476 nummod 7E,Figure
R10791 T12478 T12474 punct ),patients
R10792 T12479 T12457 punct .,inhibited
R10793 T12480 T12485 advcl Taken,suggest
R10794 T12481 T12480 advmod together,Taken
R10795 T12482 T12485 punct ",",suggest
R10796 T12483 T12484 poss our,data
R10797 T12484 T12485 nsubj data,suggest
R10798 T12485 T12485 ROOT suggest,suggest
R10799 T12486 T12487 mark that,inhaled
R10800 T12487 T12485 ccomp inhaled,suggest
R10801 T12488 T12489 nsubj FP,reduces
R10802 T12489 T12487 pcomp reduces,inhaled
R10803 T12490 T12491 amod nuclear,localization
R10804 T12491 T12489 dobj localization,reduces
R10805 T12492 T12491 prep of,localization
R10806 T12493 T12492 pobj GATA-3,of
R10807 T12494 T12491 prep in,localization
R10808 T12495 T12494 pobj vivo,in
R10809 T12496 T12489 prep by,reduces
R10810 T12497 T12498 advmod acutely,inhibiting
R10811 T12498 T12496 pcomp inhibiting,by
R17101 T20008 T20004 punct ),FP
R17102 T20009 T20001 prep on,effect
R17103 T20010 T20014 nmod GR,localisation
R17104 T20011 T20010 cc and,GR
R17105 T20012 T20010 conj GATA-3,GR
R17106 T20013 T20014 amod nuclear,localisation
R17107 T20014 T20009 pobj localisation,on
R17108 T20015 T19997 punct .,immunocytochemistry
R17109 T20016 T20021 punct (,immunoreactivity
R17110 T20017 T20021 nmod B,immunoreactivity
R17111 T20018 T20017 punct ),B
R17112 T20019 T20020 compound Nuclear,GATA-3
R17113 T20020 T20021 compound GATA-3,immunoreactivity
R17114 T20021 T20021 ROOT immunoreactivity,immunoreactivity
R17115 T20022 T20021 prep in,immunoreactivity
R17116 T20023 T20022 pobj PBMCs,in
R17117 T20024 T20021 prep from,immunoreactivity
R17118 T20025 T20028 nummod seven,patients
R17119 T20026 T20028 amod steroid-naïve,patients
R17120 T20027 T20028 compound asthma,patients
R17121 T20028 T20024 pobj patients,from
R17157 T20064 T20066 punct *,<
R17158 T20065 T20066 compound p,<
R17159 T20066 T20053 conj <,presented
R17160 T20067 T20071 nummod 0.05,test
R17161 T20068 T20071 poss Wilcoxon,test
R17162 T20069 T20068 case 's,Wilcoxon
R17163 T20070 T20071 compound rank,test
R17164 T20071 T20066 appos test,<
R17165 T20072 T20071 prep compared,test
R17166 T20073 T20072 prep with,compared
R17167 T20074 T20073 pobj placebo,with
R17168 T20075 T20053 punct .,presented
R17169 T20076 T20080 punct (,analyses
R17170 T20077 T20080 compound C,analyses
R17171 T20078 T20079 punct ),Immunoblotting
R17172 T20079 T20080 compound Immunoblotting,analyses
R17173 T20080 T20083 nsubj analyses,demonstrated
R17174 T20081 T20080 prep of,analyses
R17175 T20082 T20081 pobj PBMCs,of
R17176 T20083 T20083 ROOT demonstrated,demonstrated
R17177 T20084 T20086 det a,decrease
R17178 T20085 T20086 amod time-dependent,decrease
R17179 T20086 T20083 dobj decrease,demonstrated
R17180 T20087 T20086 prep in,decrease
R17181 T20088 T20089 amod nuclear,expression
R17182 T20089 T20087 pobj expression,in
R17183 T20090 T20089 prep of,expression
R17184 T20091 T20090 pobj GATA-3,of
R17185 T20092 T20083 punct ",",demonstrated
R17186 T20093 T20083 cc and,demonstrated
R17187 T20094 T20097 amod increased,expression
R17188 T20095 T20097 amod cytoplasmic,expression
R17189 T20096 T20097 amod GATA-3,expression
R17190 T20097 T20083 conj expression,demonstrated
R17191 T20098 T20097 prep after,expression
R17192 T20099 T20098 pobj inhalation,after
R17193 T20100 T20099 prep of,inhalation
R17194 T20101 T20100 pobj FP,of
R17195 T20102 T20083 punct .,demonstrated
R17196 T20103 T20110 punct (,demonstrated
R17197 T20104 T20107 compound D,analyses
R17198 T20105 T20106 punct ),Immunoblotting
R17199 T20106 T20107 compound Immunoblotting,analyses
R17237 T20144 T20147 amod nuclear,fractions
R17238 T20145 T20144 cc and,nuclear
R17239 T20146 T20144 conj cytoplasmic,nuclear
R17240 T20147 T20142 pobj fractions,for
R17241 T20148 T20137 advmod respectively,confirmed
R17242 T20149 T20137 punct .,confirmed
R17243 T20150 T20164 nsubjpass Quantification,shown
R17244 T20151 T20150 prep of,Quantification
R17245 T20152 T20154 det the,data
R17246 T20153 T20154 compound densitometry,data
R17247 T20154 T20151 pobj data,of
R17248 T20155 T20154 prep in,data
R17249 T20156 T20157 punct (,C
R17250 T20157 T20155 pobj C,in
R17251 T20158 T20150 punct ),Quantification
R17252 T20159 T20150 cc and,Quantification
R17253 T20160 T20161 punct (,D
R17254 T20161 T20150 conj D,Quantification
R17255 T20162 T20161 punct ),D
R17256 T20163 T20164 auxpass is,shown
R17257 T20164 T20164 ROOT shown,shown
R17258 T20165 T20164 prep as,shown
R17259 T20166 T20168 det a,plot
R17260 T20167 T20168 compound box-and-whiskers,plot
R17261 T20168 T20165 pobj plot,as
R17262 T20169 T20168 prep of,plot
R17263 T20170 T20169 pobj results,of
R17264 T20171 T20170 prep from,results
R17265 T20172 T20175 amod n,participants
R17266 T20173 T20174 punct =,6
R17267 T20174 T20175 nummod 6,participants
R17268 T20175 T20171 pobj participants,from
R17269 T20176 T20179 prep for,were
R17270 T20177 T20176 pobj which,for
R17271 T20178 T20179 nsubj data,were
R17272 T20179 T20175 relcl were,participants
R17273 T20180 T20179 acomp available,were
R17274 T20181 T20164 punct .,shown
R17275 T20182 T20186 advmod *,compared
R17276 T20183 T20184 compound p,<
R17277 T20184 T20185 compound <,0.05
R17278 T20185 T20186 advmod 0.05,compared
R17315 T20222 T20223 det The,results
R17316 T20223 T20229 nsubj results,are
R17317 T20224 T20223 acl shown,results
R17318 T20225 T20224 prep in,shown
R17319 T20226 T20227 punct (,E
R17320 T20227 T20225 pobj E,in

UBERON-AE

Id Subject Object Predicate Lexical cue
T11222 2631-2636 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T11223 2833-2838 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood

GO-BP

Id Subject Object Predicate Lexical cue
T12574 1507-1522 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T12575 5622-5637 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T12576 2585-2593 http://purl.obolibrary.org/obo/GO_0007349 denotes cellular
T12577 2594-2606 http://purl.obolibrary.org/obo/GO_0051179 denotes localization
T12578 5214-5226 http://purl.obolibrary.org/obo/GO_0051179 denotes localization
T12579 3562-3565 http://purl.obolibrary.org/obo/GO_0004707 denotes p38
T12580 3566-3570 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T12581 5424-5428 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T12582 3571-3586 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T12583 5445-5460 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T12584 5585-5599 http://purl.obolibrary.org/obo/GO_0051170 denotes nuclear import
T19579 605-617 http://purl.obolibrary.org/obo/GO_0051179 denotes localization
T20243 3761-3773 http://purl.obolibrary.org/obo/GO_0051179 denotes localization
T20244 3893-3905 http://purl.obolibrary.org/obo/GO_0051179 denotes localisation
T20245 4975-4990 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T20246 5027-5030 http://purl.obolibrary.org/obo/GO_0004707 denotes p38
T20247 5031-5035 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK

GO-MF

Id Subject Object Predicate Lexical cue
T12589 1495-1499 http://purl.obolibrary.org/obo/GO_0005136 denotes IL-4
T12590 3562-3565 http://purl.obolibrary.org/obo/GO_0004707 denotes p38
T12591 3566-3570 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T12592 5424-5428 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK
T20250 5027-5030 http://purl.obolibrary.org/obo/GO_0004707 denotes p38
T20251 5031-5035 http://purl.obolibrary.org/obo/GO_0004707 denotes MAPK

GO-CC

Id Subject Object Predicate Lexical cue
T12593 1440-1444 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T12594 2639-2644 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T12595 2841-2846 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T12596 3600-3605 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T11291 0-116 Sentence denotes The Inhibitory Effect of Corticosteroids on GATA-3 Nuclear Localization in Primary T Lymphocytes Ex Vivo and In Vivo
T11292 117-475 Sentence denotes Treatment with FP ex vivo demonstrated a concentration-dependent decrease in the direct interaction between phospho-GATA-3 and importin-α in PBMCs from patients with asthma (Figure 6A and 6B), which was significantly inhibited at 10−12 M FP (p<0.001, ANOVA and Newman-Keuls test) and completely attenuated by 10−8 M FP (p<0.001, ANOVA and Newman-Keuls test).
T11293 1425-1603 Sentence denotes Our previous T cell line studies indicated that 10−12 M FP suppresses IL-4 and -5 gene expression and attenuated the interaction of GATA-3 with importin-α (see Figures 1D and 2).
T11294 1604-1725 Sentence denotes This concentration is close to peak plasma levels obtained from asthmatic patients treated with inhaled FP (500 µg) [27].
T11295 1726-1882 Sentence denotes Inhaled FP (500 µg) treatment of seven steroid-naive asthma patients significantly reduced GATA-3–importin-α interaction in vivo in a time-dependent manner.
T11296 1883-2045 Sentence denotes This produced a >90% decrease in GATA-3–importin-α association at 2 h (median [95% CI], 13,494 [6,828–17,829] versus 879 [597–1,165]; p<0.05 Friedman's analysis).
T11297 2046-2178 Sentence denotes However, this did not reach significance using Wilcoxon's post-test analysis (W = 6.00) probably due to low numbers of participants.
T11298 2179-2276 Sentence denotes Similar results were observed when GATA-3–importin-α association was measured (Figure 6C and 6D).
T11299 2277-2325 Sentence denotes The lower dose of FP (100 µg) was not effective.
T11300 2326-2532 Sentence denotes The attenuated interaction of GATA-3 did not result from the defective recycling of importin-α, as a significant decrease in the abundance of importin-α in the cytoplasmic pool was not detected (Figure 6E).
T11301 2533-2645 Sentence denotes We further examined whether inhaled FP could affect cellular localization of GATA-3 in peripheral blood T cells.
T11302 2646-2996 Sentence denotes Treatment with inhaled FP (500 µg) for 2 h significantly increased GR nuclear translocation (Figure 7A) and concomitantly decreased the number of nuclear GATA-3 immunoreactive peripheral blood T cells (37%±4.2% versus 58.2%±4.95%, p = 0.016, W = 28.0, Wilcoxon's rank test) compared with placebo as measured by immunocytochemistry (Figure 7A and 7B).
T11303 2997-3128 Sentence denotes This was confirmed by Western blotting, which also indicated that this effect was both time- and dose-dependent (Figure 7C and 7D).
T11304 3129-3526 Sentence denotes Thus, inhaled FP (500 µg) induced significant loss in nuclear GATA-3 at 2 h (median [95% CI], 0.40 [0.27–0.53] versus 0.14 [0.11–0.19], p<0.05, W = 21.00, Wilcoxon's rank test) (Figure 7C) and cytoplasmic GATA-3 levels were enhanced by inhaled FP in a dose-dependent manner (median [95% CI], 0.0032 [0.0026–0.0039] versus 0.658 [0.592–0.720], p<0.05, W = −21.00, Wilcoxon's rank test) (Figure 7D).
T11305 3527-3662 Sentence denotes In addition, FP (500 µg) inhibited p38 MAPK phosphorylation in primary T cells in vivo at 2 h in samples from two patients (Figure 7E).
T11306 5149-5303 Sentence denotes Taken together, our data suggest that inhaled FP reduces nuclear localization of GATA-3 in vivo by acutely inhibiting phospho-GATA-3–importin association.
T11307 5304-5490 Sentence denotes This effect may be direct, through competition for importin-α or associated molecules, or secondary to an effect on p38 MAPK-mediated GATA-3 phosphorylation via rapid induction of MKP-1.
T11308 5491-5638 Sentence denotes The combination of these two interacting effects can result in complete suppression of GATA-3 nuclear import and thus Th2 cytokine gene expression.
T19286 520-638 Sentence denotes Fluticasone propionate impairs GATA-3 interaction with importin-α and GATA-3 nuclear localization in vivo and ex vivo.
T19287 639-833 Sentence denotes (A and B) Co-immunoprecipitation analysis of PBMCs from steroid-naïve asthma patients treated with FP in vitro demonstrated impaired interaction between GATA-3 and importin-α measured at 60 min.
T19288 834-1195 Sentence denotes Each bar represents the mean±SEM of at least three independent experiments; *** p<0.001 compared with control as determined by ANOVA/Newman-Keuls analysis. (C and D) Co-immunoprecipitation analyses of PBMCs from steroid-naïve asthma patients treated with inhaled FP (500 µg via a spacer) in vivo demonstrated decreased association between GATA-3 and importin-α.
T19289 1196-1366 Sentence denotes The individual values for each treatment are presented graphically. (E) Representative Western blot showing that importin-α expression was unaffected by inhalation of FP.
T19290 1367-1422 Sentence denotes Blot is representative of gels from three participants.
T19726 3707-3783 Sentence denotes Inhaled fluticasone propionate impairs GATA-3 nuclear localization in PBMCs.
T19727 3784-4055 Sentence denotes (A) Representative immunocytochemistry of showing the effect of inhaled FP (500 µg) on GR and GATA-3 nuclear localisation. (B) Nuclear GATA-3 immunoreactivity in PBMCs from seven steroid-naïve asthma patients 2 h following inhaled FP treatment (100 or 500 µg via spacer).
T19728 4056-4571 Sentence denotes The median and interquartile ranges for each treatment are presented as a box-and-whiskers plot (n = 7); * p<0.05 Wilcoxon's rank test compared with placebo. (C) Immunoblotting analyses of PBMCs demonstrated a time-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression after inhalation of FP. (D) Immunoblotting analyses of PBMCs demonstrated a dose-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression 2 h after inhalation of FP.
T19729 4572-4706 Sentence denotes Histone H1 and MEK-1 immunoblotting confirmed equivalent total protein loading for the nuclear and cytoplasmic fractions respectively.
T19730 4707-5068 Sentence denotes Quantification of the densitometry data in (C) and (D) is shown as a box-and-whiskers plot of results from n = 6 participants for which data were available. *p<0.05 compared to control. (E) Western blot analyses of PBMCs demonstrated a time-dependent decrease in dual phosphorylation (threonine-180 and tyrosine-182) of p38 MAPK after inhalation of FP (500 µg).
T19731 5069-5146 Sentence denotes The results shown in (E) are representative of samples from two participants.
T232 0-116 Sentence denotes The Inhibitory Effect of Corticosteroids on GATA-3 Nuclear Localization in Primary T Lymphocytes Ex Vivo and In Vivo
T233 117-475 Sentence denotes Treatment with FP ex vivo demonstrated a concentration-dependent decrease in the direct interaction between phospho-GATA-3 and importin-α in PBMCs from patients with asthma (Figure 6A and 6B), which was significantly inhibited at 10−12 M FP (p<0.001, ANOVA and Newman-Keuls test) and completely attenuated by 10−8 M FP (p<0.001, ANOVA and Newman-Keuls test).
T234 476-638 Sentence denotes 10.1371/journal.pmed.1000076.g006 Figure 6 Fluticasone propionate impairs GATA-3 interaction with importin-α and GATA-3 nuclear localization in vivo and ex vivo.
T235 639-833 Sentence denotes (A and B) Co-immunoprecipitation analysis of PBMCs from steroid-naïve asthma patients treated with FP in vitro demonstrated impaired interaction between GATA-3 and importin-α measured at 60 min.
T236 834-1195 Sentence denotes Each bar represents the mean±SEM of at least three independent experiments; *** p<0.001 compared with control as determined by ANOVA/Newman-Keuls analysis. (C and D) Co-immunoprecipitation analyses of PBMCs from steroid-naïve asthma patients treated with inhaled FP (500 µg via a spacer) in vivo demonstrated decreased association between GATA-3 and importin-α.
T237 1196-1366 Sentence denotes The individual values for each treatment are presented graphically. (E) Representative Western blot showing that importin-α expression was unaffected by inhalation of FP.
T238 1367-1422 Sentence denotes Blot is representative of gels from three participants.
T239 1425-1603 Sentence denotes Our previous T cell line studies indicated that 10−12 M FP suppresses IL-4 and -5 gene expression and attenuated the interaction of GATA-3 with importin-α (see Figures 1D and 2).
T240 1604-1725 Sentence denotes This concentration is close to peak plasma levels obtained from asthmatic patients treated with inhaled FP (500 µg) [27].
T241 1726-1882 Sentence denotes Inhaled FP (500 µg) treatment of seven steroid-naive asthma patients significantly reduced GATA-3–importin-α interaction in vivo in a time-dependent manner.
T242 1883-2045 Sentence denotes This produced a >90% decrease in GATA-3–importin-α association at 2 h (median [95% CI], 13,494 [6,828–17,829] versus 879 [597–1,165]; p<0.05 Friedman's analysis).
T243 2046-2178 Sentence denotes However, this did not reach significance using Wilcoxon's post-test analysis (W = 6.00) probably due to low numbers of participants.
T244 2179-2276 Sentence denotes Similar results were observed when GATA-3–importin-α association was measured (Figure 6C and 6D).
T245 2277-2325 Sentence denotes The lower dose of FP (100 µg) was not effective.
T246 2326-2532 Sentence denotes The attenuated interaction of GATA-3 did not result from the defective recycling of importin-α, as a significant decrease in the abundance of importin-α in the cytoplasmic pool was not detected (Figure 6E).
T247 2533-2645 Sentence denotes We further examined whether inhaled FP could affect cellular localization of GATA-3 in peripheral blood T cells.
T248 2646-2996 Sentence denotes Treatment with inhaled FP (500 µg) for 2 h significantly increased GR nuclear translocation (Figure 7A) and concomitantly decreased the number of nuclear GATA-3 immunoreactive peripheral blood T cells (37%±4.2% versus 58.2%±4.95%, p = 0.016, W = 28.0, Wilcoxon's rank test) compared with placebo as measured by immunocytochemistry (Figure 7A and 7B).
T249 2997-3128 Sentence denotes This was confirmed by Western blotting, which also indicated that this effect was both time- and dose-dependent (Figure 7C and 7D).
T250 3129-3526 Sentence denotes Thus, inhaled FP (500 µg) induced significant loss in nuclear GATA-3 at 2 h (median [95% CI], 0.40 [0.27–0.53] versus 0.14 [0.11–0.19], p<0.05, W = 21.00, Wilcoxon's rank test) (Figure 7C) and cytoplasmic GATA-3 levels were enhanced by inhaled FP in a dose-dependent manner (median [95% CI], 0.0032 [0.0026–0.0039] versus 0.658 [0.592–0.720], p<0.05, W = −21.00, Wilcoxon's rank test) (Figure 7D).
T251 3527-3662 Sentence denotes In addition, FP (500 µg) inhibited p38 MAPK phosphorylation in primary T cells in vivo at 2 h in samples from two patients (Figure 7E).
T252 3663-3783 Sentence denotes 10.1371/journal.pmed.1000076.g007 Figure 7 Inhaled fluticasone propionate impairs GATA-3 nuclear localization in PBMCs.
T253 3784-4055 Sentence denotes (A) Representative immunocytochemistry of showing the effect of inhaled FP (500 µg) on GR and GATA-3 nuclear localisation. (B) Nuclear GATA-3 immunoreactivity in PBMCs from seven steroid-naïve asthma patients 2 h following inhaled FP treatment (100 or 500 µg via spacer).
T254 4056-4571 Sentence denotes The median and interquartile ranges for each treatment are presented as a box-and-whiskers plot (n = 7); * p<0.05 Wilcoxon's rank test compared with placebo. (C) Immunoblotting analyses of PBMCs demonstrated a time-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression after inhalation of FP. (D) Immunoblotting analyses of PBMCs demonstrated a dose-dependent decrease in nuclear expression of GATA-3, and increased cytoplasmic GATA-3 expression 2 h after inhalation of FP.
T255 4572-4706 Sentence denotes Histone H1 and MEK-1 immunoblotting confirmed equivalent total protein loading for the nuclear and cytoplasmic fractions respectively.
T256 4707-5068 Sentence denotes Quantification of the densitometry data in (C) and (D) is shown as a box-and-whiskers plot of results from n = 6 participants for which data were available. *p<0.05 compared to control. (E) Western blot analyses of PBMCs demonstrated a time-dependent decrease in dual phosphorylation (threonine-180 and tyrosine-182) of p38 MAPK after inhalation of FP (500 µg).
T257 5069-5146 Sentence denotes The results shown in (E) are representative of samples from two participants.
T258 5149-5303 Sentence denotes Taken together, our data suggest that inhaled FP reduces nuclear localization of GATA-3 in vivo by acutely inhibiting phospho-GATA-3–importin association.
T259 5304-5490 Sentence denotes This effect may be direct, through competition for importin-α or associated molecules, or secondary to an effect on p38 MAPK-mediated GATA-3 phosphorylation via rapid induction of MKP-1.
T260 5491-5638 Sentence denotes The combination of these two interacting effects can result in complete suppression of GATA-3 nuclear import and thus Th2 cytokine gene expression.

ICD10

Id Subject Object Predicate Lexical cue
T19580 709-715 http://purl.bioontology.org/ontology/ICD10/J45.9 denotes asthma
T19581 1060-1066 http://purl.bioontology.org/ontology/ICD10/J45.9 denotes asthma
T19582 709-715 http://purl.bioontology.org/ontology/ICD10/J45 denotes asthma
T19583 1060-1066 http://purl.bioontology.org/ontology/ICD10/J45 denotes asthma
T12585 283-289 http://purl.bioontology.org/ontology/ICD10/J45.9 denotes asthma
T12586 1779-1785 http://purl.bioontology.org/ontology/ICD10/J45.9 denotes asthma
T12587 283-289 http://purl.bioontology.org/ontology/ICD10/J45 denotes asthma
T12588 1779-1785 http://purl.bioontology.org/ontology/ICD10/J45 denotes asthma
T20248 3977-3983 http://purl.bioontology.org/ontology/ICD10/J45.9 denotes asthma
T20249 3977-3983 http://purl.bioontology.org/ontology/ICD10/J45 denotes asthma

events-check-again

Id Subject Object Predicate Lexical cue Negation Speculation
T12731 4-14 Negative_regulation denotes Inhibitory
T12732 44-50 Protein denotes GATA-3
T12733 51-58 Entity denotes Nuclear
T12734 59-71 Localization denotes Localization
T12735 172-181 Regulation denotes dependent
T12736 182-190 Negative_regulation denotes decrease
T12737 205-216 Binding denotes interaction
T12738 225-232 Phosphorylation denotes phospho
T12739 233-239 Protein denotes GATA-3
T12740 334-343 Negative_regulation denotes inhibited
T12741 412-422 Negative_regulation denotes attenuated
T12742 1484-1494 Negative_regulation denotes suppresses
T12743 1484-1494 Negative_regulation denotes suppresses
T12744 1495-1499 Protein denotes IL-4
T12745 1504-1506 Protein denotes -5
T12746 1512-1522 Gene_expression denotes expression
T12747 1512-1522 Gene_expression denotes expression
T12748 1527-1537 Negative_regulation denotes attenuated
T12749 1542-1553 Binding denotes interaction
T12750 1557-1563 Protein denotes GATA-3
T12751 1809-1816 Negative_regulation denotes reduced
T12752 1817-1823 Protein denotes GATA-3
T12753 1835-1846 Binding denotes interaction
T12754 1865-1874 Regulation denotes dependent
T12755 1888-1896 Regulation denotes produced
T12756 1904-1912 Negative_regulation denotes decrease
T12757 1916-1922 Protein denotes GATA-3
T12758 1934-1945 Binding denotes association
T12759 2214-2220 Protein denotes GATA-3
T12760 2232-2243 Binding denotes association
T12761 2330-2340 Negative_regulation denotes attenuated
T12762 2341-2352 Binding denotes interaction
T12763 2356-2362 Protein denotes GATA-3
T12764 2578-2584 Regulation denotes affect true
T12765 2594-2606 Localization denotes localization
T12766 2610-2616 Protein denotes GATA-3
T12767 2703-2712 Positive_regulation denotes increased
T12768 2713-2715 Protein denotes GR
T12769 2716-2723 Entity denotes nuclear
T12770 2724-2737 Localization denotes translocation
T12771 2800-2806 Protein denotes GATA-3
T12772 3155-3162 Positive_regulation denotes induced
T12773 3175-3179 Localization denotes loss true
T12774 3183-3190 Entity denotes nuclear
T12775 3191-3197 Protein denotes GATA-3
T12776 3322-3333 Entity denotes cytoplasmic
T12777 3334-3340 Protein denotes GATA-3
T12778 3341-3347 Localization denotes levels
T12779 3353-3361 Positive_regulation denotes enhanced
T12780 3386-3395 Regulation denotes dependent
T12781 5198-5205 Negative_regulation denotes reduces
T12782 5206-5213 Entity denotes nuclear
T12783 5214-5226 Localization denotes localization
T12784 5230-5236 Protein denotes GATA-3
T12785 5256-5266 Negative_regulation denotes inhibiting
T12786 5275-5281 Protein denotes GATA-3
T12787 5291-5302 Binding denotes association
T12788 5429-5437 Positive_regulation denotes mediated
T12789 5438-5444 Protein denotes GATA-3
T12790 5445-5460 Phosphorylation denotes phosphorylation
T12791 5471-5480 Gene_expression denotes induction
T12792 5484-5489 Protein denotes MKP-1
T12793 5532-5539 Regulation denotes effects
T12794 5563-5574 Negative_regulation denotes suppression
T12795 5578-5584 Protein denotes GATA-3
T12796 5585-5592 Entity denotes nuclear
T12797 5593-5599 Localization denotes import
T20332 3738-3745 Negative_regulation denotes impairs
T20333 3746-3752 Protein denotes GATA-3
T20334 3753-3760 Entity denotes nuclear
T20335 3761-3773 Localization denotes localization
T20336 3871-3873 Protein denotes GR
T20337 3878-3884 Protein denotes GATA-3
T20338 3885-3892 Entity denotes nuclear
T20339 3893-3905 Localization denotes localisation
T20340 3893-3905 Localization denotes localisation
T20341 3919-3925 Protein denotes GATA-3
T20342 4271-4280 Regulation denotes dependent
T20343 4271-4280 Regulation denotes dependent
T20344 4281-4289 Negative_regulation denotes decrease
T20345 4293-4300 Entity denotes nuclear
T20346 4301-4311 Localization denotes expression
T20347 4315-4321 Protein denotes GATA-3
T20348 4327-4336 Positive_regulation denotes increased
T20349 4337-4348 Entity denotes cytoplasmic
T20350 4349-4355 Protein denotes GATA-3
T20351 4356-4366 Localization denotes expression
T20352 4458-4466 Negative_regulation denotes decrease
T20353 4470-4477 Entity denotes nuclear
T20354 4478-4488 Localization denotes expression
T20355 4492-4498 Protein denotes GATA-3
T20356 4514-4525 Entity denotes cytoplasmic
T20357 4526-4532 Protein denotes GATA-3
T20358 4533-4543 Localization denotes expression
T20359 4587-4592 Protein denotes MEK-1
T19629 543-550 Negative_regulation denotes impairs
T19630 543-550 Negative_regulation denotes impairs
T19631 551-557 Protein denotes GATA-3
T19632 558-569 Binding denotes interaction
T19633 590-596 Protein denotes GATA-3
T19634 597-604 Entity denotes nuclear
T19635 605-617 Localization denotes localization
T19636 763-771 Negative_regulation denotes impaired
T19637 772-783 Binding denotes interaction
T19638 792-798 Protein denotes GATA-3
T19639 1143-1152 Negative_regulation denotes decreased
T19640 1153-1164 Binding denotes association
T19641 1173-1179 Protein denotes GATA-3
R10967 T12732 T12734 themeOf GATA-3,Localization
R10968 T12733 T12734 locationOf Nuclear,Localization
R10969 T12734 T12731 themeOf Localization,Inhibitory
R10970 T12736 T12735 themeOf decrease,dependent
R10971 T12737 T12736 themeOf interaction,decrease
R10972 T12737 T12740 themeOf interaction,inhibited
R10973 T12737 T12741 themeOf interaction,attenuated
R10974 T12739 T12737 themeOf GATA-3,interaction
R10975 T12739 T12738 themeOf GATA-3,phospho
R10976 T12744 T12747 themeOf IL-4,expression
R10977 T12745 T12746 themeOf -5,expression
R10978 T12746 T12742 themeOf expression,suppresses
R10979 T12747 T12743 themeOf expression,suppresses
R10980 T12749 T12748 themeOf interaction,attenuated
R10981 T12750 T12749 themeOf GATA-3,interaction
R10982 T12751 T12754 themeOf reduced,dependent
R10983 T12752 T12753 themeOf GATA-3,interaction
R10984 T12753 T12751 themeOf interaction,reduced
R10985 T12756 T12755 themeOf decrease,produced
R10986 T12757 T12758 themeOf GATA-3,association
R10987 T12758 T12756 themeOf association,decrease
R10988 T12759 T12760 themeOf GATA-3,association
R10989 T12762 T12761 themeOf interaction,attenuated
R10990 T12763 T12762 themeOf GATA-3,interaction
R10991 T12765 T12764 themeOf localization,affect
R10992 T12766 T12765 themeOf GATA-3,localization
R10993 T12768 T12770 themeOf GR,translocation
R10994 T12769 T12770 locationOf nuclear,translocation
R10995 T12770 T12767 themeOf translocation,increased
R10996 T12773 T12772 themeOf loss,induced
R10997 T12774 T12773 locationOf nuclear,loss
R10998 T12775 T12773 themeOf GATA-3,loss
R10999 T12776 T12778 locationOf cytoplasmic,levels
R11000 T12777 T12778 themeOf GATA-3,levels
R11001 T12778 T12779 themeOf levels,enhanced
R11002 T12779 T12780 themeOf enhanced,dependent
R11003 T12782 T12783 locationOf nuclear,localization
R11004 T12783 T12781 themeOf localization,reduces
R11005 T12784 T12783 themeOf GATA-3,localization
R11006 T12785 T12781 causeOf inhibiting,reduces
R11007 T12786 T12787 themeOf GATA-3,association
R11008 T12787 T12785 themeOf association,inhibiting
R11009 T12789 T12790 themeOf GATA-3,phosphorylation
R11010 T12790 T12788 themeOf phosphorylation,mediated
R11011 T12792 T12791 themeOf MKP-1,induction
R11012 T12794 T12793 themeOf suppression,effects
R11013 T12795 T12797 themeOf GATA-3,import
R11014 T12796 T12797 locationOf nuclear,import
R11015 T12797 T12794 themeOf import,suppression
R16769 T19631 T19632 themeOf GATA-3,interaction
R16770 T19632 T19629 themeOf interaction,impairs
R16771 T19633 T19635 themeOf GATA-3,localization
R16772 T19634 T19635 locationOf nuclear,localization
R16773 T19635 T19630 themeOf localization,impairs
R16774 T19637 T19636 themeOf interaction,impaired
R16775 T19638 T19637 themeOf GATA-3,interaction
R16776 T19640 T19639 themeOf association,decreased
R16777 T19641 T19640 themeOf GATA-3,association
R17384 T20333 T20335 themeOf GATA-3,localization
R17385 T20334 T20335 locationOf nuclear,localization
R17386 T20335 T20332 themeOf localization,impairs
R17387 T20336 T20339 themeOf GR,localisation
R17388 T20337 T20340 themeOf GATA-3,localisation
R17389 T20338 T20339 locationOf nuclear,localisation
R17390 T20338 T20340 locationOf nuclear,localisation
R17391 T20344 T20342 themeOf decrease,dependent
R17392 T20345 T20346 locationOf nuclear,expression
R17393 T20346 T20344 themeOf expression,decrease
R17394 T20347 T20346 themeOf GATA-3,expression
R17395 T20348 T20343 themeOf increased,dependent
R17396 T20349 T20351 locationOf cytoplasmic,expression
R17397 T20350 T20351 themeOf GATA-3,expression
R17398 T20351 T20348 themeOf expression,increased
R17399 T20353 T20354 locationOf nuclear,expression
R17400 T20354 T20352 themeOf expression,decrease
R17401 T20355 T20354 themeOf GATA-3,expression
R17402 T20356 T20358 locationOf cytoplasmic,expression
R17403 T20357 T20358 themeOf GATA-3,expression

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T12798 225-239 Protein denotes phospho-GATA-3
T12799 244-254 Protein denotes importin-α
T12800 205-216 Binding denotes interaction
T12801 182-190 Negative_regulation denotes decrease
T12802 1479-1483 Protein denotes M FP
T12803 1495-1499 Protein denotes IL-4
T12804 1557-1563 Protein denotes GATA-3
T12805 1569-1579 Protein denotes importin-α
T12806 1512-1522 Gene_expression denotes expression
T12807 1542-1553 Binding denotes interaction
T12808 1484-1494 Negative_regulation denotes suppresses
T12809 1527-1537 Negative_regulation denotes attenuated
T12810 1817-1832 Protein denotes GATA-3–importin
T12811 1833-1834 Protein denotes α
T12812 1835-1846 Binding denotes interaction
T12813 1809-1816 Negative_regulation denotes reduced
T12814 1916-1931 Protein denotes GATA-3–importin
T12815 2356-2362 Protein denotes GATA-3
T12816 2410-2420 Protein denotes importin-α
T12817 2468-2478 Protein denotes importin-α
T12818 2341-2352 Binding denotes interaction
T12819 2455-2464 Localization denotes abundance
T12820 2439-2447 Negative_regulation denotes decrease
T12821 2610-2616 Protein denotes GATA-3
T12822 2585-2593 Entity denotes cellular
T12823 2594-2606 Localization denotes localization
T12824 2713-2715 Protein denotes GR
T12825 2716-2723 Entity denotes nuclear
T12826 2724-2737 Localization denotes translocation
T12827 2703-2712 Positive_regulation denotes increased
T12828 3322-3340 Protein denotes cytoplasmic GATA-3
T12829 3373-3375 Protein denotes FP
T12830 3183-3190 Entity denotes nuclear
T12831 3353-3361 Positive_regulation denotes enhanced
T12832 3562-3570 Protein denotes p38 MAPK
T12833 3571-3586 Phosphorylation denotes phosphorylation
T12834 3552-3561 Negative_regulation denotes inhibited
T12835 5230-5236 Protein denotes GATA-3
T12836 5206-5213 Entity denotes nuclear
T12837 5214-5226 Localization denotes localization
T12838 5198-5205 Negative_regulation denotes reduces
T12839 5355-5365 Protein denotes importin-α
T12840 5420-5423 Protein denotes p38
T12841 5484-5489 Protein denotes MKP-1
T12842 5339-5350 Binding denotes competition
T12843 5445-5460 Phosphorylation denotes phosphorylation
T12844 5471-5480 Positive_regulation denotes induction
T19610 575-585 Protein denotes importin-α
T19611 590-596 Protein denotes GATA-3
T19612 558-569 Binding denotes interaction
T19613 558-569 Binding denotes interaction
T19614 597-604 Entity denotes nuclear
T19615 605-617 Localization denotes localization
T19616 605-617 Localization denotes localization
T19617 738-740 Protein denotes FP
T19618 792-798 Protein denotes GATA-3
T19619 803-813 Protein denotes importin-α
T19620 772-783 Binding denotes interaction
T19621 1173-1179 Protein denotes GATA-3
T19622 1184-1194 Protein denotes importin-α
T19623 1153-1164 Binding denotes association
T19624 1143-1152 Negative_regulation denotes decreased
T19625 1309-1319 Protein denotes importin-α
T19626 1363-1365 Protein denotes FP
T19627 1320-1330 Gene_expression denotes expression
T19628 1335-1345 Regulation denotes unaffected
T20308 3871-3873 Protein denotes GR
T20309 3878-3905 Protein denotes GATA-3 nuclear localisation
T20310 3911-3925 Protein denotes Nuclear GATA-3
T20311 4315-4321 Protein denotes GATA-3
T20312 4337-4355 Protein denotes cytoplasmic GATA-3
T20313 4387-4389 Protein denotes FP
T20314 4293-4300 Entity denotes nuclear
T20315 4301-4311 Gene_expression denotes expression
T20316 4356-4366 Gene_expression denotes expression
T20317 4373-4383 Negative_regulation denotes inhalation
T20318 4281-4289 Negative_regulation denotes decrease
T20319 4281-4289 Negative_regulation denotes decrease
T20320 4327-4336 Positive_regulation denotes increased
T20321 4492-4498 Protein denotes GATA-3
T20322 4568-4570 Protein denotes FP
T20323 4470-4477 Entity denotes nuclear
T20324 4478-4488 Gene_expression denotes expression
T20325 4458-4466 Negative_regulation denotes decrease
T20326 4572-4582 Protein denotes Histone H1
T20327 4587-4592 Protein denotes MEK-1
T20328 5027-5030 Protein denotes p38
T20329 5010-5022 Entity denotes tyrosine-182
T20330 4975-4990 Phosphorylation denotes phosphorylation
T20331 4958-4966 Negative_regulation denotes decrease
R11016 T12798 T12800 themeOf phospho-GATA-3,interaction
R11017 T12799 T12800 themeOf importin-α,interaction
R11018 T12800 T12801 themeOf interaction,decrease
R11019 T12802 T12808 causeOf M FP,suppresses
R11020 T12803 T12806 themeOf IL-4,expression
R11021 T12804 T12807 themeOf GATA-3,interaction
R11022 T12805 T12807 themeOf importin-α,interaction
R11023 T12806 T12808 themeOf expression,suppresses
R11024 T12807 T12809 themeOf interaction,attenuated
R11025 T12810 T12812 themeOf GATA-3–importin,interaction
R11026 T12811 T12812 themeOf α,interaction
R11027 T12812 T12813 themeOf interaction,reduced
R11028 T12815 T12818 themeOf GATA-3,interaction
R11029 T12817 T12819 themeOf importin-α,abundance
R11030 T12819 T12820 themeOf abundance,decrease
R11031 T12821 T12823 themeOf GATA-3,localization
R11032 T12822 T12823 locationOf cellular,localization
R11033 T12824 T12826 themeOf GR,translocation
R11034 T12825 T12826 locationOf nuclear,translocation
R11035 T12826 T12827 themeOf translocation,increased
R11036 T12828 T12831 themeOf cytoplasmic GATA-3,enhanced
R11037 T12829 T12831 causeOf FP,enhanced
R11038 T12832 T12833 themeOf p38 MAPK,phosphorylation
R11039 T12833 T12834 themeOf phosphorylation,inhibited
R11040 T12835 T12837 themeOf GATA-3,localization
R11041 T12836 T12837 locationOf nuclear,localization
R11042 T12837 T12838 themeOf localization,reduces
R11043 T12839 T12842 themeOf importin-α,competition
R11044 T12840 T12843 themeOf p38,phosphorylation
R11045 T12841 T12844 themeOf MKP-1,induction
R16754 T19610 T19612 themeOf importin-α,interaction
R16755 T19610 T19613 themeOf importin-α,interaction
R16756 T19610 T19615 themeOf importin-α,localization
R16757 T19611 T19613 themeOf GATA-3,interaction
R16758 T19611 T19616 themeOf GATA-3,localization
R16759 T19614 T19615 locationOf nuclear,localization
R16760 T19614 T19616 locationOf nuclear,localization
R16761 T19618 T19620 themeOf GATA-3,interaction
R16762 T19619 T19620 themeOf importin-α,interaction
R16763 T19621 T19623 themeOf GATA-3,association
R16764 T19622 T19623 themeOf importin-α,association
R16765 T19623 T19624 themeOf association,decreased
R16766 T19625 T19627 themeOf importin-α,expression
R16767 T19626 T19628 causeOf FP,unaffected
R16768 T19627 T19628 themeOf expression,unaffected
R17370 T20311 T20315 themeOf GATA-3,expression
R17371 T20312 T20316 themeOf cytoplasmic GATA-3,expression
R17372 T20313 T20317 themeOf FP,inhalation
R17373 T20315 T20318 themeOf expression,decrease
R17374 T20316 T20319 themeOf expression,decrease
R17375 T20316 T20320 themeOf expression,increased
R17376 T20317 T20318 causeOf inhalation,decrease
R17377 T20317 T20319 causeOf inhalation,decrease
R17378 T20321 T20324 themeOf GATA-3,expression
R17379 T20324 T20325 themeOf expression,decrease
R17380 T20328 T20330 themeOf p38,phosphorylation
R17381 T20328 T20329 partOf p38,tyrosine-182
R17382 T20329 T20330 Site tyrosine-182,phosphorylation
R17383 T20330 T20331 themeOf phosphorylation,decrease

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation Speculation
T11235 1484-1494 Negative_regulation denotes suppresses
T11236 1484-1494 Negative_regulation denotes suppresses
T11237 1495-1499 Protein denotes IL-4
T11238 1504-1506 Protein denotes -5
T11239 1512-1522 Gene_expression denotes expression
T11240 1512-1522 Gene_expression denotes expression
T11241 1527-1537 Negative_regulation denotes attenuated
T11242 1542-1553 Binding denotes interaction
T11243 1557-1563 Protein denotes GATA-3
T11244 1809-1816 Negative_regulation denotes reduced
T11245 1817-1823 Protein denotes GATA-3
T11246 1835-1846 Binding denotes interaction
T11247 1865-1874 Regulation denotes dependent
T11248 1888-1896 Regulation denotes produced
T11249 1904-1912 Negative_regulation denotes decrease
T11250 1916-1922 Protein denotes GATA-3
T11251 1934-1945 Binding denotes association
T11252 2214-2220 Protein denotes GATA-3
T11253 2232-2243 Binding denotes association
T11254 2330-2340 Negative_regulation denotes attenuated
T11255 2341-2352 Binding denotes interaction
T11256 2356-2362 Protein denotes GATA-3
T11257 2578-2584 Regulation denotes affect true
T11258 2594-2606 Localization denotes localization
T11259 2610-2616 Protein denotes GATA-3
T11260 2703-2712 Positive_regulation denotes increased
T11261 2713-2715 Protein denotes GR
T11262 2716-2723 Entity denotes nuclear
T11263 2724-2737 Localization denotes translocation
T11264 2800-2806 Protein denotes GATA-3
T11265 3155-3162 Positive_regulation denotes induced
T11266 3175-3179 Localization denotes loss true
T11267 3183-3190 Entity denotes nuclear
T11268 3191-3197 Protein denotes GATA-3
T11269 3322-3333 Entity denotes cytoplasmic
T11270 3334-3340 Protein denotes GATA-3
T11271 3341-3347 Localization denotes levels
T11272 3353-3361 Positive_regulation denotes enhanced
T19698 3738-3745 Negative_regulation denotes impairs
T19699 3746-3752 Protein denotes GATA-3
T19700 3753-3760 Entity denotes nuclear
T19701 3761-3773 Localization denotes localization
T19702 3871-3873 Protein denotes GR
T19703 3878-3884 Protein denotes GATA-3
T19704 3885-3892 Entity denotes nuclear
T19705 3893-3905 Localization denotes localisation
T19706 3893-3905 Localization denotes localisation
T19707 3919-3925 Protein denotes GATA-3
T19708 4271-4280 Regulation denotes dependent
T19709 4271-4280 Regulation denotes dependent
T19710 4281-4289 Negative_regulation denotes decrease
T19711 4293-4300 Entity denotes nuclear
T19712 4301-4311 Localization denotes expression
T19713 4315-4321 Protein denotes GATA-3
T19714 4327-4336 Positive_regulation denotes increased
T19715 4337-4348 Entity denotes cytoplasmic
T19716 4349-4355 Protein denotes GATA-3
T19717 4356-4366 Localization denotes expression
T19718 4458-4466 Negative_regulation denotes decrease
T19719 4470-4477 Entity denotes nuclear
T19720 4478-4488 Localization denotes expression
T19721 4492-4498 Protein denotes GATA-3
T19722 4514-4525 Entity denotes cytoplasmic
T19723 4526-4532 Protein denotes GATA-3
T19724 4533-4543 Localization denotes expression
T19725 4587-4592 Protein denotes MEK-1
T11224 4-14 Negative_regulation denotes Inhibitory
T11225 44-50 Protein denotes GATA-3
T11226 51-58 Entity denotes Nuclear
T11227 59-71 Localization denotes Localization
T11228 172-181 Regulation denotes dependent
T11229 182-190 Negative_regulation denotes decrease
T11230 205-216 Binding denotes interaction
T11231 225-232 Phosphorylation denotes phospho
T11232 233-239 Protein denotes GATA-3
T11233 334-343 Negative_regulation denotes inhibited
T11234 412-422 Negative_regulation denotes attenuated
T11273 3386-3395 Regulation denotes dependent
T11274 5198-5205 Negative_regulation denotes reduces
T11275 5206-5213 Entity denotes nuclear
T11276 5214-5226 Localization denotes localization
T11277 5230-5236 Protein denotes GATA-3
T11278 5256-5266 Negative_regulation denotes inhibiting
T11279 5275-5281 Protein denotes GATA-3
T11280 5291-5302 Binding denotes association
T11281 5429-5437 Positive_regulation denotes mediated
T11282 5438-5444 Protein denotes GATA-3
T11283 5445-5460 Phosphorylation denotes phosphorylation
T11284 5471-5480 Gene_expression denotes induction
T11285 5484-5489 Protein denotes MKP-1
T11286 5532-5539 Regulation denotes effects
T11287 5563-5574 Negative_regulation denotes suppression
T11288 5578-5584 Protein denotes GATA-3
T11289 5585-5592 Entity denotes nuclear
T11290 5593-5599 Localization denotes import
T19273 543-550 Negative_regulation denotes impairs
T19274 543-550 Negative_regulation denotes impairs
T19275 551-557 Protein denotes GATA-3
T19276 558-569 Binding denotes interaction
T19277 590-596 Protein denotes GATA-3
T19278 597-604 Entity denotes nuclear
T19279 605-617 Localization denotes localization
T19280 763-771 Negative_regulation denotes impaired
T19281 772-783 Binding denotes interaction
T19282 792-798 Protein denotes GATA-3
T19283 1143-1152 Negative_regulation denotes decreased
T19284 1153-1164 Binding denotes association
T19285 1173-1179 Protein denotes GATA-3
R9623 T11262 T11263 locationOf nuclear,translocation
R9624 T11263 T11260 themeOf translocation,increased
R9625 T11266 T11265 themeOf loss,induced
R9626 T11267 T11266 locationOf nuclear,loss
R9627 T11268 T11266 themeOf GATA-3,loss
R9628 T11269 T11271 locationOf cytoplasmic,levels
R9629 T11270 T11271 themeOf GATA-3,levels
R9630 T11271 T11272 themeOf levels,enhanced
R9631 T11272 T11273 themeOf enhanced,dependent
R9632 T11275 T11276 locationOf nuclear,localization
R9633 T11276 T11274 themeOf localization,reduces
R9634 T11277 T11276 themeOf GATA-3,localization
R9635 T11278 T11274 causeOf inhibiting,reduces
R9636 T11279 T11280 themeOf GATA-3,association
R9637 T11280 T11278 themeOf association,inhibiting
R9638 T11282 T11283 themeOf GATA-3,phosphorylation
R9639 T11283 T11281 themeOf phosphorylation,mediated
R9640 T11285 T11284 themeOf MKP-1,induction
R9641 T11287 T11286 themeOf suppression,effects
R9642 T11288 T11290 themeOf GATA-3,import
R9643 T11289 T11290 locationOf nuclear,import
R9644 T11290 T11287 themeOf import,suppression
R16816 T19699 T19701 themeOf GATA-3,localization
R16817 T19700 T19701 locationOf nuclear,localization
R16818 T19701 T19698 themeOf localization,impairs
R16819 T19702 T19705 themeOf GR,localisation
R16820 T19703 T19706 themeOf GATA-3,localisation
R16821 T19704 T19705 locationOf nuclear,localisation
R16822 T19704 T19706 locationOf nuclear,localisation
R16823 T19710 T19708 themeOf decrease,dependent
R16824 T19711 T19712 locationOf nuclear,expression
R16825 T19712 T19710 themeOf expression,decrease
R16826 T19713 T19712 themeOf GATA-3,expression
R16827 T19714 T19709 themeOf increased,dependent
R16828 T19715 T19717 locationOf cytoplasmic,expression
R16829 T19716 T19717 themeOf GATA-3,expression
R16830 T19717 T19714 themeOf expression,increased
R16831 T19719 T19720 locationOf nuclear,expression
R16832 T19720 T19718 themeOf expression,decrease
R16833 T19721 T19720 themeOf GATA-3,expression
R16834 T19722 T19724 locationOf cytoplasmic,expression
R16835 T19723 T19724 themeOf GATA-3,expression
R9596 T11225 T11227 themeOf GATA-3,Localization
R9597 T11226 T11227 locationOf Nuclear,Localization
R9598 T11227 T11224 themeOf Localization,Inhibitory
R9599 T11229 T11228 themeOf decrease,dependent
R9600 T11230 T11229 themeOf interaction,decrease
R9601 T11230 T11233 themeOf interaction,inhibited
R9602 T11230 T11234 themeOf interaction,attenuated
R9603 T11232 T11230 themeOf GATA-3,interaction
R9604 T11232 T11231 themeOf GATA-3,phospho
R9605 T11237 T11240 themeOf IL-4,expression
R9606 T11238 T11239 themeOf -5,expression
R9607 T11239 T11235 themeOf expression,suppresses
R9608 T11240 T11236 themeOf expression,suppresses
R9609 T11242 T11241 themeOf interaction,attenuated
R9610 T11243 T11242 themeOf GATA-3,interaction
R9611 T11244 T11247 themeOf reduced,dependent
R9612 T11245 T11246 themeOf GATA-3,interaction
R9613 T11246 T11244 themeOf interaction,reduced
R9614 T11249 T11248 themeOf decrease,produced
R9615 T11250 T11251 themeOf GATA-3,association
R9616 T11251 T11249 themeOf association,decrease
R9617 T11252 T11253 themeOf GATA-3,association
R9618 T11255 T11254 themeOf interaction,attenuated
R9619 T11256 T11255 themeOf GATA-3,interaction
R9620 T11258 T11257 themeOf localization,affect
R9621 T11259 T11258 themeOf GATA-3,localization
R9622 T11261 T11263 themeOf GR,translocation
R16449 T19275 T19276 themeOf GATA-3,interaction
R16450 T19276 T19273 themeOf interaction,impairs
R16451 T19277 T19279 themeOf GATA-3,localization
R16452 T19278 T19279 locationOf nuclear,localization
R16453 T19279 T19274 themeOf localization,impairs
R16454 T19281 T19280 themeOf interaction,impaired
R16455 T19282 T19281 themeOf GATA-3,interaction
R16456 T19284 T19283 themeOf association,decreased
R16457 T19285 T19284 themeOf GATA-3,association

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T11896 44-50 P23771 denotes GATA-3
T11897 233-239 P23771 denotes GATA-3
T11898 1495-1499 P05112 denotes IL-4
T11899 1557-1563 P23771 denotes GATA-3
T11900 1817-1823 P23771 denotes GATA-3
T11901 1916-1922 P23771 denotes GATA-3
T11902 2214-2220 P23771 denotes GATA-3
T11903 2356-2362 P23771 denotes GATA-3
T11904 2610-2616 P23771 denotes GATA-3
T11905 2713-2715 P04150 denotes GR
T11906 2800-2806 P23771 denotes GATA-3
T11907 3191-3197 P23771 denotes GATA-3
T11908 3334-3340 P23771 denotes GATA-3
T11909 3562-3565 O15264 denotes p38
T11910 3562-3565 Q16539 denotes p38
T11911 3562-3565 Q15759 denotes p38
T11912 3562-3565 P53778 denotes p38
T11913 5230-5236 P23771 denotes GATA-3
T11914 5275-5281 P23771 denotes GATA-3
T11915 5420-5423 Q16539 denotes p38
T11916 5420-5423 P53778 denotes p38
T11917 5420-5423 Q15759 denotes p38
T11918 5420-5423 O15264 denotes p38
T11919 5438-5444 P23771 denotes GATA-3
T11920 5484-5489 P28562 denotes MKP-1
T11921 5578-5584 P23771 denotes GATA-3
T19426 551-557 P23771 denotes GATA-3
T19427 590-596 P23771 denotes GATA-3
T19428 792-798 P23771 denotes GATA-3
T19429 1173-1179 P23771 denotes GATA-3
T19970 3746-3752 P23771 denotes GATA-3
T19971 3871-3873 P04150 denotes GR
T19972 3878-3884 P23771 denotes GATA-3
T19973 3919-3925 P23771 denotes GATA-3
T19974 4315-4321 P23771 denotes GATA-3
T19975 4349-4355 P23771 denotes GATA-3
T19976 4492-4498 P23771 denotes GATA-3
T19977 4526-4532 P23771 denotes GATA-3
T19978 4587-4592 Q02750 denotes MEK-1
T19979 5027-5030 Q16539 denotes p38
T19980 5027-5030 Q15759 denotes p38
T19981 5027-5030 P53778 denotes p38
T19982 5027-5030 O15264 denotes p38

test2

Id Subject Object Predicate Lexical cue Negation Speculation
T11160 15-21 Regulation denotes Effect
T11161 44-50 Protein denotes GATA-3
T11162 51-58 Entity denotes Nuclear
T11163 59-71 Localization denotes Localization
T11164 172-181 Regulation denotes dependent
T11165 182-190 Negative_regulation denotes decrease
T11166 205-216 Binding denotes interaction
T11167 225-232 Phosphorylation denotes phospho
T11168 233-239 Protein denotes GATA-3
T11169 334-343 Negative_regulation denotes inhibited
T11170 412-422 Negative_regulation denotes attenuated
T11171 1484-1494 Negative_regulation denotes suppresses
T11172 1495-1499 Protein denotes IL-4
T11173 1504-1506 Protein denotes -5
T11174 1512-1522 Gene_expression denotes expression
T11175 1527-1537 Negative_regulation denotes attenuated
T11176 1542-1553 Binding denotes interaction
T11177 1557-1563 Protein denotes GATA-3
T11178 1809-1816 Negative_regulation denotes reduced
T11179 1817-1823 Protein denotes GATA-3
T11180 1835-1846 Binding denotes interaction
T11181 1865-1874 Regulation denotes dependent
T11182 1904-1912 Negative_regulation denotes decrease
T11183 1916-1922 Protein denotes GATA-3 true
T11184 1934-1945 Binding denotes association
T11185 2214-2220 Protein denotes GATA-3
T11186 2232-2243 Binding denotes association
T11187 2330-2340 Negative_regulation denotes attenuated
T11188 2341-2352 Binding denotes interaction true
T11189 2356-2362 Protein denotes GATA-3
T11190 2439-2447 Negative_regulation denotes decrease
T11191 2578-2584 Regulation denotes affect
T11192 2594-2606 Localization denotes localization
T11193 2610-2616 Protein denotes GATA-3
T11194 2703-2712 Positive_regulation denotes increased
T11195 2713-2715 Protein denotes GR
T11196 2716-2723 Entity denotes nuclear
T11197 2724-2737 Localization denotes translocation
T11198 2800-2806 Protein denotes GATA-3
T11199 3155-3162 Positive_regulation denotes induced
T11200 3175-3179 Negative_regulation denotes loss
T11201 3191-3197 Protein denotes GATA-3
T11202 3334-3340 Protein denotes GATA-3
T11203 3353-3361 Positive_regulation denotes enhanced
T11204 5198-5205 Negative_regulation denotes reduces
T11205 5206-5213 Entity denotes nuclear
T11206 5214-5226 Localization denotes localization
T11207 5230-5236 Protein denotes GATA-3
T11208 5256-5266 Negative_regulation denotes inhibiting
T11209 5267-5274 Phosphorylation denotes phospho
T11210 5275-5281 Protein denotes GATA-3
T11211 5291-5302 Binding denotes association
T11212 5410-5416 Regulation denotes effect
T11213 5429-5437 Positive_regulation denotes mediated
T11214 5438-5444 Protein denotes GATA-3
T11215 5445-5460 Phosphorylation denotes phosphorylation
T11216 5471-5480 Positive_regulation denotes induction
T11217 5484-5489 Protein denotes MKP-1
T11218 5563-5574 Negative_regulation denotes suppression
T11219 5578-5584 Protein denotes GATA-3
T11220 5585-5592 Entity denotes nuclear
T11221 5593-5599 Localization denotes import
T19261 543-550 Negative_regulation denotes impairs
T19262 551-557 Protein denotes GATA-3
T19263 558-569 Binding denotes interaction
T19264 590-596 Protein denotes GATA-3
T19265 597-604 Entity denotes nuclear
T19266 605-617 Localization denotes localization
T19267 763-771 Negative_regulation denotes impaired
T19268 772-783 Binding denotes interaction
T19269 792-798 Protein denotes GATA-3
T19270 1143-1152 Negative_regulation denotes decreased
T19271 1153-1164 Binding denotes association
T19272 1173-1179 Protein denotes GATA-3
T19670 3738-3745 Negative_regulation denotes impairs
T19671 3746-3752 Protein denotes GATA-3
T19672 3753-3760 Entity denotes nuclear
T19673 3761-3773 Localization denotes localization
T19674 3871-3873 Protein denotes GR
T19675 3878-3884 Protein denotes GATA-3
T19676 3885-3892 Entity denotes nuclear
T19677 3893-3905 Localization denotes localisation
T19678 3919-3925 Protein denotes GATA-3
T19679 4271-4280 Regulation denotes dependent
T19680 4281-4289 Negative_regulation denotes decrease
T19681 4293-4300 Entity denotes nuclear
T19682 4301-4311 Gene_expression denotes expression
T19683 4315-4321 Protein denotes GATA-3
T19684 4327-4336 Positive_regulation denotes increased
T19685 4337-4348 Entity denotes cytoplasmic
T19686 4349-4355 Protein denotes GATA-3
T19687 4356-4366 Gene_expression denotes expression
T19688 4448-4457 Regulation denotes dependent
T19689 4458-4466 Negative_regulation denotes decrease
T19690 4470-4477 Entity denotes nuclear
T19691 4478-4488 Gene_expression denotes expression
T19692 4492-4498 Protein denotes GATA-3
T19693 4504-4513 Positive_regulation denotes increased
T19694 4514-4525 Entity denotes cytoplasmic
T19695 4526-4532 Protein denotes GATA-3
T19696 4533-4543 Gene_expression denotes expression
T19697 4587-4592 Protein denotes MEK-1
R9548 T11161 T11163 themeOf GATA-3,Localization
R9549 T11162 T11163 locationOf Nuclear,Localization
R9550 T11163 T11160 themeOf Localization,Effect
R9551 T11166 T11165 themeOf interaction,decrease
R9552 T11166 T11170 themeOf interaction,attenuated
R9553 T11166 T11169 themeOf interaction,inhibited
R9554 T11167 T11170 themeOf phospho,attenuated
R9555 T11167 T11169 themeOf phospho,inhibited
R9556 T11168 T11166 themeOf GATA-3,interaction
R9557 T11168 T11167 themeOf GATA-3,phospho
R9558 T11172 T11174 themeOf IL-4,expression
R9559 T11173 T11174 themeOf -5,expression
R9560 T11174 T11171 themeOf expression,suppresses
R9561 T11176 T11175 themeOf interaction,attenuated
R9562 T11177 T11176 themeOf GATA-3,interaction
R9563 T11178 T11181 themeOf reduced,dependent
R9564 T11179 T11180 themeOf GATA-3,interaction
R9565 T11180 T11178 themeOf interaction,reduced
R9566 T11183 T11184 themeOf GATA-3,association
R9567 T11184 T11182 themeOf association,decrease
R9568 T11185 T11186 themeOf GATA-3,association
R9569 T11187 T11190 themeOf attenuated,decrease
R9570 T11188 T11187 themeOf interaction,attenuated
R9571 T11188 T11190 themeOf interaction,decrease
R9572 T11189 T11188 themeOf GATA-3,interaction
R9573 T11192 T11191 themeOf localization,affect
R9574 T11193 T11192 themeOf GATA-3,localization
R9575 T11195 T11197 themeOf GR,translocation
R9576 T11196 T11197 locationOf nuclear,translocation
R9577 T11197 T11194 themeOf translocation,increased
R9578 T11200 T11199 themeOf loss,induced
R9579 T11200 T11203 themeOf loss,enhanced
R9580 T11201 T11200 themeOf GATA-3,loss
R9581 T11202 T11203 themeOf GATA-3,enhanced
R9582 T11202 T11200 themeOf GATA-3,loss
R9583 T11205 T11206 locationOf nuclear,localization
R9584 T11206 T11204 themeOf localization,reduces
R9585 T11207 T11206 themeOf GATA-3,localization
R9586 T11208 T11204 causeOf inhibiting,reduces
R9587 T11209 T11208 themeOf phospho,inhibiting
R9588 T11210 T11211 themeOf GATA-3,association
R9589 T11211 T11208 themeOf association,inhibiting
R9590 T11214 T11215 themeOf GATA-3,phosphorylation
R9591 T11215 T11213 themeOf phosphorylation,mediated
R9592 T11217 T11216 themeOf MKP-1,induction
R9593 T11219 T11221 themeOf GATA-3,import
R9594 T11220 T11221 locationOf nuclear,import
R9595 T11221 T11218 themeOf import,suppression
R16440 T19262 T19263 themeOf GATA-3,interaction
R16441 T19263 T19261 themeOf interaction,impairs
R16442 T19264 T19266 themeOf GATA-3,localization
R16443 T19265 T19266 locationOf nuclear,localization
R16444 T19266 T19261 themeOf localization,impairs
R16445 T19268 T19267 themeOf interaction,impaired
R16446 T19269 T19268 themeOf GATA-3,interaction
R16447 T19271 T19270 themeOf association,decreased
R16448 T19272 T19271 themeOf GATA-3,association
R16798 T19671 T19673 themeOf GATA-3,localization
R16799 T19672 T19673 locationOf nuclear,localization
R16800 T19673 T19670 themeOf localization,impairs
R16801 T19674 T19677 themeOf GR,localisation
R16802 T19675 T19677 themeOf GATA-3,localisation
R16803 T19676 T19677 locationOf nuclear,localisation
R16804 T19681 T19682 locationOf nuclear,expression
R16809 T19687 T19684 themeOf expression,increased
R16805 T19682 T19680 themeOf expression,decrease
R16806 T19683 T19682 themeOf GATA-3,expression
R16807 T19685 T19687 locationOf cytoplasmic,expression
R16808 T19686 T19687 themeOf GATA-3,expression
R16810 T19690 T19691 locationOf nuclear,expression
R16811 T19691 T19689 themeOf expression,decrease
R16812 T19692 T19691 themeOf GATA-3,expression
R16813 T19694 T19696 locationOf cytoplasmic,expression
R16814 T19695 T19696 themeOf GATA-3,expression
R16815 T19696 T19693 themeOf expression,increased